{
 "instance": {
  "f20f2021_nanodimen.htm": {
   "axisCustom": 8,
   "axisStandard": 28,
   "contextCount": 357,
   "dts": {
    "calculationLink": {
     "local": [
      "nndm-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "nndm-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "f20f2021_nanodimen.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nndm-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nndm-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nndm-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd"
     ]
    }
   },
   "elementCount": 975,
   "entityCount": 1,
   "hidden": {
    "http://www.Nanodimensionltd.com/20211231": 118,
    "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 97,
    "http://xbrl.sec.gov/dei/2021q4": 6,
    "total": 221
   },
   "keyCustom": 323,
   "keyStandard": 288,
   "memberCustom": 78,
   "memberStandard": 35,
   "nsprefix": "nndm",
   "nsuri": "http://www.Nanodimensionltd.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Trade Receivables and Other Receivables",
     "role": "http://www.Nanodimensionltd.com/role/TradeReceivablesandOtherReceivables",
     "shortName": "Trade Receivables and Other Receivables",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c287",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nndm:ShareOptionProgramsOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "099 - Disclosure - Share-Based Payment (Details) - Schedule of fair value of the share options",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0",
     "shortName": "Share-Based Payment (Details) - Schedule of fair value of the share options",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c286",
      "decimals": "INF",
      "lang": null,
      "name": "nndm:ShareOptionProgramsOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c292",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:NumberOfShareOptionsGrantedOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100 - Disclosure - Share-Based Payment (Details) - Schedule of fair value of the share options",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable00",
     "shortName": "Share-Based Payment (Details) - Schedule of fair value of the share options",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c291",
      "decimals": "0",
      "lang": null,
      "name": "nndm:NumberOfShareOptionsGrantedOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c133",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired",
      "reportCount": 1,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "101 - Disclosure - Financial Instruments (Details)",
     "role": "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails",
     "shortName": "Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "lang": null,
      "name": "nndm:ContingentConsiderationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfCashTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "102 - Disclosure - Financial Instruments (Details) - Schedule of classification and linkage terms of financial instruments",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable",
     "shortName": "Financial Instruments (Details) - Schedule of classification and linkage terms of financial instruments",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfClassificationAndLinkageTermsOfFinancialInstrumentsExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "lang": null,
      "name": "nndm:BankDeposits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfSensitivityAnalysisOfChangesInExchangeRateOfDollarExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c315",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "103 - Disclosure - Financial Instruments (Details) - Schedule of sensitivity analysis of changes in exchange rate of dollar",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable",
     "shortName": "Financial Instruments (Details) - Schedule of sensitivity analysis of changes in exchange rate of dollar",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfSensitivityAnalysisOfChangesInExchangeRateOfDollarExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c315",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfFinancialInstrumentsPositionExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:LiabilityInRespectOfWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "104 - Disclosure - Financial Instruments (Details) - Schedule of fair value of financial instruments position",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoffinancialinstrumentspositionTable",
     "shortName": "Financial Instruments (Details) - Schedule of fair value of financial instruments position",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfFinancialInstrumentsPositionExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:LiabilityInRespectOfWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfLevel3FinancialInstrumentsCarriedAtFairValueExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:FinancialInstrumentsCarriedAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "105 - Disclosure - Financial Instruments (Details) - Schedule of Level 3 financial instruments carried at fair value",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofLevel3financialinstrumentscarriedatfairvalueTable",
     "shortName": "Financial Instruments (Details) - Schedule of Level 3 financial instruments carried at fair value",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfLevel3FinancialInstrumentsCarriedAtFairValueExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:FinancialInstrumentsCarriedAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfRepaymentDatesOfFinancialLiabilitiesExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "106 - Disclosure - Financial Instruments (Details) - Schedule of repayment dates of financial liabilities",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable",
     "shortName": "Financial Instruments (Details) - Schedule of repayment dates of financial liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfRepaymentDatesOfFinancialLiabilitiesExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NoncurrentLeaseLiabilities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "107 - Disclosure - Leases (Details)",
     "role": "http://www.Nanodimensionltd.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfRestrictionsOnDistributionOfRevaluationSurplusToShareholdersRightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c334",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RightofuseAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "108 - Disclosure - Leases (Details) - Schedule of lease liability and right of use asset",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable",
     "shortName": "Leases (Details) - Schedule of lease liability and right of use asset",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c328",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:RightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Inventory",
     "role": "http://www.Nanodimensionltd.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "109 - Disclosure - Leases (Details) - Schedule of maturity analysis of the group's lease liabilities",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofmaturityanalysisofthegroupsleaseliabilitiesTable",
     "shortName": "Leases (Details) - Schedule of maturity analysis of the group's lease liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LeaseLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:ShareBasedPaymentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110 - Disclosure - Transactions and balances with related parties (Details)",
     "role": "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails",
     "shortName": "Transactions and balances with related parties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:ShareBasedPaymentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfBalancesWithRelatedParty",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c354",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherPayables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111 - Disclosure - Transactions and balances with related parties (Details) - Schedule of balances with related parties",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofbalanceswithrelatedpartiesTable",
     "shortName": "Transactions and balances with related parties (Details) - Schedule of balances with related parties",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfBalancesWithRelatedParty",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c354",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherPayables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfControllingShareholderBenefits",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:SalariesAndRelatedExpensesRelatedPartiesEmployedByTheGroup",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "112 - Disclosure - Transactions and balances with related parties (Details) - Schedule of shareholder and other related parties benefits",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofshareholderandotherrelatedpartiesbenefitsTable",
     "shortName": "Transactions and balances with related parties (Details) - Schedule of shareholder and other related parties benefits",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfControllingShareholderBenefits",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:SalariesAndRelatedExpensesRelatedPartiesEmployedByTheGroup",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:ConsiderationFullCashPaidDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "113 - Disclosure - Events after the reporting date (Details)",
     "role": "http://www.Nanodimensionltd.com/role/EventsafterthereportingdateDetails",
     "shortName": "Events after the reporting date (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:ConsiderationFullCashPaidDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Property plant and equipment, net",
     "role": "http://www.Nanodimensionltd.com/role/Propertyplantandequipmentnet",
     "shortName": "Property plant and equipment, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Intangible Assets",
     "role": "http://www.Nanodimensionltd.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Subsidiaries",
     "role": "http://www.Nanodimensionltd.com/role/Subsidiaries",
     "shortName": "Subsidiaries",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Other Payables",
     "role": "http://www.Nanodimensionltd.com/role/OtherPayables",
     "shortName": "Other Payables",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Liability in Respect of Government Grants",
     "role": "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrants",
     "shortName": "Liability in Respect of Government Grants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - Equity",
     "role": "http://www.Nanodimensionltd.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - Revenues",
     "role": "http://www.Nanodimensionltd.com/role/Revenues",
     "shortName": "Revenues",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCostOfSalesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Cost of Revenues",
     "role": "http://www.Nanodimensionltd.com/role/CostofRevenues",
     "shortName": "Cost of Revenues",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCostOfSalesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Consolidated Statements of Financial Position",
     "role": "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
     "shortName": "Consolidated Statements of Financial Position",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfFurtherDetailOfProfitOrLossSectionsExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Further Detail of Profit or Loss",
     "role": "http://www.Nanodimensionltd.com/role/FurtherDetailofProfitorLoss",
     "shortName": "Further Detail of Profit or Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfFurtherDetailOfProfitOrLossSectionsExplanatoryTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - Income Tax",
     "role": "http://www.Nanodimensionltd.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - Loss Per Share",
     "role": "http://www.Nanodimensionltd.com/role/LossPerShare",
     "shortName": "Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Employee Benefits",
     "role": "http://www.Nanodimensionltd.com/role/EmployeeBenefits",
     "shortName": "Employee Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Share-Based Payment",
     "role": "http://www.Nanodimensionltd.com/role/ShareBasedPayment",
     "shortName": "Share-Based Payment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Financial Instruments",
     "role": "http://www.Nanodimensionltd.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Leases",
     "role": "http://www.Nanodimensionltd.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Other long-term liabilities",
     "role": "http://www.Nanodimensionltd.com/role/Otherlongtermliabilities",
     "shortName": "Other long-term liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentLiabilitiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Transactions and balances with related parties",
     "role": "http://www.Nanodimensionltd.com/role/Transactionsandbalanceswithrelatedparties",
     "shortName": "Transactions and balances with related parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - Events after the reporting date",
     "role": "http://www.Nanodimensionltd.com/role/Eventsafterthereportingdate",
     "shortName": "Events after the reporting date",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Income",
     "role": "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement",
     "shortName": "Consolidated Statements of Profit or Loss and Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "nndm:CostOfRevenuesBeforeAmortizationOfIntangible",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - Accounting Policies, by Policy (Policies)",
     "role": "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutExchangeRateExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutExchangeRateExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - Cash (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/CashTables",
     "shortName": "Cash (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - Trade Receivables and Other Receivables (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/TradeReceivablesandOtherReceivablesTables",
     "shortName": "Trade Receivables and Other Receivables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - Inventory (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "034 - Disclosure - Property plant and equipment, net (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/PropertyplantandequipmentnetTables",
     "shortName": "Property plant and equipment, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "035 - Disclosure - Intangible Assets (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "036 - Disclosure - Subsidiaries (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/SubsidiariesTables",
     "shortName": "Subsidiaries (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutSubsidiariesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutComponentsOfOtherPayablesExplantory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "037 - Disclosure - Other Payables (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/OtherPayablesTables",
     "shortName": "Other Payables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutComponentsOfOtherPayablesExplantory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfComponentsLiabilityInRespectOfGovernmentGrantsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "038 - Disclosure - Liability in Respect of Government Grants (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsTables",
     "shortName": "Liability in Respect of Government Grants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfComponentsLiabilityInRespectOfGovernmentGrantsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c37",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Consolidated Statements of Changes in Equity",
     "role": "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3",
     "shortName": "Consolidated Statements of Changes in Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c37",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutEquityExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "039 - Disclosure - Equity (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutEquityExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfComponentsOfRevenueExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "040 - Disclosure - Revenues (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/RevenuesTables",
     "shortName": "Revenues (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfComponentsOfRevenueExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutCostOfSalesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "041 - Disclosure - Cost of Revenues (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/CostofRevenuesTables",
     "shortName": "Cost of Revenues (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutCostOfSalesExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutComponentsOfExpenseAndIncomeDetailOfProfitOrLossSectionsExplantory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "042 - Disclosure - Further Detail of Profit or Loss (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/FurtherDetailofProfitorLossTables",
     "shortName": "Further Detail of Profit or Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutComponentsOfExpenseAndIncomeDetailOfProfitOrLossSectionsExplantory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutTaxesOnIncomeExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "043 - Disclosure - Income Tax (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/IncomeTaxTables",
     "shortName": "Income Tax (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutTaxesOnIncomeExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutEarningsPerShareExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "044 - Disclosure - Loss Per Share (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/LossPerShareTables",
     "shortName": "Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutEarningsPerShareExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:ScheduleOfCompositionOfEmployeeBenefitsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "045 - Disclosure - Employee Benefits (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/EmployeeBenefitsTables",
     "shortName": "Employee Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:ScheduleOfCompositionOfEmployeeBenefitsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "046 - Disclosure - Share-Based Payment (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/ShareBasedPaymentTables",
     "shortName": "Share-Based Payment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfClassificationAndLinkageTermsOfFinancialInstrumentsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "047 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfClassificationAndLinkageTermsOfFinancialInstrumentsExplanatoryTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "048 - Disclosure - Leases (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfBalancesWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "049 - Disclosure - Transactions and balances with related parties (Tables)",
     "role": "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesTables",
     "shortName": "Transactions and balances with related parties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfBalancesWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:AggregateGrossProceeds",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "050 - Disclosure - General (Details)",
     "role": "http://www.Nanodimensionltd.com/role/GeneralDetails",
     "shortName": "General (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:AggregateGrossProceeds",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DisposalsIntangibleAssetsAndGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "051 - Disclosure - Basis of Preparation (Details)",
     "role": "http://www.Nanodimensionltd.com/role/BasisofPreparationDetails",
     "shortName": "Basis of Preparation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-6",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DisposalsIntangibleAssetsAndGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c49",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:EstimatedUsefulLivesOfCapitalizedDevelopmentCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "052 - Disclosure - Significant Accounting Policies (Details)",
     "role": "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c49",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:EstimatedUsefulLivesOfCapitalizedDevelopmentCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "nndm:DisclosureOfDetailedInformationAboutExchangeRateExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "1",
      "first": true,
      "lang": null,
      "name": "nndm:ConsumerPriceIndex",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "053 - Disclosure - Significant Accounting Policies (Details) - Schedule of details regarding the exchange rate",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofdetailsregardingtheexchangerateTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of details regarding the exchange rate",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "nndm:DisclosureOfDetailedInformationAboutExchangeRateExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c52",
      "decimals": "2",
      "lang": null,
      "name": "nndm:ExchangeRateOfCHF",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "nndm:DisclosureOfDetailedInformationAboutDepreciationRatesUsefulLifeSpanAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c55",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "nndm:DepreciationRatesUsefulLifeSpanOfAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "054 - Disclosure - Significant Accounting Policies (Details) - Schedule of property plant and equipment, useful life span of the assets",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of property plant and equipment, useful life span of the assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "nndm:DisclosureOfDetailedInformationAboutDepreciationRatesUsefulLifeSpanAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c55",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "nndm:DepreciationRatesUsefulLifeSpanOfAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "nndm:ScheduleOfEstimatedUsefulLivesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c65",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "nndm:EstimatedUsefulLives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "055 - Disclosure - Significant Accounting Policies (Details) - Schedule of estimated useful lives",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable",
     "shortName": "Significant Accounting Policies (Details) - Schedule of estimated useful lives",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "nndm:ScheduleOfEstimatedUsefulLivesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c65",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "nndm:EstimatedUsefulLives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:RestrictedDeposits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "056 - Disclosure - Cash (Details)",
     "role": "http://www.Nanodimensionltd.com/role/CashDetails",
     "shortName": "Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:OtherCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfCashTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:BankAccountsOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "057 - Disclosure - Cash (Details) - Schedule of components of cash",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable",
     "shortName": "Cash (Details) - Schedule of components of cash",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfCashTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:BankAccountsOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:NetTrustForEarnout",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "058 - Disclosure - Trade Receivables and Other Receivables (Details)",
     "role": "http://www.Nanodimensionltd.com/role/TradeReceivablesandOtherReceivablesDetails",
     "shortName": "Trade Receivables and Other Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:NetTrustForEarnout",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralHedgeAccountingExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "005 - Disclosure - General",
     "role": "http://www.Nanodimensionltd.com/role/General",
     "shortName": "General",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfGeneralHedgeAccountingExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:TradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "059 - Disclosure - Trade Receivables and Other Receivables (Details) - Schedule of trade receivables",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleoftradereceivablesTable",
     "shortName": "Trade Receivables and Other Receivables (Details) - Schedule of trade receivables",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:TradeReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:GovernmentAuthorities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060 - Disclosure - Trade Receivables and Other Receivables (Details) - Schedule of other receivables",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofotherreceivablesTable",
     "shortName": "Trade Receivables and Other Receivables (Details) - Schedule of other receivables",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:GovernmentAuthorities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061 - Disclosure - Inventory (Details) - Schedule of inventory",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofinventoryTable",
     "shortName": "Inventory (Details) - Schedule of inventory",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutInventoriesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "062 - Disclosure - Property plant and equipment, net (Details)",
     "role": "http://www.Nanodimensionltd.com/role/PropertyplantandequipmentnetDetails",
     "shortName": "Property plant and equipment, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "063 - Disclosure - Property plant and equipment, net (Details) - Schedule of property plant and equipment, net",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable",
     "shortName": "Property plant and equipment, net (Details) - Schedule of property plant and equipment, net",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:RecoverableAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "064 - Disclosure - Intangible Assets (Details)",
     "role": "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails",
     "shortName": "Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:RecoverableAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:GrossCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "065 - Disclosure - Intangible Assets (Details) - Schedule of movement in carrying amount",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable",
     "shortName": "Intangible Assets (Details) - Schedule of movement in carrying amount",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c31",
      "decimals": "-3",
      "lang": null,
      "name": "nndm:GrossCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c131",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "nndm:OwnsPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "066 - Disclosure - Subsidiaries (Details)",
     "role": "http://www.Nanodimensionltd.com/role/SubsidiariesDetails",
     "shortName": "Subsidiaries (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c131",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "nndm:OwnsPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutSubsidiariesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c144",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "067 - Disclosure - Subsidiaries (Details) - Schedule of group's material subsidiaries",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable",
     "shortName": "Subsidiaries (Details) - Schedule of group's material subsidiaries",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutSubsidiariesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c144",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfAcquisitionDateFairValueOfEachMajorClassOfConsiderationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c164",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "068 - Disclosure - Subsidiaries (Details) - Schedule of acquisition date fair value of each major class of consideration",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable",
     "shortName": "Subsidiaries (Details) - Schedule of acquisition date fair value of each major class of consideration",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfAcquisitionDateFairValueOfEachMajorClassOfConsiderationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c164",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "006 - Disclosure - Basis of Preparation",
     "role": "http://www.Nanodimensionltd.com/role/BasisofPreparation",
     "shortName": "Basis of Preparation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "069 - Disclosure - Subsidiaries (Details) - Schedule of acquisition date fair value of each major class of consideration (Parentheticals)",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable_Parentheticals",
     "shortName": "Subsidiaries (Details) - Schedule of acquisition date fair value of each major class of consideration (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c165",
      "decimals": "INF",
      "lang": null,
      "name": "ifrs-full:NumberOfSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAtTheDateOfAcquisitionTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c164",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070 - Disclosure - Subsidiaries (Details) - Schedule of assets acquired and liabilities assumed at the date of acquisition",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
     "shortName": "Subsidiaries (Details) - Schedule of assets acquired and liabilities assumed at the date of acquisition",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAtTheDateOfAcquisitionTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c164",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "071 - Disclosure - Subsidiaries (Details) - Schedule of cash flows derived for the Group as a result of the acquisition",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable",
     "shortName": "Subsidiaries (Details) - Schedule of cash flows derived for the Group as a result of the acquisition",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutComponentsOfOtherPayablesExplantory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AccrualsClassifiedAsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "072 - Disclosure - Other Payables (Details) - Schedule of other payables",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofotherpayablesTable",
     "shortName": "Other Payables (Details) - Schedule of other payables",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutComponentsOfOtherPayablesExplantory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AccrualsClassifiedAsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:TotalApprovedBudgetForDevelopmentProject",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "073 - Disclosure - Liability in Respect of Government Grants (Details)",
     "role": "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails",
     "shortName": "Liability in Respect of Government Grants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:TotalApprovedBudgetForDevelopmentProject",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfComponentsLiabilityInRespectOfGovernmentGrantsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:GovernmentGrants",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "074 - Disclosure - Liability in Respect of Government Grants (Details) - Schedule of liability in respect of government grants",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofliabilityinrespectofgovernmentgrantsTable",
     "shortName": "Liability in Respect of Government Grants (Details) - Schedule of liability in respect of government grants",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfComponentsLiabilityInRespectOfGovernmentGrantsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:GovernmentGrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IssuedCapital",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "075 - Disclosure - Equity (Details)",
     "role": "http://www.Nanodimensionltd.com/role/EquityDetails",
     "shortName": "Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c3",
      "decimals": "0",
      "lang": null,
      "name": "nndm:RemainingFinancialLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutEquityExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:IssuedAndPaidUpShareCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "076 - Disclosure - Equity (Details) - Schedule of share capital",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofsharecapitalTable",
     "shortName": "Equity (Details) - Schedule of share capital",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutEquityExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:IssuedAndPaidUpShareCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutIssuedShareCapitalExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:OrdinarySharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "077 - Disclosure - Equity (Details) - Schedule of issued share capital",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofissuedsharecapitalTable",
     "shortName": "Equity (Details) - Schedule of issued share capital",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutIssuedShareCapitalExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:OrdinarySharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfComponentsOfRevenueExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyDevelopmentAndProjectManagementExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "078 - Disclosure - Revenues (Details) - Schedule of revenue",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable",
     "shortName": "Revenues (Details) - Schedule of revenue",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfComponentsOfRevenueExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyDevelopmentAndProjectManagementExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - Significant Accounting Policies",
     "role": "http://www.Nanodimensionltd.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "079 - Disclosure - Revenues (Details) - Schedule of revenues per geographical locations",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofrevenuespergeographicallocationsTable",
     "shortName": "Revenues (Details) - Schedule of revenues per geographical locations",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c205",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "080 - Disclosure - Revenues (Details) - Schedule of timing of revenue recognition",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleoftimingofrevenuerecognitionTable",
     "shortName": "Revenues (Details) - Schedule of timing of revenue recognition",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutTimingOfRevenueRecognitionTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c214",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutDerivingFromContractsWithCustomers",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "081 - Disclosure - Revenues (Details) - Schedule of contract assets and contract liabilities deriving from contracts with customers",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofcontractassetsandcontractliabilitiesderivingfromcontractswithcustomersTable",
     "shortName": "Revenues (Details) - Schedule of contract assets and contract liabilities deriving from contracts with customers",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutDerivingFromContractsWithCustomers",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutCostOfSalesExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RawMaterialsAndConsumablesUsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "082 - Disclosure - Cost of Revenues (Details) - Schedule of cost of revenues",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofcostofrevenuesTable",
     "shortName": "Cost of Revenues (Details) - Schedule of cost of revenues",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutCostOfSalesExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RawMaterialsAndConsumablesUsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutComponentsOfExpenseAndIncomeDetailOfProfitOrLossSectionsExplantory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:PayrollExpenseRelatedToResearchAndDevelopmentExpensesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "083 - Disclosure - Further Detail of Profit or Loss (Details) - Schedule of further detail of profit or loss",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable",
     "shortName": "Further Detail of Profit or Loss (Details) - Schedule of further detail of profit or loss",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutComponentsOfExpenseAndIncomeDetailOfProfitOrLossSectionsExplantory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:PayrollExpenseRelatedToResearchAndDevelopmentExpensesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "084 - Disclosure - Income Tax (Details)",
     "role": "http://www.Nanodimensionltd.com/role/IncomeTaxDetails",
     "shortName": "Income Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutTaxesOnIncomeExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "085 - Disclosure - Income Tax (Details) - Schedule of composition of income tax expense (income)",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofincometaxexpenseincomeTable",
     "shortName": "Income Tax (Details) - Schedule of composition of income tax expense (income)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutTaxesOnIncomeExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "086 - Disclosure - Income Tax (Details) - Schedule of movement in deferred tax assets and liabilities",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofmovementindeferredtaxassetsandliabilitiesTable",
     "shortName": "Income Tax (Details) - Schedule of movement in deferred tax assets and liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:EquityReverseStockSplit",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "087 - Disclosure - Loss Per Share (Details)",
     "role": "http://www.Nanodimensionltd.com/role/LossPerShareDetails",
     "shortName": "Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:EquityReverseStockSplit",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutEarningsPerShareExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WeightedAverageShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "088 - Disclosure - Loss Per Share (Details) - Schedule of basic loss per share",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofbasiclosspershareTable",
     "shortName": "Loss Per Share (Details) - Schedule of basic loss per share",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutEarningsPerShareExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WeightedAverageShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfCashAndRestrictedDepositsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - Cash",
     "role": "http://www.Nanodimensionltd.com/role/Cash",
     "shortName": "Cash",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nndm:DisclosureOfCashAndRestrictedDepositsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfWeightedAverageNumberOfOrdinarySharesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nndm:WeightedAverageNumberOfOrdinaryShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "089 - Disclosure - Loss Per Share (Details) - Schedule of weighted average number of ordinary shares",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesTable",
     "shortName": "Loss Per Share (Details) - Schedule of weighted average number of ordinary shares",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfWeightedAverageNumberOfOrdinarySharesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nndm:WeightedAverageNumberOfOrdinaryShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:LossAttributableToOwnersOfTheCompanydilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nndm:LossUsedToCalculateBasicLossPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "090 - Disclosure - Loss Per Share (Details) - Schedule of loss attributable to owners of the company (diluted)",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleoflossattributabletoownersofthecompanydilutedTable",
     "shortName": "Loss Per Share (Details) - Schedule of loss attributable to owners of the company (diluted)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:LossAttributableToOwnersOfTheCompanydilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nndm:LossUsedToCalculateBasicLossPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:WeightedAverageNumberOfOrdinarySharesdilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nndm:WeightedAverageNumberOfOrdinarySharesUsedToCalculateLossPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "091 - Disclosure - Loss Per Share (Details) - Schedule of weighted average number of ordinary shares (diluted)",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesdilutedTable",
     "shortName": "Loss Per Share (Details) - Schedule of weighted average number of ordinary shares (diluted)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:WeightedAverageNumberOfOrdinarySharesdilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "nndm:WeightedAverageNumberOfOrdinarySharesUsedToCalculateLossPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:QualifyingInsurancePoliciesAmountContributedFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "092 - Disclosure - Employee Benefits (Details)",
     "role": "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails",
     "shortName": "Employee Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:QualifyingInsurancePoliciesAmountContributedFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfCompositionOfEmployeeBenefitsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "093 - Disclosure - Employee Benefits (Details) - Schedule of composition of employee benefits",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofemployeebenefitsTable",
     "shortName": "Employee Benefits (Details) - Schedule of composition of employee benefits",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfCompositionOfEmployeeBenefitsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfMovementInNetDefinedBenefitLiabilitiesassetsAndInTheirComponentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:EffectOfMovementsInExchangeRates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "094 - Disclosure - Employee Benefits (Details) - Schedule of movement in net defined benefit liabilities (assets) and in their components",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable",
     "shortName": "Employee Benefits (Details) - Schedule of movement in net defined benefit liabilities (assets) and in their components",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfMovementInNetDefinedBenefitLiabilitiesassetsAndInTheirComponentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:EffectOfMovementsInExchangeRates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfPrincipalActuarialAssumptionsAtTheReportingDateexpressedAsWeightedAveragesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ActuarialAssumptionOfDiscountRates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "095 - Disclosure - Employee Benefits (Details) - Schedule of principal actuarial assumptions at the reporting date (expressed as weighted averages)",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleofprincipalactuarialassumptionsatthereportingdateexpressedasweightedaveragesTable",
     "shortName": "Employee Benefits (Details) - Schedule of principal actuarial assumptions at the reporting date (expressed as weighted averages)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfPrincipalActuarialAssumptionsAtTheReportingDateexpressedAsWeightedAveragesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c2",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ActuarialAssumptionOfDiscountRates",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfTheRelevantActuarialAssumptionsHoldingOtherAssumptionsConstantWouldHaveAffectedTheDefinedBenefitObligationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c236",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:FutureSalaryIncrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "096 - Disclosure - Employee Benefits (Details) - Schedule of the relevant actuarial assumptions, holding other assumptions constant",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantTable",
     "shortName": "Employee Benefits (Details) - Schedule of the relevant actuarial assumptions, holding other assumptions constant",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:ScheduleOfTheRelevantActuarialAssumptionsHoldingOtherAssumptionsConstantWouldHaveAffectedTheDefinedBenefitObligationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c236",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "nndm:FutureSalaryIncrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c344",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:NumberOfGrantedNonTradableShareOptions",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "097 - Disclosure - Share-Based Payment (Details)",
     "role": "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails",
     "shortName": "Share-Based Payment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "nndm:DescriptionOfShareOptionsVestedInSharebasedPaymentArrangement",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c254",
      "decimals": null,
      "lang": "en-US",
      "name": "nndm:DescriptionOfShareOptionsVestedInSharebasedPaymentArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c277",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:EquityInstrumentsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "098 - Disclosure - Share-Based Payment (Details) - Schedule of fair value of the share options",
     "role": "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable",
     "shortName": "Share-Based Payment (Details) - Schedule of fair value of the share options",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "nndm:DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2021_nanodimen.htm",
      "contextRef": "c277",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "nndm:EquityInstrumentsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 123,
   "tag": {
    "country_HK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "HONG KONG",
        "terseLabel": "Hong-Kong [Member]"
       }
      }
     },
     "localname": "HK",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "America [Member]"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenuespergeographicallocationsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United Kingdom, Pounds",
        "terseLabel": "GBP [Member]"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_ILS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Israel, New Shekels",
        "terseLabel": "NIS [Member]"
       }
      }
     },
     "localname": "ILS",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "USD [Member]"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r269",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r269",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r269",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address",
        "terseLabel": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name",
        "terseLabel": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard",
        "terseLabel": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r269",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement",
        "terseLabel": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report",
        "terseLabel": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r269",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ifrs-full_AccountingProfit": {
     "auth_ref": [
      "r60",
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accounting profit",
        "terseLabel": "Profit"
       }
      }
     },
     "localname": "AccountingProfit",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AccrualsClassifiedAsCurrent": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of accruals classified as current. [Refer: Accruals]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accruals classified as current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccrualsClassifiedAsCurrent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AccumulatedOtherComprehensiveIncome": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income",
        "terseLabel": "Accumulated loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "auth_ref": [
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Consideration transferred, acquisition-date fair value",
        "terseLabel": "Total consideration transferred",
        "verboseLabel": "Business combination consideration"
       }
      }
     },
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable",
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": {
     "auth_ref": [
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, intangible assets and goodwill",
        "terseLabel": "Acquisitions through"
       }
      }
     },
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, property, plant and equipment",
        "terseLabel": "Acquisitions through business combinations"
       }
      }
     },
     "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates",
        "terseLabel": "Discount rate as of December 31"
       }
      }
     },
     "localname": "ActuarialAssumptionOfDiscountRates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofprincipalactuarialassumptionsatthereportingdateexpressedasweightedaveragesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected rate of inflation that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of inflation",
        "terseLabel": "Price inflation"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfInflation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofprincipalactuarialassumptionsatthereportingdateexpressedasweightedaveragesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of pension increases",
        "terseLabel": "Future pension growth"
       }
      }
     },
     "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreases",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofprincipalactuarialassumptionsatthereportingdateexpressedasweightedaveragesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions to right-of-use assets",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsToRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "nndm_AdjustmentsForChangesInAssetsAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in inventories",
        "terseLabel": "Decrease (increase) in inventory"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "nndm_AdjustmentsForChangesInAssetsAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade and other receivables",
        "terseLabel": "Decrease in other receivables"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for depreciation and amortisation expense",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForFinanceIncomeCost": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for finance income (cost)",
        "negatedLabel": "Financing expenses (income), net"
       }
      }
     },
     "localname": "AdjustmentsForFinanceIncomeCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss",
        "terseLabel": "Impairment losses"
       }
      }
     },
     "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncomeTaxExpense": {
     "auth_ref": [
      "r149"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for income tax expense",
        "terseLabel": "Income tax"
       }
      }
     },
     "localname": "AdjustmentsForIncomeTaxExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofincometaxexpenseincomeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "nndm_AdjustmentsForChangesInAssetsAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade accounts payable",
        "terseLabel": "Increase (decrease) in trade payables"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "nndm_AdjustmentsForChangesInAssetsAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade and other payables",
        "terseLabel": "Increase in other payables"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLoss": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss)",
        "totalLabel": "Profit loss"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss) [abstract]",
        "terseLabel": "Adjustments:"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "terseLabel": "Share-based payments",
        "verboseLabel": "Replacement of share-based payment awards"
       }
      }
     },
     "localname": "AdjustmentsForSharebasedPayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow",
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "auth_ref": [
      "r28",
      "r83",
      "r192",
      "r201",
      "r202",
      "r223",
      "r236",
      "r237",
      "r252",
      "r253",
      "r255",
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]"
       }
      }
     },
     "localname": "AggregatedTimeBandsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmaturityanalysisofthegroupsleaseliabilitiesTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllLevelsOfFairValueHierarchyMember": {
     "auth_ref": [
      "r81",
      "r181"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "All levels of fair value hierarchy [member]"
       }
      }
     },
     "localname": "AllLevelsOfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amortisation, intangible assets other than goodwill",
        "negatedLabel": "Amortization for the year"
       }
      }
     },
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmountsReceivableRelatedPartyTransactions": {
     "auth_ref": [
      "r97",
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts receivable, related party transactions",
        "terseLabel": "Amount received"
       }
      }
     },
     "localname": "AmountsReceivableRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ApplicableTaxRate": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      },
      "en-us": {
       "role": {
        "label": "Applicable tax rate",
        "terseLabel": "Percentage of corporate tax rates"
       }
      }
     },
     "localname": "ApplicableTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r24",
      "r180",
      "r181",
      "r182",
      "r242",
      "r245"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AverageEffectiveTaxRate": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Average effective tax rate",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "AverageEffectiveTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_BankAndSimilarCharges": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of bank and similar charges recognised by the entity as an expense."
       }
      },
      "en-us": {
       "role": {
        "label": "Bank and similar charges",
        "terseLabel": "Bank fees"
       }
      }
     },
     "localname": "BankAndSimilarCharges",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      },
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share",
        "terseLabel": "Basic loss per share (USD) (in Dollars per share)"
       }
      }
     },
     "localname": "BasicEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BasisForAttributingRevenuesFromExternalCustomersToIndividualCountries": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the basis for attributing revenues from external customers to individual countries. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of basis for attributing revenues from external customers to individual countries",
        "terseLabel": "Description of revenue"
       }
      }
     },
     "localname": "BasisForAttributingRevenuesFromExternalCustomersToIndividualCountries",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_Borrowings": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings",
        "terseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "Borrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r208",
      "r235",
      "r255"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Bottom of range [member]",
        "terseLabel": "Bottom of range [member]",
        "verboseLabel": "Bottom of Range [Member]"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails",
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails",
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails",
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BuildingsMember": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Buildings [member]",
        "netLabel": "Building [Member]",
        "terseLabel": "Buildings [Member]",
        "verboseLabel": "Buildings [member]"
       }
      }
     },
     "localname": "BuildingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable",
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BusinessCombinationsAxis": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Business combinations [axis]"
       }
      }
     },
     "localname": "BusinessCombinationsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_Cash": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r18",
      "r152",
      "r176"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash at end of year",
        "periodStartLabel": "Cash at beginning of the year",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents if different from statement of financial position",
        "terseLabel": "Total cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashEquivalents": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash equivalents",
        "negatedLabel": "Cash and cash equivalents paid"
       }
      }
     },
     "localname": "CashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r136",
      "r153"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "Cash flow from financing activities:"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r136",
      "r153"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "Cash flow from investing activities:"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "terseLabel": "Cash flow from operating activities:"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperations": {
     "auth_ref": [
      "r145",
      "r154"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash from (used in) the entity's operations."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities",
        "negatedLabel": "Acquisition of subsidiary, net of cash acquired"
       }
      }
     },
     "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      }
     },
     "localname": "CategoriesOfRelatedPartiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails",
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/LeasesDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofbalanceswithrelatedpartiesTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable",
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "auth_ref": [
      "r117",
      "r120",
      "r183",
      "r199"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      }
     },
     "localname": "ClassesOfAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "auth_ref": [
      "r117",
      "r183",
      "r199"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets [member]"
       }
      }
     },
     "localname": "ClassesOfAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "auth_ref": [
      "r226",
      "r228",
      "r230",
      "r232"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails",
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialInstrumentsMember": {
     "auth_ref": [
      "r226",
      "r228",
      "r230",
      "r232"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial instruments, class [member]"
       }
      }
     },
     "localname": "ClassesOfFinancialInstrumentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails",
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets and goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementindeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfInventoriesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory [Abstract]"
       }
      }
     },
     "localname": "ClassesOfInventoriesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfOrdinarySharesAxis": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of ordinary shares [axis]"
       }
      }
     },
     "localname": "ClassesOfOrdinarySharesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      }
     },
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable",
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share capital [member]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails",
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3",
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r4",
      "r43",
      "r157",
      "r159",
      "r168",
      "r173"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "totalLabel": "Total comprehensive loss for the year"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r4",
      "r45"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to non-controlling interests",
        "negatedLabel": "Comprehensive loss attributable to Non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "auth_ref": [
      "r4",
      "r46"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to owners of parent",
        "totalLabel": "Comprehensive loss attributable to Owners of the Company"
       }
      }
     },
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ConcentrationsOfRiskAxis": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Concentrations of risk [axis]"
       }
      }
     },
     "localname": "ConcentrationsOfRiskAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ConsiderationPaidReceived": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Consideration paid (received)",
        "terseLabel": "Consideration received, net",
        "verboseLabel": "Consideration of warrants issued (in Dollars)"
       }
      }
     },
     "localname": "ConsiderationPaidReceived",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r213"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Contingent consideration recognised as of acquisition date",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContractLiabilities": {
     "auth_ref": [
      "r187",
      "r191"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of an entity\u2019s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer."
       }
      },
      "en-us": {
       "role": {
        "label": "Contract liabilities",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CostOfSales": {
     "auth_ref": [
      "r2",
      "r53"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "totalLabel": "Total cost of revenues"
       }
      }
     },
     "localname": "CostOfSales",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssets": {
     "auth_ref": [
      "r29",
      "r168",
      "r169"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "CurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentContractLiabilities": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current contract liabilities. [Refer: Contract liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current contract liabilities",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "CurrentContractLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcontractassetsandcontractliabilitiesderivingfromcontractswithcustomersTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentDerivativeFinancialLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current derivative financial liabilities",
        "terseLabel": "Financial derivatives"
       }
      }
     },
     "localname": "CurrentDerivativeFinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentGovernmentGrants": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current government grants",
        "terseLabel": "Current maturities in respect of government grants"
       }
      }
     },
     "localname": "CurrentGovernmentGrants",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofliabilityinrespectofgovernmentgrantsTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r196"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "negatedLabel": "Lease liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilities": {
     "auth_ref": [
      "r31",
      "r168",
      "r171"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepaid expenses",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "CurrentPrepaidExpenses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofotherreceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current prepayments and other current assets",
        "terseLabel": "Prepaid expenses and other receivables"
       }
      }
     },
     "localname": "CurrentPrepaymentsAndOtherCurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentProvisionsForEmployeeBenefits": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current provisions for employee benefits",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "CurrentProvisionsForEmployeeBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current tax expense (income)",
        "terseLabel": "Current tax expense"
       }
      }
     },
     "localname": "CurrentTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofincometaxexpenseincomeTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTradeReceivables": {
     "auth_ref": [
      "r30",
      "r33"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade receivables",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "CurrentTradeReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CustomerrelatedIntangibleAssetsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for customer-related intangible assets acquired in a business combination. [Refer: Customer-related intangible assets [member]; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Customer-related intangible assets recognised as of acquisition date",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerrelatedIntangibleAssetsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxAssets": {
     "auth_ref": [
      "r21",
      "r25",
      "r63"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax assets",
        "terseLabel": "Deferred tax"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income)",
        "terseLabel": "Deferred tax income",
        "verboseLabel": "Changes recognized in profit or loss"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofincometaxexpenseincomeTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementindeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax [Abstract]"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncomeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "auth_ref": [
      "r21",
      "r25",
      "r63"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities",
        "negatedLabel": "Deferred taxes",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Deferred tax liability (asset)",
        "periodEndLabel": "Balance of deferred tax asset (liability) as at December 31, 2021",
        "periodStartLabel": "Balance of deferred tax asset (liability) as at January 1, 2021",
        "terseLabel": "Deferred payment",
        "verboseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredTaxLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementindeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DefinedBenefitObligationAtPresentValue": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]"
       }
      },
      "en-us": {
       "role": {
        "label": "Defined benefit obligation, at present value",
        "terseLabel": "Increase defined benefit obligation (in Dollars)"
       }
      }
     },
     "localname": "DefinedBenefitObligationAtPresentValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationExpense": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DerivativeFinancialLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Derivative financial liabilities",
        "terseLabel": "Financial derivatives"
       }
      }
     },
     "localname": "DerivativeFinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DerivativesAmountContributedToFairValueOfPlanAssets": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount derivatives contribute to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [member]; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Derivatives, amount contributed to fair value of plan assets",
        "terseLabel": "Fair value amount"
       }
      }
     },
     "localname": "DerivativesAmountContributedToFairValueOfPlanAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for earnings per share [text block]",
        "terseLabel": "Loss per share"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for employee benefits [text block]",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for finance income and costs. [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for finance income and costs [text block]",
        "terseLabel": "Financing income and expenses"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for financial instruments. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for financial instruments [text block]",
        "terseLabel": "Basis of consolidation"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for the currency of the primary economic environment in which the entity operates."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for functional currency [text block]",
        "terseLabel": "Foreign currency"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for government grants [text block]",
        "terseLabel": "Government grants"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrants",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for the impairment of non-financial assets. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for impairment of non-financial assets [text block]",
        "terseLabel": "Impairment of non-financial assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for leases [text block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for measuring inventories [text block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for property, plant and equipment [text block]",
        "terseLabel": "Property plant and equipment"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for provisions. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for provisions [text block]",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for recognition of revenue [text block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for research and development expense [text block]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for treasury shares. [Refer: Treasury shares]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of accounting policy for treasury shares [text block]",
        "terseLabel": "Treasury shares and Ordinary Shares"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForTreasurySharesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected volatility, share options granted",
        "terseLabel": "Range of expected share price volatility"
       }
      }
     },
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfFactThatMultiemployerPlanIsDefinedBenefitPlan": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the fact that a multi-employer or state plan is a defined benefit plan. [Refer: Multi-employer defined benefit plans [member]; State defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of fact that multi-employer or state plan is defined benefit plan",
        "terseLabel": "Description of defined benefit plan"
       }
      }
     },
     "localname": "DescriptionOfFactThatMultiemployerPlanIsDefinedBenefitPlan",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfNatureOfNonadjustingEventAfterReportingPeriod": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the nature of a non-adjusting event after the reporting period. [Refer: Non-adjusting events after reporting period [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of nature of non-adjusting event after reporting period",
        "terseLabel": "Events after the reporting date, description"
       }
      }
     },
     "localname": "DescriptionOfNatureOfNonadjustingEventAfterReportingPeriod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EventsafterthereportingdateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfRestrictionsOnDistributionOfRevaluationSurplusToShareholdersRightofuseAssets": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of any restrictions on the distribution to shareholders of the balance of the revaluation surplus for right-of-use assets. [Refer: Revaluation surplus; Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of restrictions on distribution of revaluation surplus to shareholders, right-of-use assets",
        "terseLabel": "Description of aforesaid lease agreements end"
       }
      }
     },
     "localname": "DescriptionOfRestrictionsOnDistributionOfRevaluationSurplusToShareholdersRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Risk free interest rate, share options granted",
        "terseLabel": "Range of weighted average of risk-free interest rate"
       }
      }
     },
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of vesting requirements for share-based payment arrangement",
        "terseLabel": "Vesting schedule description"
       }
      }
     },
     "localname": "DescriptionOfVestingRequirementsForSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share",
        "terseLabel": "Diluted loss per share (USD) (in Dollars per share)"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for the preparation of the financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation of financial statements [text block]",
        "terseLabel": "Basis of Preparation"
       }
      }
     },
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/BasisofPreparation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for changes in accounting policies, accounting estimates and errors."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of changes in accounting policies, accounting estimates and errors [text block]",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfCostOfSalesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of the cost of sales. [Refer: Cost of sales]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of cost of sales [text block]",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "DisclosureOfCostOfSalesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CostofRevenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of derivative financial instruments [text block]",
        "terseLabel": "Financial instruments"
       }
      }
     },
     "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [text block]",
        "terseLabel": "Schedule of movement in carrying amount"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [text block]",
        "terseLabel": "Schedule of property plant and equipment, net"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/PropertyplantandequipmentnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of earnings per share [text block]",
        "terseLabel": "Loss per share"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for employee benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of employee benefits [text block]",
        "terseLabel": "Employee Benefits"
       }
      }
     },
     "localname": "DisclosureOfEmployeeBenefitsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "Events after the reporting date"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Eventsafterthereportingdate"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeneralHedgeAccountingExplanatory": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for general hedge accounting."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of general hedge accounting [text block]",
        "terseLabel": "General"
       }
      }
     },
     "localname": "DisclosureOfGeneralHedgeAccountingExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/General"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [text block]",
        "terseLabel": "Schedule of revenues per geographical locations"
       }
      }
     },
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for government grants."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of government grants [text block]",
        "terseLabel": "Liability in respect of government grants"
       }
      }
     },
     "localname": "DisclosureOfGovernmentGrantsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of income tax [text block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets [text block]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of inventories [text block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DisclosureOfInventoriesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "auth_ref": [
      "r203",
      "r204"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of leases [text block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "DisclosureOfLeasesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of maturity analysis of operating lease payments [text block]",
        "terseLabel": "Schedule of maturity analysis of the group's lease liabilities"
       }
      }
     },
     "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [text block]",
        "terseLabel": "Schedule of cash flows derived for the Group as a result of the acquisition"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOtherNoncurrentLiabilitiesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other non-current liabilities. [Refer: Other non-current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other non-current liabilities [text block]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "DisclosureOfOtherNoncurrentLiabilitiesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Otherlongtermliabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "terseLabel": "Property plant and equipment, net"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Propertyplantandequipmentnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of quantitative information about right-of-use assets [text block]",
        "terseLabel": "Schedule of lease liability and right of use asset"
       }
      }
     },
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of related party [text block]",
        "terseLabel": "Transactions and balances with related parties"
       }
      }
     },
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Transactionsandbalanceswithrelatedparties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRevenueExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of revenue [text block]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "DisclosureOfRevenueExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Revenues"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share-based payment arrangements [text block]",
        "terseLabel": "Share-based payment"
       }
      }
     },
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPayment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "auth_ref": [
      "r107",
      "r110",
      "r179"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [text block]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Subsidiaries"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other payables [text block]",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/OtherPayables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other receivables [text block]",
        "terseLabel": "Trade receivable and Other receivables"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TradeReceivablesandOtherReceivables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions and balances with related parties [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisposalsIntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in intangible assets and goodwill resulting from disposals. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals, intangible assets and goodwill",
        "terseLabel": "Goodwill and intangible asset"
       }
      }
     },
     "localname": "DisposalsIntangibleAssetsAndGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/BasisofPreparationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals, property, plant and equipment",
        "negatedLabel": "Disposals",
        "terseLabel": "Disposals"
       }
      }
     },
     "localname": "DisposalsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DistributionCosts": {
     "auth_ref": [
      "r2",
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of costs relating to the distribution of goods and services."
       }
      },
      "en-us": {
       "role": {
        "label": "Distribution costs",
        "terseLabel": "Contributed costs"
       }
      }
     },
     "localname": "DistributionCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsPaidToNoncontrollingInterests": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends paid to non-controlling interests. [Refer: Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends paid to non-controlling interests",
        "terseLabel": "Investment of non-controlling party in subsidiary"
       }
      }
     },
     "localname": "DividendsPaidToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r146",
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Effect of exchange rate fluctuations on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EmployeeBenefitsExpense": {
     "auth_ref": [
      "r1",
      "r3",
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment."
       }
      },
      "en-us": {
       "role": {
        "label": "Employee benefits expense",
        "terseLabel": "Share based payment expenses"
       }
      }
     },
     "localname": "EmployeeBenefitsExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EntitysTotalForBusinessCombinationsMember": {
     "auth_ref": [
      "r217",
      "r220"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for business combinations [member]"
       }
      }
     },
     "localname": "EntitysTotalForBusinessCombinationsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/GeneralDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      }
     },
     "localname": "EntitysTotalForRelatedPartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails",
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/LeasesDetails",
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r24",
      "r36",
      "r156",
      "r158",
      "r180",
      "r181",
      "r182"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent",
        "totalLabel": "Equity attributable to owners of the company"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityInstrumentsPercentageContributedToFairValueOfPlanAssets": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage equity instruments contribute to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [member]] [Contrast: Equity instruments, amount contributed to fair value of plan assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity instruments, percentage contributed to fair value of plan assets",
        "terseLabel": "Percentage of benefit liability"
       }
      }
     },
     "localname": "EquityInstrumentsPercentageContributedToFairValueOfPlanAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [member]"
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails",
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3",
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EstimatedFinancialEffectContingentLiabilitiesInBusinessCombination": {
     "auth_ref": [
      "r215"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the estimated financial effect of contingent liabilities in a business combination that were not recognised because their fair value cannot be measured reliably. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Estimated financial effect, contingent liabilities in business combination",
        "terseLabel": "Estimated cost"
       }
      }
     },
     "localname": "EstimatedFinancialEffectContingentLiabilitiesInBusinessCombination",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EstimatedFinancialEffectOfContingentAssets": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the estimated financial effect of possible assets that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within control of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Estimated financial effect of contingent assets",
        "terseLabel": "Estimated transaction date"
       }
      }
     },
     "localname": "EstimatedFinancialEffectOfContingentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EstimatedFinancialEffectOfContingentLiabilities": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the estimated financial effect of contingent liabilities. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Estimated financial effect of contingent liabilities",
        "terseLabel": "Estimated value"
       }
      }
     },
     "localname": "EstimatedFinancialEffectOfContingentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Exercise price, share options granted",
        "terseLabel": "Warrants per share (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePriceShareOptionsGranted2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_ExpectedDividendShareOptionsGranted": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of an expected dividend used to calculate the fair value of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected dividend, share options granted",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ExpectedDividendShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense recognised during the period in respect of bad or doubtful debts due from related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense recognised during period for bad and doubtful debts for related party transaction",
        "negatedLabel": "Provision for impairment"
       }
      }
     },
     "localname": "ExpenseRecognisedDuringPeriodForBadAndDoubtfulDebtsForRelatedPartyTransaction",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftradereceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The explanation of the changes in the entity's applicable income tax rate(s) compared to the previous accounting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Explanation of changes in applicable tax rates to previous accounting period",
        "terseLabel": "Description of corporate tax rate reduced"
       }
      }
     },
     "localname": "ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ExplanationOfMeasurementBasesUsedInPreparingFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The explanation of the measurement basis (or bases) used in preparing the financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Explanation of measurement bases used in preparing financial statements [text block]",
        "terseLabel": "Financial instruments"
       }
      }
     },
     "localname": "ExplanationOfMeasurementBasesUsedInPreparingFinancialStatements",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_FeeAndCommissionExpense": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to fees and commissions."
       }
      },
      "en-us": {
       "role": {
        "label": "Fee and commission expense",
        "terseLabel": "Fees"
       }
      }
     },
     "localname": "FeeAndCommissionExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceCosts": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance costs",
        "terseLabel": "Finance expense"
       }
      }
     },
     "localname": "FinanceCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement",
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncome": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income",
        "terseLabel": "Finance income"
       }
      }
     },
     "localname": "FinanceIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement",
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssets": {
     "auth_ref": [
      "r224",
      "r226",
      "r227",
      "r230",
      "r231"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets",
        "terseLabel": "Backlog",
        "verboseLabel": "Financial assets"
       }
      }
     },
     "localname": "FinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilities": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities",
        "terseLabel": "Financial liabilities",
        "verboseLabel": "Financial liability"
       }
      }
     },
     "localname": "FinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities, at fair value",
        "terseLabel": "Earn-out cash consideration \u2013 contingent consideration",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "FinancialLiabilitiesAtFairValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoffinancialinstrumentspositionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinishedGoods": {
     "auth_ref": [
      "r34",
      "r91"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ScheduleofinventoryTable": {
       "order": 2.0,
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current finished goods",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "FinishedGoods",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofinventoryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gains (losses) on change in fair value of derivatives",
        "terseLabel": "Changes in exchange rate"
       }
      }
     },
     "localname": "GainsLossesOnChangeInFairValueOfDerivatives",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GainsLossesOnFinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Abstract]"
       }
      }
     },
     "localname": "GainsLossesOnFinancialInstrumentsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "General and administrative expense",
        "terseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GeographicalAreasAxis": {
     "auth_ref": [
      "r77",
      "r194",
      "r250",
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      }
     },
     "localname": "GeographicalAreasAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_GeographicalAreasMember": {
     "auth_ref": [
      "r77",
      "r194",
      "r250",
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Geographical areas [member]"
       }
      }
     },
     "localname": "GeographicalAreasMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GoodsOrServicesTransferredAtPointInTimeMember": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for goods or services transferred to customers at a point in time. [Refer: Performance obligations satisfied at point in time [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goods or services transferred at point in time [member]",
        "terseLabel": "Goods transferred at a point in time [Member]"
       }
      }
     },
     "localname": "GoodsOrServicesTransferredAtPointInTimeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftimingofrevenuerecognitionTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GoodsOrServicesTransferredOverTimeMember": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for goods or services transferred to customers over time. [Refer: Performance obligations satisfied over time [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goods or services transferred over time [member]",
        "terseLabel": "Goods and services transferred over time [Member]"
       }
      }
     },
     "localname": "GoodsOrServicesTransferredOverTimeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftimingofrevenuerecognitionTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Goodwill": {
     "auth_ref": [
      "r16",
      "r121",
      "r122",
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GoodwillMember": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill [member]",
        "terseLabel": "Goodwill [Member]"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GovernmentGrants": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Government grants",
        "periodEndLabel": "Balance as of December 31",
        "periodStartLabel": "Balance as of January 1"
       }
      }
     },
     "localname": "GovernmentGrants",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofliabilityinrespectofgovernmentgrantsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GrossProfit": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": {
     "auth_ref": [
      "r214",
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Identifiable assets acquired (liabilities assumed)",
        "terseLabel": "Total identifiable net assets acquired"
       }
      }
     },
     "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLoss": {
     "auth_ref": [
      "r119",
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss",
        "terseLabel": "Impairment loss"
       }
      }
     },
     "localname": "ImpairmentLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentLossOnFinancialAssets": {
     "auth_ref": [
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment loss on financial assets",
        "negatedLabel": "Impairment loss"
       }
      }
     },
     "localname": "ImpairmentLossOnFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "auth_ref": [
      "r49",
      "r58",
      "r60",
      "r61",
      "r104",
      "r178",
      "r241"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense (income)",
        "negatedLabel": "Taxes benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseContinuingOperations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes",
        "totalLabel": "Increase in cash"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes",
        "negatedLabel": "Effect of changes in exchange rates"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a contingent consideration asset (liability) relating to a business combination."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in contingent consideration asset (liability)",
        "terseLabel": "Contingent consideration (in Dollars)"
       }
      }
     },
     "localname": "IncreaseDecreaseInContingentConsiderationAssetLiability",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in number of ordinary shares issued",
        "terseLabel": "Effect of shares issued during the year",
        "verboseLabel": "Ordinary shares issued (in Shares)"
       }
      }
     },
     "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesTable",
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in deferred tax liability (asset) resulting from business combinations. [Refer: Deferred tax liability (asset)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through business combinations, deferred tax liability (asset)",
        "terseLabel": "Deferred tax asset (liability) acquired in business combinations (see Note 9.B)"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementindeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of warrants."
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of warrants, equity",
        "terseLabel": "Exercise of warrants and options and conversion of convertible notes"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsAndGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwillAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IntangibleAssetsAndGoodwillMember": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill [member]"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementindeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r16",
      "r130"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "auth_ref": [
      "r118",
      "r131",
      "r199"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill [member]",
        "terseLabel": "Intangible assets and inventories [Member]"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementindeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets with indefinite useful life [axis]"
       }
      }
     },
     "localname": "IntangibleAssetsWithIndefiniteUsefulLifeAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest paid, classified as financing activities",
        "negatedLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Inventories": {
     "auth_ref": [
      "r17",
      "r30",
      "r90"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      },
      "http://www.Nanodimensionltd.com/role/ScheduleofinventoryTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current inventories",
        "terseLabel": "Inventory",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Inventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/ScheduleofinventoryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InventoriesTotal": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]"
       }
      },
      "en-us": {
       "role": {
        "label": "Inventories",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoriesTotal",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InventoryRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r214",
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Inventory recognised as of acquisition date",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentIncome": {
     "auth_ref": [
      "r50",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investment income, such as interest and dividends."
       }
      },
      "en-us": {
       "role": {
        "label": "Investment income",
        "terseLabel": "Amount invested"
       }
      }
     },
     "localname": "InvestmentIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssueOfConvertibleInstruments": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The change in equity resulting from the issuing of convertible instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Issue of convertible instruments",
        "terseLabel": "Convertible notes"
       }
      }
     },
     "localname": "IssueOfConvertibleInstruments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssueOfEquity": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Issue of equity",
        "terseLabel": "Issuance of Ordinary Shares, net"
       }
      }
     },
     "localname": "IssueOfEquity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Share capital",
        "verboseLabel": "Authorized share capital"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapitalMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital [member]",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Key management personnel compensation, share-based payment",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r11",
      "r201",
      "r202",
      "r236",
      "r238",
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than four years and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than four years and not later than five years [member]",
        "terseLabel": "One to five years [Member]"
       }
      }
     },
     "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmaturityanalysisofthegroupsleaseliabilitiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearMember": {
     "auth_ref": [
      "r27",
      "r262",
      "r264"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year [member]",
        "terseLabel": "More than a year [Member]"
       }
      }
     },
     "localname": "LaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r196"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmaturityanalysisofthegroupsleaseliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LeaseReceivablesMember": {
     "auth_ref": [
      "r225",
      "r229",
      "r231"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for receivables related to leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease receivables [member]",
        "terseLabel": "Leases of offices [Member]"
       }
      }
     },
     "localname": "LeaseReceivablesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      },
      "en-us": {
       "role": {
        "label": "Leasehold improvements [member]",
        "terseLabel": "Leasehold Improvements [Member]",
        "verboseLabel": "Leasehold improvements [member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 2 of fair value hierarchy [member]",
        "terseLabel": "Level 2 [Member]",
        "verboseLabel": "Level 2 of fair value hierarchy [member]"
       }
      }
     },
     "localname": "Level2OfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 3 of fair value hierarchy [member]",
        "terseLabel": "Level 3 [Member]"
       }
      }
     },
     "localname": "Level3OfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "auth_ref": [
      "r81",
      "r181"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]"
       }
      }
     },
     "localname": "LevelsOfFairValueHierarchyAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_Liabilities": {
     "auth_ref": [
      "r24",
      "r180",
      "r181",
      "r182",
      "r242",
      "r246"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LoansAndAdvancesToCustomers": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of loans and advances the entity has made to customers."
       }
      },
      "en-us": {
       "role": {
        "label": "Loans and advances to customers",
        "negatedLabel": "Shareholder\u2019s loans"
       }
      }
     },
     "localname": "LoansAndAdvancesToCustomers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LoansAndReceivables": {
     "auth_ref": [
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Loans and receivables",
        "negatedLabel": "Shareholder\u2019s loan"
       }
      }
     },
     "localname": "LoansAndReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LongtermDeposits": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of long-term deposits held by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Long-term deposits",
        "terseLabel": "Restricted deposits"
       }
      }
     },
     "localname": "LongtermDeposits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MajorBusinessCombinationMember": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for major business combinations. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Major business combination [member]",
        "terseLabel": "Major Business Combination [Member]",
        "verboseLabel": "Major business combination [member]"
       }
      }
     },
     "localname": "MajorBusinessCombinationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MajorCustomersAxis": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Major customers [axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MajorCustomersMember": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Customers [member]"
       }
      }
     },
     "localname": "MajorCustomersMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_MaturityAxis": {
     "auth_ref": [
      "r28",
      "r83",
      "r192",
      "r201",
      "r202",
      "r223",
      "r234",
      "r236",
      "r252",
      "r253",
      "r255",
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      }
     },
     "localname": "MaturityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmaturityanalysisofthegroupsleaseliabilitiesTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MergerReserve": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity that may result in relation to a business combination outside the scope of IFRS 3."
       }
      },
      "en-us": {
       "role": {
        "label": "Merger reserve",
        "terseLabel": "Acquisition through business combinations"
       }
      }
     },
     "localname": "MergerReserve",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MotorVehiclesMember": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing self-propelled ground vehicles used in the entity's operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Motor vehicles [member]",
        "terseLabel": "Motor Vehicles [Member]"
       }
      }
     },
     "localname": "MotorVehiclesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NetAssetsLiabilities": {
     "auth_ref": [
      "r11",
      "r160"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Assets (liabilities)",
        "terseLabel": "Total net financial assets (liabilities)"
       }
      }
     },
     "localname": "NetAssetsLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      }
     },
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/EventsafterthereportingdateDetails",
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NonadjustingEventsMember": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [member]"
       }
      }
     },
     "localname": "NonadjustingEventsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/EventsafterthereportingdateDetails",
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncontrollingInterests": {
     "auth_ref": [
      "r22",
      "r161",
      "r164"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests [member]",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r29",
      "r168",
      "r170"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentGovernmentGrants": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current government grants",
        "terseLabel": "Liability in respect of government grants",
        "verboseLabel": "Long term liability in respect of government grants"
       }
      }
     },
     "localname": "NoncurrentGovernmentGrants",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/ScheduleofliabilityinrespectofgovernmentgrantsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLeasePrepayments": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current prepayments for leases. [Refer: Non-current prepayments]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current lease prepayments",
        "terseLabel": "Lease prepayments"
       }
      }
     },
     "localname": "NoncurrentLeasePrepayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r31",
      "r168",
      "r172"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentProvisionsForEmployeeBenefits": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current provisions for employee benefits",
        "negatedLabel": "Recognized liability for defined benefit plan, net"
       }
      }
     },
     "localname": "NoncurrentProvisionsForEmployeeBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofemployeebenefitsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "auth_ref": [
      "r26",
      "r201",
      "r202",
      "r236",
      "r238",
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Not later than one year [member]",
        "terseLabel": "First year [Member]",
        "verboseLabel": "Less than one year [Member]"
       }
      }
     },
     "localname": "NotLaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmaturityanalysisofthegroupsleaseliabilitiesTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NotionalAmount": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      },
      "en-us": {
       "role": {
        "label": "Notional amount",
        "terseLabel": "Additional debt amount"
       }
      }
     },
     "localname": "NotionalAmount",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NumberOfSharesAuthorised": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares authorised."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares authorised",
        "terseLabel": "Authorized share capital"
       }
      }
     },
     "localname": "NumberOfSharesAuthorised",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofsharecapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesIssued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "terseLabel": "Ordinary shares",
        "verboseLabel": "Ordinary shares issued (in Shares)"
       }
      }
     },
     "localname": "NumberOfSharesIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OrdinarySharesMember": {
     "auth_ref": [
      "r39",
      "r112"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ordinary shares [member]",
        "terseLabel": "Ordinary shares [member]"
       }
      }
     },
     "localname": "OrdinarySharesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherCashAndCashEquivalents": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents of the subsidiary"
       }
      }
     },
     "localname": "OtherCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "auth_ref": [
      "r6",
      "r42",
      "r51",
      "r175"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income",
        "terseLabel": "Other comprehensive loss for the year"
       }
      }
     },
     "localname": "OtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income [abstract]",
        "terseLabel": "Other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_OtherCurrentAssets": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current assets",
        "terseLabel": "Other current assets",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "OtherCurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentFinancialLiabilities": {
     "auth_ref": [
      "r20",
      "r177"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current financial liabilities",
        "terseLabel": "Current portion of other long-term liability"
       }
      }
     },
     "localname": "OtherCurrentFinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "negatedLabel": "Other current liabilities",
        "negatedTerseLabel": "Total"
       }
      }
     },
     "localname": "OtherCurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofemployeebenefitsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentNonfinancialLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current non-financial liabilities",
        "negatedLabel": "Total"
       }
      }
     },
     "localname": "OtherCurrentNonfinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofemployeebenefitsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentPayables": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other current payables",
        "terseLabel": "Other payables",
        "verboseLabel": "Other payables, Total"
       }
      }
     },
     "localname": "OtherCurrentPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentReceivables": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other current receivables",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherCurrentReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherEmployeeExpense": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of employee expenses that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other employee expense",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherEmployeeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcostofrevenuesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherGainsLosses": {
     "auth_ref": [
      "r1",
      "r2"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other gains (losses)",
        "terseLabel": "Loss"
       }
      }
     },
     "localname": "OtherGainsLosses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherIntangibleAssets": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other intangible assets",
        "terseLabel": "Trademark"
       }
      }
     },
     "localname": "OtherIntangibleAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current assets",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNonfinancialAssets": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-financial assets",
        "terseLabel": "Other short-term receivables"
       }
      }
     },
     "localname": "OtherNonfinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNonfinancialLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-financial liabilities",
        "terseLabel": "Presented under non-current liabilities"
       }
      }
     },
     "localname": "OtherNonfinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoffinancialinstrumentspositionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other operating income (expense)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherPayables": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other payables",
        "negatedLabel": "Other accounts payable and accrued expenses",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "OtherPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofbalanceswithrelatedpartiesTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherPropertyPlantAndEquipment": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other property, plant and equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "OtherPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/PropertyplantandequipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherReceivables": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other receivables",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcontractassetsandcontractliabilitiesderivingfromcontractswithcustomersTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherRevenue": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other revenue",
        "terseLabel": "Contributed revenue"
       }
      }
     },
     "localname": "OtherRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherShorttermEmployeeBenefits": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense from employee benefits (other than termination benefits), which are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services, that the entity does not separately disclose in the same statement or note. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other short-term employee benefits",
        "negatedLabel": "Short-term employee benefits"
       }
      }
     },
     "localname": "OtherShorttermEmployeeBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofemployeebenefitsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ParentMember": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an entity that controls one or more entities."
       }
      },
      "en-us": {
       "role": {
        "label": "Parent [member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Lease payments"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of shares and voting interests",
        "netLabel": "Percentage of voting equity interests acquired",
        "terseLabel": "Voting interests",
        "totalLabel": "Voting interest",
        "verboseLabel": "Percentage of voting interests"
       }
      }
     },
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails",
      "http://www.Nanodimensionltd.com/role/GeneralDetails",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails",
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PresentationOfLeasesForLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "PresentationOfLeasesForLesseeAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary": {
     "auth_ref": [
      "r105",
      "r108",
      "r162",
      "r165"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The principal place of business of a subsidiary. [Refer: Principal place of business; Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Principal place of business of subsidiary",
        "terseLabel": "Principal location of the company's activity"
       }
      }
     },
     "localname": "PrincipalPlaceOfBusinessOfSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from proceeds from contributions of non-controlling interests. [Refer: Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from contributions of non-controlling interests",
        "terseLabel": "Proceeds from non-controlling interests"
       }
      }
     },
     "localname": "ProceedsFromContributionsOfNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of options",
        "terseLabel": "Exercise of warrants and options"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssueOfOrdinaryShares": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issue of ordinary shares",
        "terseLabel": "Proceeds from issuance of Ordinary Shares, warrants and convertible notes, net"
       }
      }
     },
     "localname": "ProceedsFromIssueOfOrdinaryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "auth_ref": [
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issuing shares",
        "terseLabel": "Gross proceeds from offering"
       }
      }
     },
     "localname": "ProceedsFromIssuingShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "auth_ref": [
      "r193",
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      }
     },
     "localname": "ProductsAndServicesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProductsAndServicesMember": {
     "auth_ref": [
      "r193",
      "r248"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [member]"
       }
      }
     },
     "localname": "ProductsAndServicesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      },
      "en-us": {
       "role": {
        "label": "Professional fees expense",
        "terseLabel": "Professional services"
       }
      }
     },
     "localname": "ProfessionalFeesExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r41",
      "r142",
      "r157",
      "r159",
      "r168",
      "r242",
      "r244",
      "r254",
      "r260"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      },
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "terseLabel": "Loss for the year",
        "totalLabel": "Loss for the year",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow",
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement",
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share",
        "terseLabel": "Equity instruments \u2013 with holdback restrictions"
       }
      }
     },
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "nndm_TotalOwnerLossAfterTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to owners of parent",
        "negatedLabel": "Loss attributable to Non-controlling interests"
       }
      }
     },
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "auth_ref": [
      "r1",
      "r2",
      "r222",
      "r242",
      "r244"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Profit (loss) before tax",
        "totalLabel": "Loss before taxes on income"
       }
      }
     },
     "localname": "ProfitLossBeforeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyDevelopmentAndProjectManagementExpense": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from property development and project management."
       }
      },
      "en-us": {
       "role": {
        "label": "Property development and project management expense",
        "terseLabel": "Research and development services"
       }
      }
     },
     "localname": "PropertyDevelopmentAndProjectManagementExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r15",
      "r72"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "terseLabel": "Property plant and equipment, net",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment that would have been recognised had the revalued assets been carried under the cost model. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment, revalued assets, at cost",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gross carrying amount of fully depreciated property, plant and equipment that is still in use. [Refer: Gross carrying amount [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment, gross carrying amount of fully depreciated assets still in use",
        "periodEndLabel": "Ending balance"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r73",
      "r118",
      "r199"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "auth_ref": [
      "r106",
      "r109",
      "r166"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in subsidiary",
        "terseLabel": "The Group's ownership interest in the subsidiary"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProportionOfVotingRightsHeldByNoncontrollingInterests": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of the voting rights in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of voting rights held by non-controlling interests",
        "terseLabel": "Voting power perecentage"
       }
      }
     },
     "localname": "ProportionOfVotingRightsHeldByNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Acquisition of property plant and equipment"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r208",
      "r235",
      "r255"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails",
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable",
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r208",
      "r235",
      "r255"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ranges [member]"
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails",
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable",
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RawMaterials": {
     "auth_ref": [
      "r34",
      "r91"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ScheduleofinventoryTable": {
       "order": 1.0,
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current raw materials",
        "terseLabel": "Raw materials and work in progress"
       }
      }
     },
     "localname": "RawMaterials",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofinventoryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RawMaterialsAndConsumablesUsed": {
     "auth_ref": [
      "r1",
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of raw materials and consumables used in the production process or in the rendering of services. [Refer: Current raw materials]"
       }
      },
      "en-us": {
       "role": {
        "label": "Raw materials and consumables used",
        "terseLabel": "Raw materials, auxiliary materials and consumables"
       }
      }
     },
     "localname": "RawMaterialsAndConsumablesUsed",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcostofrevenuesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RecognisedAssetsDefinedBenefitPlan": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net defined benefit asset",
        "terseLabel": "Net asset (in Dollars)"
       }
      }
     },
     "localname": "RecognisedAssetsDefinedBenefitPlan",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RelatedPartiesMember": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for related parties. Related parties are persons or entities that are related to the entity that is preparing its financial statements (the reporting entity). (a) A person or a close member of that person\u2019s family is related to a reporting entity if that person: (i) has control or joint control over the reporting entity; (ii) has significant influence over the reporting entity; or (iii) is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. (b) An entity is related to a reporting entity if any of the following conditions applies: (i) The entity and the reporting entity are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others). (ii) One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member). (iii) Both entities are joint ventures of the same third party. (iv) One entity is a joint venture of a third entity and the other entity is an associate of the third entity. (v) The entity is a post-employment benefit plan for the benefit of employees of either the reporting entity or an entity related to the reporting entity. If the reporting entity is itself such a plan, the sponsoring employers are also related to the reporting entity. (vi) The entity is controlled or jointly controlled by a person identified in (a). (vii) A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity). (viii) The entity, or any member of a group of which it is a part, provides key management personnel services to the reporting entity or to the parent of the reporting entity. [Refer: Joint ventures [member]; Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Related parties [member]",
        "terseLabel": "Related Parties [Member]"
       }
      }
     },
     "localname": "RelatedPartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofbalanceswithrelatedpartiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Repayments of borrowings, classified as financing activities",
        "negatedLabel": "Repayment of bank loans"
       }
      }
     },
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      },
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "terseLabel": "Research and development expenses, net"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement",
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation",
        "terseLabel": "Foreign currency translation reserve"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "auth_ref": [
      "r10",
      "r95"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of exchange differences on translation [member]",
        "terseLabel": "Foreign currency translation reserve"
       }
      }
     },
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Restricted cash and cash equivalents",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted deposits"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r9",
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Accumulated loss"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Revenue": {
     "auth_ref": [
      "r1",
      "r2",
      "r47",
      "r168",
      "r174",
      "r222",
      "r240",
      "r243",
      "r248",
      "r249",
      "r251"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue",
        "terseLabel": "Revenues",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement",
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenuespergeographicallocationsTable",
      "http://www.Nanodimensionltd.com/role/ScheduleoftimingofrevenuerecognitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]"
       }
      }
     },
     "localname": "RevenueAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "auth_ref": [
      "r188",
      "r189"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue from contracts with customers",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "RevenueFromContractsWithCustomers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": {
     "auth_ref": [
      "r52",
      "r71"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of reversal of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Reversal of impairment loss recognised in profit or loss; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reversal of impairment loss recognised in profit or loss, property, plant and equipment",
        "terseLabel": "Impairment loss"
       }
      }
     },
     "localname": "ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/PropertyplantandequipmentnetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssets": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "terseLabel": "Right of use assets",
        "verboseLabel": "Right of use asset"
       }
      }
     },
     "localname": "RightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet",
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RoyaltyExpense": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from royalties."
       }
      },
      "en-us": {
       "role": {
        "label": "Royalty expense",
        "negatedLabel": "Payment of royalties"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofliabilityinrespectofgovernmentgrantsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to the marketing and selling of goods or services."
       }
      },
      "en-us": {
       "role": {
        "label": "Sales and marketing expense",
        "terseLabel": "Sales and marketing expenses"
       }
      }
     },
     "localname": "SalesAndMarketingExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement",
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SegmentsAxis": {
     "auth_ref": [
      "r78",
      "r120",
      "r190",
      "r242",
      "r259"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [axis]"
       }
      }
     },
     "localname": "SegmentsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsMember": {
     "auth_ref": [
      "r78",
      "r120",
      "r190",
      "r247",
      "r259"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [member]"
       }
      }
     },
     "localname": "SegmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expense",
        "terseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Share issue related cost",
        "terseLabel": "Share issuance as part of business combination"
       }
      }
     },
     "localname": "ShareIssueRelatedCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharePremiumMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      },
      "en-us": {
       "role": {
        "label": "Share premium [member]",
        "terseLabel": "Share premium and capital reserves"
       }
      }
     },
     "localname": "SharePremiumMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term deposits, not classified as cash equivalents",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShorttermEmployeeBenefitsAccruals": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term employee benefits accruals",
        "negatedLabel": "Employees and related"
       }
      }
     },
     "localname": "ShorttermEmployeeBenefitsAccruals",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShorttermWarrantyProvision": {
     "auth_ref": [
      "r124",
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current provision for warranties. [Refer: Warranty provision]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current warranty provision",
        "terseLabel": "Employees and related liabilities"
       }
      }
     },
     "localname": "ShorttermWarrantyProvision",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityLineItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TaxRateEffectFromChangeInTaxRate": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Tax rate effect from change in tax rate",
        "terseLabel": "Tax rate"
       }
      }
     },
     "localname": "TaxRateEffectFromChangeInTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_TimingOfTransferOfGoodsOrServicesAxis": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Timing of transfer of goods or services [axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodsOrServicesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftimingofrevenuerecognitionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TimingOfTransferOfGoodsOrServicesMember": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all timings of the transfer of goods or services in contracts with customers. It also represents the standard value for the 'Timing of transfer of goods or services' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Timing of transfer of goods or services [member]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodsOrServicesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftimingofrevenuerecognitionTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r208",
      "r235",
      "r255"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Top of range [member]",
        "netLabel": "Top of range [Member]",
        "terseLabel": "Top of range [member]",
        "verboseLabel": "Top of Range [Member]"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails",
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails",
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails",
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "auth_ref": [
      "r32",
      "r37"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current trade payables",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherPayables": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other payables",
        "negatedLabel": "Trade payable"
       }
      }
     },
     "localname": "TradeAndOtherPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherPayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Payables [Abstract]"
       }
      }
     },
     "localname": "TradeAndOtherPayablesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business."
       }
      },
      "en-us": {
       "role": {
        "label": "Trade payables",
        "negatedLabel": "Trade accounts payable",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherPayablesToTradeSuppliers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables [Abstract]"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TradeReceivables": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      },
      "en-us": {
       "role": {
        "label": "Trade receivables",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "TradeReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleoftradereceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TravelExpense": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from travel."
       }
      },
      "en-us": {
       "role": {
        "label": "Travel expense",
        "terseLabel": "Travel abroad"
       }
      }
     },
     "localname": "TravelExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TreasuryShares": {
     "auth_ref": [
      "r36",
      "r111"
     ],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      },
      "en-us": {
       "role": {
        "label": "Treasury shares",
        "negatedLabel": "Treasury shares"
       }
      }
     },
     "localname": "TreasuryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TreasurySharesMember": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      },
      "en-us": {
       "role": {
        "label": "Treasury shares [member]",
        "netLabel": "Treasury Shares [Member]",
        "terseLabel": "Treasury shares",
        "verboseLabel": "Ordinary Shares [Member]"
       }
      }
     },
     "localname": "TreasurySharesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3",
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfInterestRatesAxis": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of interest rates [axis]"
       }
      }
     },
     "localname": "TypesOfInterestRatesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      }
     },
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_VehiclesMember": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Vehicles [member]",
        "terseLabel": "Vehicles [Member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WagesAndSalaries": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Wages and salaries",
        "terseLabel": "Salaries, wages and related expenses"
       }
      }
     },
     "localname": "WagesAndSalaries",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcostofrevenuesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_WeightedAverageSharePrice2019": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average share price. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average share price",
        "terseLabel": "Share price (in Dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageSharePrice2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageShares": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "terseLabel": "Weighted average number of Ordinary Shares"
       }
      }
     },
     "localname": "WeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofbasiclosspershareTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ADSSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ADSSharesMember",
        "terseLabel": "ADS [Member]"
       }
      }
     },
     "localname": "ADSSharesMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_AResearchAndDevelopmentExpensesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AResearchAndDevelopmentExpensesNetAbstract",
        "terseLabel": "A. Research and development expenses, net"
       }
      }
     },
     "localname": "AResearchAndDevelopmentExpensesNetAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_AccordingToComponentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AccordingToComponentsAbstract",
        "terseLabel": "According to components -"
       }
      }
     },
     "localname": "AccordingToComponentsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcostofrevenuesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_AccumulatedDepreciationAndAmortisation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of accumulated depreciation and amortisation of property, plant and equipment.",
        "label": "AccumulatedDepreciationAndAmortisation",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedDepreciationAndAmortisation",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AccumulatedLoss": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated loss.",
        "label": "AccumulatedLoss",
        "terseLabel": "Accumulated loss"
       }
      }
     },
     "localname": "AccumulatedLoss",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AccumulatedLossesBeforeMerger": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated losses before the merger.",
        "label": "AccumulatedLossesBeforeMerger",
        "terseLabel": "Remaining amount"
       }
      }
     },
     "localname": "AccumulatedLossesBeforeMerger",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AcquisitionOfARightofuseAsset": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of a right-of-use asset.",
        "label": "AcquisitionOfARightofuseAsset",
        "terseLabel": "Acquisition of a right-of-use asset"
       }
      }
     },
     "localname": "AcquisitionOfARightofuseAsset",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ActiveBenefitLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ActiveBenefitLiabilityMember",
        "terseLabel": "Active Benefit Liability [Member]"
       }
      }
     },
     "localname": "ActiveBenefitLiabilityMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_ActuarialAssumptionofInterestRateontheSavingsAccounts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ActuarialAssumptionofInterestRateontheSavingsAccounts",
        "terseLabel": "Interest rate on the savings account"
       }
      }
     },
     "localname": "ActuarialAssumptionofInterestRateontheSavingsAccounts",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofprincipalactuarialassumptionsatthereportingdateexpressedasweightedaveragesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_AdditionsDepreciationPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in accumulated depreciation and amortisation of property, plant and equipment resulting from additions.",
        "label": "AdditionsDepreciationPropertyPlantAndEquipment",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsDepreciationPropertyPlantAndEquipment",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AdditionsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase in property, plant and equipment resulting from additions. [Refer: Property, plant and equipment]",
        "label": "AdditionsPropertyPlantAndEquipment",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsPropertyPlantAndEquipment",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AdjustmentForIncreaseDecreaseInTradePayables": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "nndm_AdjustmentsForChangesInAssetsAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in trade payables.",
        "label": "AdjustmentForIncreaseDecreaseInTradePayables",
        "terseLabel": "Increase (decrease) in trade receivables"
       }
      }
     },
     "localname": "AdjustmentForIncreaseDecreaseInTradePayables",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AdjustmentsForChangesInAssetsAndLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for changes in assets and liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "AdjustmentsForChangesInAssetsAndLiabilities",
        "totalLabel": "Changes in assets and liabilities"
       }
      }
     },
     "localname": "AdjustmentsForChangesInAssetsAndLiabilities",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AdministrationCostNotReflectedInReturnOnPlanAssetsDefinedBenefitPlans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of administration costs in the current period related to defined benefit plans that are not reflected in the return on plan assets. [Refer: Administrative expenses; Post-employment benefit expense in profit or loss, defined benefit plans] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from administration costs not reflected in return on plan assets; Return on plan assets excluding interest income or expense, net of tax, defined benefit plans; Return on plan assets excluding interest income or expense, before tax, defined benefit plans]",
        "label": "AdministrationCostNotReflectedInReturnOnPlanAssetsDefinedBenefitPlans",
        "terseLabel": "Balance as of January 1"
       }
      }
     },
     "localname": "AdministrationCostNotReflectedInReturnOnPlanAssetsDefinedBenefitPlans",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AdministrationCostNotReflectedInReturnOnPlanAssetsDefinedBenefitPlansendingbalance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "AdministrationCostNotReflectedInReturnOnPlanAssetsDefinedBenefitPlansendingbalance",
        "terseLabel": "Balance as of December 31"
       }
      }
     },
     "localname": "AdministrationCostNotReflectedInReturnOnPlanAssetsDefinedBenefitPlansendingbalance",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AggregateAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount.",
        "label": "AggregateAmount",
        "terseLabel": "Aggregate amount",
        "verboseLabel": "Aggregate amount (in Dollars)"
       }
      }
     },
     "localname": "AggregateAmount",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails",
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AggregateGrossProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate gross proceeds.",
        "label": "AggregateGrossProceeds",
        "terseLabel": "Aggregate gross proceeds"
       }
      }
     },
     "localname": "AggregateGrossProceeds",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/GeneralDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AmericanDepositaryShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AmericanDepositaryShareMember",
        "terseLabel": "ADSs [Member]"
       }
      }
     },
     "localname": "AmericanDepositaryShareMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_AmortizationAndImpairmentLossesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AmortizationAndImpairmentLossesAbstract",
        "terseLabel": "Amortization and impairment losses"
       }
      }
     },
     "localname": "AmortizationAndImpairmentLossesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_AmortizationAndImpairmentLossesAmortizationForTheYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization and impairment losses, Amortization for the year.",
        "label": "AmortizationAndImpairmentLossesAmortizationForTheYear",
        "terseLabel": "Amortization and impairment losses, Amortization for the year"
       }
      }
     },
     "localname": "AmortizationAndImpairmentLossesAmortizationForTheYear",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AmountDepositedInEscrow": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amount deposited in escrow.",
        "label": "AmountDepositedInEscrow",
        "terseLabel": "Amount deposited in escrow"
       }
      }
     },
     "localname": "AmountDepositedInEscrow",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AmountsRecognizedInRespectOfGovernmentGrantsLiabilityNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts recognized in respect of government grants liability, net.",
        "label": "AmountsRecognizedInRespectOfGovernmentGrantsLiabilityNet",
        "negatedLabel": "Amounts recognized in respect of government grants liability, net"
       }
      }
     },
     "localname": "AmountsRecognizedInRespectOfGovernmentGrantsLiabilityNet",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AnnualInterestRates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate is the amount charged, expressed as a percentage of principal, by a lender to a borrower for the use of assets. Interest rates are typically noted on an annual basis, known as the annual percentage rate (APR).",
        "label": "AnnualInterestRates",
        "terseLabel": "Annual interest rate"
       }
      }
     },
     "localname": "AnnualInterestRates",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_ArisingFromBusinessCombinations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arising from business combinations.",
        "label": "ArisingFromBusinessCombinations",
        "terseLabel": "Arising from business combinations"
       }
      }
     },
     "localname": "ArisingFromBusinessCombinations",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofLevel3financialinstrumentscarriedatfairvalueTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AsianPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AsianPacificMember",
        "terseLabel": "Asia Pacific [Member]"
       }
      }
     },
     "localname": "AsianPacificMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenuespergeographicallocationsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_AttributedToFairValueOfFinancialDerivative": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Attributed to fair value of financial derivative.",
        "label": "AttributedToFairValueOfFinancialDerivative",
        "terseLabel": "Net issuance consideration, total"
       }
      }
     },
     "localname": "AttributedToFairValueOfFinancialDerivative",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AttributedToWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Attributed to warrants.",
        "label": "AttributedToWarrants",
        "terseLabel": "Attributed to warrants"
       }
      }
     },
     "localname": "AttributedToWarrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_AwardsTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AwardsTypeAxis",
        "terseLabel": "Awards Type [Axis]"
       }
      }
     },
     "localname": "AwardsTypeAxis",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_AwardsTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "AwardsType [Domain]"
       }
      }
     },
     "localname": "AwardsTypeDomain",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_BSalesAndMarketingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BSalesAndMarketingExpensesAbstract",
        "terseLabel": "B. Sales and marketing expenses"
       }
      }
     },
     "localname": "BSalesAndMarketingExpensesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_BankAccounts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An arrangement made with a bank whereby one may deposit and withdraw money and in some cases be paid interest.",
        "label": "BankAccounts",
        "terseLabel": "Bank accounts- dominated in NIS"
       }
      }
     },
     "localname": "BankAccounts",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_BankAccountsDominatedInGBP": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "BankAccountsDominatedInGBP",
        "terseLabel": "Bank accounts- dominated in GBP"
       }
      }
     },
     "localname": "BankAccountsDominatedInGBP",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_BankAccountsDominatedInUsd": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An arrangement made with a bank whereby one may deposit and withdraw money and in some cases be paid interest in USD.",
        "label": "BankAccountsDominatedInUsd",
        "terseLabel": "Bank accounts- dominated in USD"
       }
      }
     },
     "localname": "BankAccountsDominatedInUsd",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_BankAccountsOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A&amp;amp;amp;amp;amp;amp;amp;amp;amp;#160;bank account&amp;amp;amp;amp;amp;amp;amp;amp;amp;#160;can be a deposit&amp;amp;amp;amp;amp;amp;amp;amp;amp;#160;account, a credit card&amp;amp;amp;amp;amp;amp;amp;amp;amp;#160;account, or any&amp;amp;amp;amp;amp;amp;amp;amp;amp;#160;other&amp;amp;amp;amp;amp;amp;amp;amp;amp;#160;type of&amp;amp;amp;amp;amp;amp;amp;amp;amp;#160;account&amp;amp;amp;amp;amp;amp;amp;amp;amp;#160;offered by a financial institution, and represents the funds that a customer has entrusted to the financial institution and from which the customer can make withdrawals.",
        "label": "BankAccountsOther",
        "terseLabel": "Bank accounts- other"
       }
      }
     },
     "localname": "BankAccountsOther",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_BankDeposits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amonut of bank deposits.",
        "label": "BankDeposits",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "BankDeposits",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_BankDepositsNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of bank deposits.",
        "label": "BankDepositsNonCurrent",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "BankDepositsNonCurrent",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_BankInterestAndFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank interest and fees.",
        "label": "BankInterestAndFees",
        "terseLabel": "Bank interest and fees"
       }
      }
     },
     "localname": "BankInterestAndFees",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_BusinessAcquisitionsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BusinessAcquisitionsAxis",
        "terseLabel": "Business Acquisitions [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionsAxis",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_BusinessAcquisitionsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BusinessAcquisitions [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionsDomain",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_BusinessCombinationDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BusinessCombinationDescription",
        "terseLabel": "Business combination description"
       }
      }
     },
     "localname": "BusinessCombinationDescription",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_BusinessCombinationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BusinessCombinationMember",
        "terseLabel": "Business Combination [Member]"
       }
      }
     },
     "localname": "BusinessCombinationMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_CGeneralAndAdministrativeExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CGeneralAndAdministrativeExpensesAbstract",
        "terseLabel": "C. General and administrative expenses"
       }
      }
     },
     "localname": "CGeneralAndAdministrativeExpensesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_CapitalLossForTaxPurposes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of capital loss for tax purposes.",
        "label": "CapitalLossForTaxPurposes",
        "terseLabel": "Capital loss for tax purposes"
       }
      }
     },
     "localname": "CapitalLossForTaxPurposes",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_CapitalizedDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CapitalizedDevelopmentCostsMember",
        "terseLabel": "Capitalized development costs [Member]"
       }
      }
     },
     "localname": "CapitalizedDevelopmentCostsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_CarryForwardTaxLossesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CarryForwardTaxLossesMember",
        "terseLabel": "Carry- forward tax losses [Member]"
       }
      }
     },
     "localname": "CarryForwardTaxLossesMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementindeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_CarryingAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CarryingAmountAbstract",
        "terseLabel": "Carrying amount"
       }
      }
     },
     "localname": "CarryingAmountAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_CarryingAmountAbstract0": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CarryingAmountAbstract0",
        "terseLabel": "Carrying amount"
       }
      }
     },
     "localname": "CarryingAmountAbstract0",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_CashDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash (Details) [Line Items]"
       }
      }
     },
     "localname": "CashDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_CashDetailsScheduleofcomponentsofcashLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash (Details) - Schedule of components of cash [Line Items]"
       }
      }
     },
     "localname": "CashDetailsScheduleofcomponentsofcashLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_CashDetailsScheduleofcomponentsofcashTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash (Details) - Schedule of components of cash [Table]"
       }
      }
     },
     "localname": "CashDetailsScheduleofcomponentsofcashTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_CashDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash (Details) [Table]"
       }
      }
     },
     "localname": "CashDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_CashPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash payments.",
        "label": "CashPayments",
        "terseLabel": "Cash payments"
       }
      }
     },
     "localname": "CashPayments",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ChangeInConsumerPriceIndex": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ChangeInConsumerPriceIndex",
        "terseLabel": "Change in percentages of CHF"
       }
      }
     },
     "localname": "ChangeInConsumerPriceIndex",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofdetailsregardingtheexchangerateTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ChangeInPercentagesOfCHF": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in percentages of CHF.",
        "label": "ChangeInPercentagesOfCHF",
        "terseLabel": "Change in percentages of CHF"
       }
      }
     },
     "localname": "ChangeInPercentagesOfCHF",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofdetailsregardingtheexchangerateTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ChangesFromBusinessCombinationsAndLossOfControl": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "ChangesFromBusinessCombinationsAndLossOfControl",
        "terseLabel": "Changes from business combinations and loss of control"
       }
      }
     },
     "localname": "ChangesFromBusinessCombinationsAndLossOfControl",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ChangesInAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ChangesInAssetsAndLiabilitiesAbstract",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "ChangesInAssetsAndLiabilitiesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ChangesInFairValueOfSharePriceProtectionLiability": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes in fair value of share price protection liability.",
        "label": "ChangesInFairValueOfSharePriceProtectionLiability",
        "terseLabel": "Changes in fair value of share price protection liability"
       }
      }
     },
     "localname": "ChangesInFairValueOfSharePriceProtectionLiability",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoflossattributabletoownersofthecompanydilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ChangesInFairValueOfWarrantsClassifiedAsLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes in fair value of warrants classified as liabilities.",
        "label": "ChangesInFairValueOfWarrantsClassifiedAsLiabilities",
        "terseLabel": "Changes in fair value of warrants classified as liabilities"
       }
      }
     },
     "localname": "ChangesInFairValueOfWarrantsClassifiedAsLiabilities",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoflossattributabletoownersofthecompanydilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ChangesInFairValueunrealized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of changes in fair value (unrealized).",
        "label": "ChangesInFairValueunrealized",
        "terseLabel": "Changes in fair value (unrealized)"
       }
      }
     },
     "localname": "ChangesInFairValueunrealized",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofLevel3financialinstrumentscarriedatfairvalueTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ChangesInMarginPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ChangesInMarginPercentage",
        "terseLabel": "Changes in margin percentage"
       }
      }
     },
     "localname": "ChangesInMarginPercentage",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_ClassOfWarrantOrRightsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ClassOfWarrantOrRightsOutstanding",
        "terseLabel": "Right to purchase exercised ordinary shares (in Shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightsOutstanding",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ClassOfWarrantsOrRightTitleOfSecurityWarrantsOrRightsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ClassOfWarrantsOrRightTitleOfSecurityWarrantsOrRightsOutstanding",
        "terseLabel": "Warrants description",
        "verboseLabel": "Warrants vesting term"
       }
      }
     },
     "localname": "ClassOfWarrantsOrRightTitleOfSecurityWarrantsOrRightsOutstanding",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ClosingDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing date.",
        "label": "ClosingDate",
        "terseLabel": "Closing date"
       }
      }
     },
     "localname": "ClosingDate",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nndm_ClosingSalePrices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing sale price.",
        "label": "ClosingSalePrices",
        "terseLabel": "Closing sale prices"
       }
      }
     },
     "localname": "ClosingSalePrices",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_CompensationForDirectorsNotEmployedByTheGroup": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of compensation for directors not employed.",
        "label": "CompensationForDirectorsNotEmployedByTheGroup",
        "terseLabel": "Compensation for directors not employed by the Group"
       }
      }
     },
     "localname": "CompensationForDirectorsNotEmployedByTheGroup",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofshareholderandotherrelatedpartiesbenefitsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ComputersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computers member",
        "label": "ComputersMember",
        "terseLabel": "Computers [Member]"
       }
      }
     },
     "localname": "ComputersMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_ConsiderationFullCashPaidDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consideration full cash paid description.",
        "label": "ConsiderationFullCashPaidDescription",
        "terseLabel": "Consideration full cash paid, description"
       }
      }
     },
     "localname": "ConsiderationFullCashPaidDescription",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EventsafterthereportingdateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ConsolidatedStatementsOfChangesInEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements of Changes in Equity [Abstract]"
       }
      }
     },
     "localname": "ConsolidatedStatementsOfChangesInEquityAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ConstitutedIssuedAndPaidUpShareCapitalPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Constituted issued and paid up share capital percentage.",
        "label": "ConstitutedIssuedAndPaidUpShareCapitalPercentage",
        "terseLabel": "Constituted issued and paid up share capital percentage"
       }
      }
     },
     "localname": "ConstitutedIssuedAndPaidUpShareCapitalPercentage",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_ConsultantsAndEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ConsultantsAndEmployeesMember",
        "terseLabel": "Consultants and Employees [Member]"
       }
      }
     },
     "localname": "ConsultantsAndEmployeesMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ConsumablesMember",
        "terseLabel": "Consumables [Member]"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_ConsumerPriceIndex": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information regarding consumer price index.",
        "label": "ConsumerPriceIndex",
        "terseLabel": "Consumer Price Index"
       }
      }
     },
     "localname": "ConsumerPriceIndex",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofdetailsregardingtheexchangerateTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ContingentConsiderationInBusinessCombination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration in business combination.",
        "label": "ContingentConsiderationInBusinessCombination",
        "terseLabel": "Contingent consideration in business combination"
       }
      }
     },
     "localname": "ContingentConsiderationInBusinessCombination",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoffinancialinstrumentspositionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ContingentConsiderationInBusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ContingentConsiderationInBusinessCombinationsAbstract",
        "terseLabel": "Contingent consideration in business combinations"
       }
      }
     },
     "localname": "ContingentConsiderationInBusinessCombinationsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofLevel3financialinstrumentscarriedatfairvalueTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ContingentConsiderationIncreased": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount contingent consideration increased.",
        "label": "ContingentConsiderationIncreased",
        "terseLabel": "Contingent consideration increased"
       }
      }
     },
     "localname": "ContingentConsiderationIncreased",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ContingentConsiderationLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contingent consideration liability.",
        "label": "ContingentConsiderationLiability",
        "terseLabel": "Contingent consideration liability (in Dollars)"
       }
      }
     },
     "localname": "ContingentConsiderationLiability",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ConversionOfConvertibleNotesAndWarrantsToEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of convertible notes and warrants to equity.",
        "label": "ConversionOfConvertibleNotesAndWarrantsToEquity",
        "terseLabel": "Conversion of convertible notes and warrants to equity"
       }
      }
     },
     "localname": "ConversionOfConvertibleNotesAndWarrantsToEquity",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ConvertibleNotesMember",
        "terseLabel": "Convertible notes [Member]"
       }
      }
     },
     "localname": "ConvertibleNotesMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_CostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CostAbstract",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "CostAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_CostAbstract0": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CostAbstract0",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "CostAbstract0",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_CostOfRevenueAmortizationOfIntangible": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_CostOfSales",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Revenue Amortization Of Intangible",
        "label": "CostOfRevenueAmortizationOfIntangible",
        "terseLabel": "Cost of revenues - amortization of assets recognized in business combination and technology"
       }
      }
     },
     "localname": "CostOfRevenueAmortizationOfIntangible",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_CostOfRevenues": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of revenues.",
        "label": "CostOfRevenues",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "CostOfRevenues",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcostofrevenuesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_CostOfRevenuesBeforeAmortizationOfIntangible": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "ifrs-full_CostOfSales",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold before amortization of intangible.",
        "label": "CostOfRevenuesBeforeAmortizationOfIntangible",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfRevenuesBeforeAmortizationOfIntangible",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_CustomerRelationshipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CustomerRelationshipMember",
        "terseLabel": "Customer relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_DFinanceIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DFinanceIncomeAbstract",
        "terseLabel": "D. Finance income"
       }
      }
     },
     "localname": "DFinanceIncomeAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_DateOfAcquisition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of acquisition.",
        "label": "DateOfAcquisition",
        "terseLabel": "Date of acquisition"
       }
      }
     },
     "localname": "DateOfAcquisition",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_DebTInstrumentConvertibleConversionPrice1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DebTInstrumentConvertibleConversionPrice1",
        "terseLabel": "Conversion price (in Dollars per share)"
       }
      }
     },
     "localname": "DebTInstrumentConvertibleConversionPrice1",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_DebtInstrumentConvertibleConversionPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DebtInstrumentConvertibleConversionPrice",
        "terseLabel": "Conversion price (in Dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_DebtInstrumentsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DebtInstrumentsDescription",
        "terseLabel": "Ordinary Shares, description"
       }
      }
     },
     "localname": "DebtInstrumentsDescription",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_DeductioinFromSharePremium": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deduction from share premium.",
        "label": "DeductioinFromSharePremium",
        "terseLabel": "Deduction from share premium (in Dollars)"
       }
      }
     },
     "localname": "DeductioinFromSharePremium",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_DeepCubeLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DeepCubeLtdMember",
        "terseLabel": "DeepCube Ltd [Member]"
       }
      }
     },
     "localname": "DeepCubeLtdMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/GeneralDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable_Parentheticals",
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_DeepCubeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DeepCubeMember",
        "terseLabel": "DeepCube [Member]"
       }
      }
     },
     "localname": "DeepCubeMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_DeepCubesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DeepCubesMember",
        "terseLabel": "DeepCube [Member]"
       }
      }
     },
     "localname": "DeepCubesMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_DefinedBenefitObligationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DefinedBenefitObligationMember",
        "terseLabel": "Defined benefit obligation [Member]"
       }
      }
     },
     "localname": "DefinedBenefitObligationMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_DepositAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deposit amount.",
        "label": "DepositAmount",
        "terseLabel": "Deposited amount (in Dollars)"
       }
      }
     },
     "localname": "DepositAmount",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_DepositedAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deposited amount.",
        "label": "DepositedAmount",
        "terseLabel": "Deposited amount"
       }
      }
     },
     "localname": "DepositedAmount",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_DepreciationAccruedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DepreciationAccruedAbstract",
        "terseLabel": "Depreciation accrued"
       }
      }
     },
     "localname": "DepreciationAccruedAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_DepreciationAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount indicates depreciation.",
        "label": "DepreciationAmount",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationAmount",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_DepreciationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of depreciation cost.",
        "label": "DepreciationCost",
        "negatedLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationCost",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_DepreciationRatesUsefulLifeSpanOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation rates useful life span of assets.",
        "label": "DepreciationRatesUsefulLifeSpanOfAssets",
        "terseLabel": "Depreciation rates useful life span of assets"
       }
      }
     },
     "localname": "DepreciationRatesUsefulLifeSpanOfAssets",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_DepreciationSalesAndMarketingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "DepreciationSalesAndMarketingExpenses",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationSalesAndMarketingExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_DescriptionOfShareOptionsVestedInSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of share options vested in a share-based payment arrangement.",
        "label": "DescriptionOfShareOptionsVestedInSharebasedPaymentArrangement",
        "terseLabel": "Number of vested share options, description"
       }
      }
     },
     "localname": "DescriptionOfShareOptionsVestedInSharebasedPaymentArrangement",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_DevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DevelopmentCostsMember",
        "terseLabel": "Development Costs\t[Member]"
       }
      }
     },
     "localname": "DevelopmentCostsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_DirectorsAndCEOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DirectorsAndCEOMember",
        "terseLabel": "Directors and CEO [Member]"
       }
      }
     },
     "localname": "DirectorsAndCEOMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_DirectorsAndChiefExecutiveOfficierMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DirectorsAndChiefExecutiveOfficierMember",
        "terseLabel": "Directors and CEO [Member]"
       }
      }
     },
     "localname": "DirectorsAndChiefExecutiveOfficierMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable00",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentTables"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_DirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors Member",
        "label": "DirectorsMember",
        "terseLabel": "Directors [Member]"
       }
      }
     },
     "localname": "DirectorsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_DisclosureOfBalancesWithRelatedParty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of balances with related party.",
        "label": "DisclosureOfBalancesWithRelatedParty",
        "terseLabel": "Schedule of balances with related parties"
       }
      }
     },
     "localname": "DisclosureOfBalancesWithRelatedParty",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfCashAndRestrictedDepositsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of cash and restricted deposits.",
        "label": "DisclosureOfCashAndRestrictedDepositsExplanatory",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "DisclosureOfCashAndRestrictedDepositsExplanatory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Cash"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfCashAndRestrictedDepositsExplanatoryAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Cash And Restricted Deposits Explanatory [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCashAndRestrictedDepositsExplanatoryAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_DisclosureOfCashTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DisclosureOfCashTableTextBlock",
        "terseLabel": "Schedule of components of cash"
       }
      }
     },
     "localname": "DisclosureOfCashTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfClassificationAndLinkageTermsOfFinancialInstrumentsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of classification and linkage terms of financial instruments explanatory table text block",
        "label": "DisclosureOfClassificationAndLinkageTermsOfFinancialInstrumentsExplanatoryTableTextBlock",
        "terseLabel": "Schedule of classification and linkage terms of financial instruments"
       }
      }
     },
     "localname": "DisclosureOfClassificationAndLinkageTermsOfFinancialInstrumentsExplanatoryTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfComponentsLiabilityInRespectOfGovernmentGrantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of components of liability in respect of government grants.",
        "label": "DisclosureOfComponentsLiabilityInRespectOfGovernmentGrantsTableTextBlock",
        "terseLabel": "Schedule of liability in respect of government grants"
       }
      }
     },
     "localname": "DisclosureOfComponentsLiabilityInRespectOfGovernmentGrantsTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfComponentsOfRevenueExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of components of revenue from products and services.",
        "label": "DisclosureOfComponentsOfRevenueExplanatoryTableTextBlock",
        "terseLabel": "Schedule of revenue"
       }
      }
     },
     "localname": "DisclosureOfComponentsOfRevenueExplanatoryTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfControllingShareholderBenefits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of controlling shareholder benefits.",
        "label": "DisclosureOfControllingShareholderBenefits",
        "terseLabel": "Schedule of shareholder and other related parties benefits"
       }
      }
     },
     "localname": "DisclosureOfControllingShareholderBenefits",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfCostOfSalesTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of cost of sales [text block] [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCostOfSalesTextBlockAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutComponentsOfExpenseAndIncomeDetailOfProfitOrLossSectionsExplantory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The discloure of detailed information about components of expense and income detail of profit or loss sections explantory.",
        "label": "DisclosureOfDetailedInformationAboutComponentsOfExpenseAndIncomeDetailOfProfitOrLossSectionsExplantory",
        "terseLabel": "Schedule of further detail of profit or loss"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutComponentsOfExpenseAndIncomeDetailOfProfitOrLossSectionsExplantory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FurtherDetailofProfitorLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutComponentsOfOtherPayablesExplantory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about components of other payables explantory.",
        "label": "DisclosureOfDetailedInformationAboutComponentsOfOtherPayablesExplantory",
        "terseLabel": "Schedule of other payables"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutComponentsOfOtherPayablesExplantory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/OtherPayablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutCostOfSalesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Detailed Information About Cost Of Sales Explanatory Table Text Block",
        "label": "DisclosureOfDetailedInformationAboutCostOfSalesExplanatoryTableTextBlock",
        "terseLabel": "Schedule of cost of revenues"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutCostOfSalesExplanatoryTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CostofRevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of detailed information about deferred tax assets and liabilities.",
        "label": "DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesTableTextBlock",
        "terseLabel": "Schedule of movement in deferred tax assets and liabilities"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutDepreciationRatesUsefulLifeSpanAssetsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about depreciation is calculated in equal yearly rates during the period of the useful life span of the assets.",
        "label": "DisclosureOfDetailedInformationAboutDepreciationRatesUsefulLifeSpanAssetsExplanatory",
        "terseLabel": "Schedule of property plant and equipment, useful life span of the assets"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutDepreciationRatesUsefulLifeSpanAssetsExplanatory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutDerivingFromContractsWithCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DisclosureOfDetailedInformationAboutDerivingFromContractsWithCustomers",
        "terseLabel": "Schedule of contract assets and contract liabilities deriving from contracts with customers"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutDerivingFromContractsWithCustomers",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutEarningsPerShareExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about earnings per share.",
        "label": "DisclosureOfDetailedInformationAboutEarningsPerShareExplanatoryTableTextBlock",
        "terseLabel": "Schedule of basic loss per share"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutEarningsPerShareExplanatoryTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutEquityExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of classes of equity.",
        "label": "DisclosureOfDetailedInformationAboutEquityExplanatory",
        "terseLabel": "Schedule of share capital"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutEquityExplanatory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutExchangeRateExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about the exchange rate.",
        "label": "DisclosureOfDetailedInformationAboutExchangeRateExplanatory",
        "terseLabel": "Schedule of details regarding the exchange rate"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutExchangeRateExplanatory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutInventoriesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about inventories.",
        "label": "DisclosureOfDetailedInformationAboutInventoriesExplanatory",
        "terseLabel": "Schedule of inventory"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutInventoriesExplanatory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutIssuedShareCapitalExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of issued share capital.",
        "label": "DisclosureOfDetailedInformationAboutIssuedShareCapitalExplanatory",
        "terseLabel": "Schedule of issued share capital"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutIssuedShareCapitalExplanatory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about other receivables.",
        "label": "DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory",
        "terseLabel": "Schedule of other receivables"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutOtherReceivablesExplanatory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TradeReceivablesandOtherReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about sharebased payment arrangements explanatory.",
        "label": "DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock",
        "terseLabel": "Schedule of fair value of the share options"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutSharebasedPaymentArrangementsExplanatoryTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutSubsidiariesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DisclosureOfDetailedInformationAboutSubsidiariesExplanatory",
        "terseLabel": "Summary of group's material subsidiaries"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutSubsidiariesExplanatory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutTaxesOnIncomeExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about adjustment between the theoretical tax amount and the income tax amount.",
        "label": "DisclosureOfDetailedInformationAboutTaxesOnIncomeExplanatoryTableTextBlock",
        "terseLabel": "Schedule of composition of income tax expense (income)"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutTaxesOnIncomeExplanatoryTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutTimingOfRevenueRecognitionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of timing of revenue recognition.",
        "label": "DisclosureOfDetailedInformationAboutTimingOfRevenueRecognitionTableTextBlock",
        "terseLabel": "Schedule of timing of revenue recognition"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutTimingOfRevenueRecognitionTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/RevenuesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
        "terseLabel": "Schedule of trade receivables"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutTradeReceivablesExplanatory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TradeReceivablesandOtherReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfEmployeeBenefitsTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of employee benefits [text block] [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfEmployeeBenefitsTextBlockAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_DisclosureOfFinancialInstrumentsPositionExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of fair value of financial instruments position.",
        "label": "DisclosureOfFinancialInstrumentsPositionExplanatoryTableTextBlock",
        "terseLabel": "Schedule of fair value of financial instruments position"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsPositionExplanatoryTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfFurtherDetailOfProfitOrLossSectionsExplanatoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of further detail of profit or loss sections explanatory.",
        "label": "DisclosureOfFurtherDetailOfProfitOrLossSectionsExplanatoryTextBlock",
        "terseLabel": "Further detail of profit or loss"
       }
      }
     },
     "localname": "DisclosureOfFurtherDetailOfProfitOrLossSectionsExplanatoryTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FurtherDetailofProfitorLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfGeneralHedgeAccountingTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of general hedge accounting [text block] [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfGeneralHedgeAccountingTextBlockAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_DisclosureOfLevel3FinancialInstrumentsCarriedAtFairValueExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Level 3 financial instruments carried at fair value.",
        "label": "DisclosureOfLevel3FinancialInstrumentsCarriedAtFairValueExplanatoryTableTextBlock",
        "terseLabel": "Schedule of Level 3 financial instruments carried at fair value"
       }
      }
     },
     "localname": "DisclosureOfLevel3FinancialInstrumentsCarriedAtFairValueExplanatoryTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfOtherNonCurrentLiabilitiesTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of other non-current liabilities [text block] [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfOtherNonCurrentLiabilitiesTextBlockAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_DisclosureOfRepaymentDatesOfFinancialLiabilitiesExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Repayment Dates Of Financial Liabilities Explanatory Table Text Block",
        "label": "DisclosureOfRepaymentDatesOfFinancialLiabilitiesExplanatoryTableTextBlock",
        "terseLabel": "Schedule of repayment dates of financial liabilities"
       }
      }
     },
     "localname": "DisclosureOfRepaymentDatesOfFinancialLiabilitiesExplanatoryTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfSensitivityAnalysisOfChangesInExchangeRateOfDollarExplanatoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DisclosureOfSensitivityAnalysisOfChangesInExchangeRateOfDollarExplanatoryTableTextBlock",
        "terseLabel": "Schedule of sensitivity analysis of changes in exchange rate of dollar"
       }
      }
     },
     "localname": "DisclosureOfSensitivityAnalysisOfChangesInExchangeRateOfDollarExplanatoryTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DisclosureOfWeightedAverageNumberOfOrdinarySharesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The disclosure of detailed information about weighted average number of ordinary shares.",
        "label": "DisclosureOfWeightedAverageNumberOfOrdinarySharesTableTextBlock",
        "terseLabel": "Schedule of weighted average number of ordinary shares"
       }
      }
     },
     "localname": "DisclosureOfWeightedAverageNumberOfOrdinarySharesTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_DiscountRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "DiscountRate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DiscountRate",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_DisposalDepreciationPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The decrease in accumulated depreciation and amortisation of property, plant and equipment resulting from disposals.",
        "label": "DisposalDepreciationPropertyPlantAndEquipment",
        "terseLabel": "Disposals"
       }
      }
     },
     "localname": "DisposalDepreciationPropertyPlantAndEquipment",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_EBITDABasedEarnOutDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of EBITDA based earn out.",
        "label": "EBITDABasedEarnOutDescription",
        "terseLabel": "EBITDA based earn out, description"
       }
      }
     },
     "localname": "EBITDABasedEarnOutDescription",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ESSEMTECAGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ESSEMTECAGMember",
        "terseLabel": "Essemtec AG [Member]",
        "verboseLabel": "ESSEMTEC AG [Member]"
       }
      }
     },
     "localname": "ESSEMTECAGMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_EarnOutConsideration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earn out consideration.",
        "label": "EarnOutConsideration",
        "terseLabel": "Earn out consideration"
       }
      }
     },
     "localname": "EarnOutConsideration",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_EarnOutConsiderationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn out consideration percentage.",
        "label": "EarnOutConsiderationPercentage",
        "terseLabel": "Earn out consideration percentage"
       }
      }
     },
     "localname": "EarnOutConsiderationPercentage",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_EffectOfChangesInExchangeRate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of changes in exchange rates.",
        "label": "EffectOfChangesInExchangeRate",
        "terseLabel": "Effect of changes in exchange rates"
       }
      }
     },
     "localname": "EffectOfChangesInExchangeRate",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_EffectOfConversionOfNotesinDollars": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of conversion of notes.",
        "label": "EffectOfConversionOfNotesinDollars",
        "terseLabel": "Effect of conversion of notes"
       }
      }
     },
     "localname": "EffectOfConversionOfNotesinDollars",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_EffectOfMovementsInExchangeRates": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "EffectOfMovementsInExchangeRates",
        "terseLabel": "Effect of movements in exchange rates"
       }
      }
     },
     "localname": "EffectOfMovementsInExchangeRates",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_EffectOfShareOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EffectOfShareOptionsExercised",
        "terseLabel": "Effect of share options exercised"
       }
      }
     },
     "localname": "EffectOfShareOptionsExercised",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_EffectOfSharePriceProtectionOnIssue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of share price protection on issue.",
        "label": "EffectOfSharePriceProtectionOnIssue",
        "terseLabel": "Effect of share price protection on issue"
       }
      }
     },
     "localname": "EffectOfSharePriceProtectionOnIssue",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesdilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_EffectOfWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants exercised.",
        "label": "EffectOfWarrantsExercised",
        "terseLabel": "Effect of warrants exercised"
       }
      }
     },
     "localname": "EffectOfWarrantsExercised",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_EffectOfWarrantsOnIssue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of warrants on issue.",
        "label": "EffectOfWarrantsOnIssue",
        "terseLabel": "Effect of warrants on issue"
       }
      }
     },
     "localname": "EffectOfWarrantsOnIssue",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesdilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_EmployeeBenefitsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Benefits (Details) [Line Items]"
       }
      }
     },
     "localname": "EmployeeBenefitsDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_EmployeeBenefitsDetailsScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Benefits (Details) - Schedule of movement in net defined benefit liabilities (assets) and in their components [Line Items]"
       }
      }
     },
     "localname": "EmployeeBenefitsDetailsScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_EmployeeBenefitsDetailsScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Benefits (Details) - Schedule of movement in net defined benefit liabilities (assets) and in their components [Table]"
       }
      }
     },
     "localname": "EmployeeBenefitsDetailsScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_EmployeeBenefitsDetailsScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Benefits (Details) - Schedule of the relevant actuarial assumptions, holding other assumptions constant [Line Items]"
       }
      }
     },
     "localname": "EmployeeBenefitsDetailsScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_EmployeeBenefitsDetailsScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Benefits (Details) - Schedule of the relevant actuarial assumptions, holding other assumptions constant [Table]"
       }
      }
     },
     "localname": "EmployeeBenefitsDetailsScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_EmployeeBenefitsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Benefits (Details) [Table]"
       }
      }
     },
     "localname": "EmployeeBenefitsDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_EmployeesAndConsultantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EmployeesAndConsultantsMember",
        "terseLabel": "Employees and consultants [Member]"
       }
      }
     },
     "localname": "EmployeesAndConsultantsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentTables"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_EmployeesConsultantAndOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EmployeesConsultantAndOfficerMember",
        "terseLabel": "Employees Consultant and Officers [Member]",
        "verboseLabel": "Employees consultant and officers [Member]"
       }
      }
     },
     "localname": "EmployeesConsultantAndOfficerMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_EquityDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity (Details) [Line Items]"
       }
      }
     },
     "localname": "EquityDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_EquityDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity (Details) [Table]"
       }
      }
     },
     "localname": "EquityDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_EquityInstruments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity instruments.",
        "label": "EquityInstruments",
        "terseLabel": "Equity instruments (2,249,232 Ordinary Shares)"
       }
      }
     },
     "localname": "EquityInstruments",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_EquityInstrumentsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments granted.",
        "label": "EquityInstrumentsGranted",
        "terseLabel": "Number of equity instruments granted"
       }
      }
     },
     "localname": "EquityInstrumentsGranted",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_EquityReverseStockSplit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.",
        "label": "EquityReverseStockSplit",
        "terseLabel": "Reverse split, description"
       }
      }
     },
     "localname": "EquityReverseStockSplit",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_EssemtecAndDeepCubeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EssemtecAndDeepCubeMember",
        "terseLabel": "Essemtec and DeepCube [Member]"
       }
      }
     },
     "localname": "EssemtecAndDeepCubeMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_EssemtecMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EssemtecMember",
        "terseLabel": "Essemtec [Member]"
       }
      }
     },
     "localname": "EssemtecMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_EssemtecsUnderlying": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Essemtec\u2019s underlying.",
        "label": "EssemtecsUnderlying",
        "terseLabel": "Essemtec\u2019s underlying (in Francs)"
       }
      }
     },
     "localname": "EssemtecsUnderlying",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_EssemtecsUnderlyingGrossProfit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Essemtec\u2019s underlying gross profit.",
        "label": "EssemtecsUnderlyingGrossProfit",
        "terseLabel": "Essemtec\u2019s underlying gross profit (in Francs)"
       }
      }
     },
     "localname": "EssemtecsUnderlyingGrossProfit",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_EstimatedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated percentage.",
        "label": "EstimatedPercentage",
        "terseLabel": "Estimated percentage"
       }
      }
     },
     "localname": "EstimatedPercentage",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_EstimatedUsefulLives": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated useful lives.",
        "label": "EstimatedUsefulLives",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "EstimatedUsefulLives",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_EstimatedUsefulLivesOfCapitalizedDevelopmentCosts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EstimatedUsefulLivesOfCapitalizedDevelopmentCosts",
        "terseLabel": "Estimated useful lives of the capitalized development costs"
       }
      }
     },
     "localname": "EstimatedUsefulLivesOfCapitalizedDevelopmentCosts",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nndm_EuropeAndIsraelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EuropeAndIsraelMember",
        "terseLabel": "Europe and Israel [Member]"
       }
      }
     },
     "localname": "EuropeAndIsraelMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenuespergeographicallocationsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_EventsAfterReportingPeriodMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EventsAfterReportingPeriodMember",
        "terseLabel": "Non-adjusting events after reporting period [member]"
       }
      }
     },
     "localname": "EventsAfterReportingPeriodMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/EventsafterthereportingdateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_EventsafterthereportingdateDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events after the reporting date (Details) [Line Items]"
       }
      }
     },
     "localname": "EventsafterthereportingdateDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EventsafterthereportingdateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_EventsafterthereportingdateDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events after the reporting date (Details) [Table]"
       }
      }
     },
     "localname": "EventsafterthereportingdateDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EventsafterthereportingdateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ExchangeRateDifferences": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of exchange rate differences.",
        "label": "ExchangeRateDifferences",
        "terseLabel": "Exchange rate differences"
       }
      }
     },
     "localname": "ExchangeRateDifferences",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ExchangeRateOfCHF": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange rate of CHF.",
        "label": "ExchangeRateOfCHF",
        "terseLabel": "Exchange rate of CHF"
       }
      }
     },
     "localname": "ExchangeRateOfCHF",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofdetailsregardingtheexchangerateTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ExchangeRateOfEuro": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ExchangeRateOfEuro",
        "terseLabel": "Exchange rate of Euro"
       }
      }
     },
     "localname": "ExchangeRateOfEuro",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofdetailsregardingtheexchangerateTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ExchangeRateOfNis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ExchangeRateOfNis",
        "terseLabel": "Exchange rate of NIS"
       }
      }
     },
     "localname": "ExchangeRateOfNis",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofdetailsregardingtheexchangerateTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ExchangedEquitySettledSharebasedPaymentAwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ExchangedEquitySettledSharebasedPaymentAwards",
        "terseLabel": "Exchanged equity-settled share-based payment awards"
       }
      }
     },
     "localname": "ExchangedEquitySettledSharebasedPaymentAwards",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price.",
        "label": "ExercisePrice",
        "terseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePrice",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ExercisePriceForOption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exercise price of options.",
        "label": "ExercisePriceForOption",
        "terseLabel": "Exercise price per option (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePriceForOption",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ExercisePriceForWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exercise price of warrants.",
        "label": "ExercisePriceForWarrants",
        "terseLabel": "Exercise price (in Dollars per share)",
        "verboseLabel": "Warrants exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePriceForWarrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ExercisePricePerPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per price.",
        "label": "ExercisePricePerPrice",
        "terseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePricePerPrice",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ExercisePriceRange": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range.",
        "label": "ExercisePriceRange",
        "terseLabel": "Exercise price range (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePriceRange",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_FairValueAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount.",
        "label": "FairValueAmount",
        "terseLabel": "Fair value amount"
       }
      }
     },
     "localname": "FairValueAmount",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FairValueAssumptionExpectedDividendYield": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected dividend yield.",
        "label": "FairValueAssumptionExpectedDividendYield",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "FairValueAssumptionExpectedDividendYield",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_FairValueAssumptionExpectedTermOfWarrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of warrant.",
        "label": "FairValueAssumptionExpectedTermOfWarrant",
        "terseLabel": "Expected term of warrant"
       }
      }
     },
     "localname": "FairValueAssumptionExpectedTermOfWarrant",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nndm_FairValueAssumptionExpectedVolatility": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected volatility.",
        "label": "FairValueAssumptionExpectedVolatility",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "FairValueAssumptionExpectedVolatility",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_FairValueAssumptionRiskfreeRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk-free rate.",
        "label": "FairValueAssumptionRiskfreeRate",
        "terseLabel": "Risk-free rate"
       }
      }
     },
     "localname": "FairValueAssumptionRiskfreeRate",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_FairValueAtTheTransactionDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at the transaction date.",
        "label": "FairValueAtTheTransactionDate",
        "terseLabel": "Fair value at the transaction date"
       }
      }
     },
     "localname": "FairValueAtTheTransactionDate",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FairValueOfGrantOfShareBasedPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of grant of share based payment at grant date.",
        "label": "FairValueOfGrantOfShareBasedPayment",
        "terseLabel": "Fair value of grant of share based payment (in Dollars)"
       }
      }
     },
     "localname": "FairValueOfGrantOfShareBasedPayment",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FairValueOfOptionsGranted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value in the grant date.",
        "label": "FairValueOfOptionsGranted",
        "terseLabel": "Fair value in the grant date (thousands USD)"
       }
      }
     },
     "localname": "FairValueOfOptionsGranted",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FairValueOfPlanAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FairValueOfPlanAssetsMember",
        "terseLabel": "Fair value of plan assets [Member]"
       }
      }
     },
     "localname": "FairValueOfPlanAssetsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_FairValueOfPosteAquisitionCompensationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "FairValueOfPosteAquisitionCompensationCost",
        "terseLabel": "Fair value of post aquisition compensation cost (in Dollars)"
       }
      }
     },
     "localname": "FairValueOfPosteAquisitionCompensationCost",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FairValueOfSharesPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of shares price.",
        "label": "FairValueOfSharesPrice",
        "terseLabel": "Fair value of shares price (in Dollars per share)"
       }
      }
     },
     "localname": "FairValueOfSharesPrice",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_FairValueOfTheWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the warrants.",
        "label": "FairValueOfTheWarrants",
        "terseLabel": "Fair value of the warrants (in Dollars)"
       }
      }
     },
     "localname": "FairValueOfTheWarrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FairValueOfTheWarrantsDecreased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the warrants decreased.",
        "label": "FairValueOfTheWarrantsDecreased",
        "terseLabel": "Fair value of the warrants decreased (in Dollars)"
       }
      }
     },
     "localname": "FairValueOfTheWarrantsDecreased",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FinanceExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FinanceExpenseAbstract",
        "terseLabel": "Finance expense"
       }
      }
     },
     "localname": "FinanceExpenseAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancialInstrumentsCarriedAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "FinancialInstrumentsCarriedAtFairValue",
        "periodEndLabel": "Balance as of December 31, 2021",
        "periodStartLabel": "Balance as of January 1, 2021"
       }
      }
     },
     "localname": "FinancialInstrumentsCarriedAtFairValue",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofLevel3financialinstrumentscarriedatfairvalueTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FinancialInstrumentsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments (Details) [Line Items]"
       }
      }
     },
     "localname": "FinancialInstrumentsDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancialInstrumentsDetailsScheduleofclassificationandlinkagetermsoffinancialinstrumentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments (Details) - Schedule of classification and linkage terms of financial instruments [Line Items]"
       }
      }
     },
     "localname": "FinancialInstrumentsDetailsScheduleofclassificationandlinkagetermsoffinancialinstrumentsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancialInstrumentsDetailsScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments (Details) - Schedule of classification and linkage terms of financial instruments [Table]"
       }
      }
     },
     "localname": "FinancialInstrumentsDetailsScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancialInstrumentsDetailsScheduleofrepaymentdatesoffinancialliabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments (Details) - Schedule of repayment dates of financial liabilities [Line Items]"
       }
      }
     },
     "localname": "FinancialInstrumentsDetailsScheduleofrepaymentdatesoffinancialliabilitiesLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancialInstrumentsDetailsScheduleofrepaymentdatesoffinancialliabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments (Details) - Schedule of repayment dates of financial liabilities [Table]"
       }
      }
     },
     "localname": "FinancialInstrumentsDetailsScheduleofrepaymentdatesoffinancialliabilitiesTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancialInstrumentsDetailsScheduleofsensitivityanalysisofchangesinexchangerateofdollarLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments (Details) - Schedule of sensitivity analysis of changes in exchange rate of dollar [Line Items]"
       }
      }
     },
     "localname": "FinancialInstrumentsDetailsScheduleofsensitivityanalysisofchangesinexchangerateofdollarLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancialInstrumentsDetailsScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments (Details) - Schedule of sensitivity analysis of changes in exchange rate of dollar [Table]"
       }
      }
     },
     "localname": "FinancialInstrumentsDetailsScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancialInstrumentsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments (Details) [Table]"
       }
      }
     },
     "localname": "FinancialInstrumentsDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancialLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FinancialLiabilitiesAbstract",
        "terseLabel": "Financial liabilities:"
       }
      }
     },
     "localname": "FinancialLiabilitiesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoffinancialinstrumentspositionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancialLiabilitiesAtAmortizedCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial liabilities at amortized cost.",
        "label": "FinancialLiabilitiesAtAmortizedCosts",
        "negatedLabel": "Financial liabilities at amortized cost"
       }
      }
     },
     "localname": "FinancialLiabilitiesAtAmortizedCosts",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FinancualInstrumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FinancualInstrumentAxis",
        "terseLabel": "Financual Instrument [Axis]"
       }
      }
     },
     "localname": "FinancualInstrumentAxis",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_FinancualInstrumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FinancualInstrument [Domain]"
       }
      }
     },
     "localname": "FinancualInstrumentDomain",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_ForeignCurrencyTranslationDifferencesForForeignOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign currency translation differences for foreign operations.",
        "label": "ForeignCurrencyTranslationDifferencesForForeignOperations",
        "terseLabel": "Foreign currency translation differences for foreign operations"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationDifferencesForForeignOperations",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FounderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FounderMember",
        "terseLabel": "Founder [Member]"
       }
      }
     },
     "localname": "FounderMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_FundraisingExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This amount indicating fundraising expenses.",
        "label": "FundraisingExpense",
        "terseLabel": "Fundraising expenses"
       }
      }
     },
     "localname": "FundraisingExpense",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_FutureSalaryGrowth": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FutureSalaryGrowth",
        "negatedLabel": "Future salary growth"
       }
      }
     },
     "localname": "FutureSalaryGrowth",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofprincipalactuarialassumptionsatthereportingdateexpressedasweightedaveragesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_FutureSalaryIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "FutureSalaryIncrease",
        "terseLabel": "Future salary growth"
       }
      }
     },
     "localname": "FutureSalaryIncrease",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_GainLossOnDispositionOfAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "GainLossOnDispositionOfAsset",
        "negatedLabel": "Loss from disposal of property plant and equipment and right-of-use assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAsset",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_GainsLossesOnExchangeDifferencesOnTranslationNetsOfTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "GainsLossesOnExchangeDifferencesOnTranslationNetsOfTaxes",
        "terseLabel": "Exchange rate differences"
       }
      }
     },
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetsOfTaxes",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_GeneralDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Hedge Accounting [Abstract]"
       }
      }
     },
     "localname": "GeneralDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_GeneralDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General (Details) [Table]"
       }
      }
     },
     "localname": "GeneralDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/GeneralDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_GeneralLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of general hedge accounting [Abstract]"
       }
      }
     },
     "localname": "GeneralLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/General"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_GeneralMeetingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GeneralMeetingMember",
        "terseLabel": "General Meeting [Member]"
       }
      }
     },
     "localname": "GeneralMeetingMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_GeneralTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General [Table]"
       }
      }
     },
     "localname": "GeneralTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/General"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_GeographicalsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "GeographicalsAxis",
        "terseLabel": "Geographicals [Axis]"
       }
      }
     },
     "localname": "GeographicalsAxis",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenuespergeographicallocationsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_GeographicalsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographicals [Domain]"
       }
      }
     },
     "localname": "GeographicalsDomain",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenuespergeographicallocationsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_GovernmentAuthorities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of receivables in respect to goverment authorities.",
        "label": "GovernmentAuthorities",
        "terseLabel": "Government authorities"
       }
      }
     },
     "localname": "GovernmentAuthorities",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofotherreceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_GovernmentGrant": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goverments grants costs related to research and development expenses.",
        "label": "GovernmentGrant",
        "negatedLabel": "Less \u2013 government grants"
       }
      }
     },
     "localname": "GovernmentGrant",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_GovernmentGrantsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of government grants received.",
        "label": "GovernmentGrantsReceived",
        "terseLabel": "Amounts received during the year"
       }
      }
     },
     "localname": "GovernmentGrantsReceived",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofliabilityinrespectofgovernmentgrantsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_GovernmentGrantsRecognizedAsOffsetFromResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of government grants recognized as an offset from research and development expenses.",
        "label": "GovernmentGrantsRecognizedAsOffsetFromResearchAndDevelopmentExpenses",
        "negatedLabel": "Amounts recognized as an offset from research and development expenses"
       }
      }
     },
     "localname": "GovernmentGrantsRecognizedAsOffsetFromResearchAndDevelopmentExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofliabilityinrespectofgovernmentgrantsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_GovernmentGrantsRevaluationLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of revaluation of the liability in respect of government grants.",
        "label": "GovernmentGrantsRevaluationLiability",
        "terseLabel": "Revaluation of the liability"
       }
      }
     },
     "localname": "GovernmentGrantsRevaluationLiability",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofliabilityinrespectofgovernmentgrantsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_GrantedOptionsToPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted options to purchase.",
        "label": "GrantedOptionsToPurchase",
        "terseLabel": "Granted options to purchase (in Shares)"
       }
      }
     },
     "localname": "GrantedOptionsToPurchase",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_GrantedOptionsToPurchaseInAddition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted options to purchase in addition.",
        "label": "GrantedOptionsToPurchaseInAddition",
        "terseLabel": "In addition granted options to purchase (in Shares)"
       }
      }
     },
     "localname": "GrantedOptionsToPurchaseInAddition",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_GrossCarryingAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross carrying amount recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon.",
        "label": "GrossCarryingAmount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "GrossCarryingAmount",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_GrossMarginBasedEarnOut": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of gross margin based earn-out.",
        "label": "GrossMarginBasedEarnOut",
        "terseLabel": "Gross margin based earn out, description"
       }
      }
     },
     "localname": "GrossMarginBasedEarnOut",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_GrossProfitBasedEarnOutDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of gross profit based earn out.",
        "label": "GrossProfitBasedEarnOutDescription",
        "terseLabel": "Gross profit based earn out, description"
       }
      }
     },
     "localname": "GrossProfitBasedEarnOutDescription",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ImpairmentLossesOnIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": 5.0,
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment losses on intangible assets.",
        "label": "ImpairmentLossesOnIntangibleAssets",
        "terseLabel": "Impairment losses"
       }
      }
     },
     "localname": "ImpairmentLossesOnIntangibleAssets",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_IncludedInOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IncludedInOtherComprehensiveIncomeAbstract",
        "terseLabel": "Included in other comprehensive income"
       }
      }
     },
     "localname": "IncludedInOtherComprehensiveIncomeAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_IncomeTaxDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax (Details) [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_IncomeTaxDetailsScheduleofmovementindeferredtaxassetsandliabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax (Details) - Schedule of movement in deferred tax assets and liabilities [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxDetailsScheduleofmovementindeferredtaxassetsandliabilitiesLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementindeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_IncomeTaxDetailsScheduleofmovementindeferredtaxassetsandliabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax (Details) - Schedule of movement in deferred tax assets and liabilities [Table]"
       }
      }
     },
     "localname": "IncomeTaxDetailsScheduleofmovementindeferredtaxassetsandliabilitiesTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementindeferredtaxassetsandliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_IncomeTaxDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax (Details) [Table]"
       }
      }
     },
     "localname": "IncomeTaxDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_IncreaseDecreaseInExchangeRatesOfEuro": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInExchangeRatesOfEuro",
        "terseLabel": "Change in percentages of Euro"
       }
      }
     },
     "localname": "IncreaseDecreaseInExchangeRatesOfEuro",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofdetailsregardingtheexchangerateTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_IncreaseDecreaseInExchangeRatesOfNis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInExchangeRatesOfNis",
        "terseLabel": "Change in percentages of NIS"
       }
      }
     },
     "localname": "IncreaseDecreaseInExchangeRatesOfNis",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofdetailsregardingtheexchangerateTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_IncreaseInDeferredTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseInDeferredTax",
        "terseLabel": "Increase in deferred tax"
       }
      }
     },
     "localname": "IncreaseInDeferredTax",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_IncreaseThroughBusinessCombinationExplanatory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase through business combination.",
        "label": "IncreaseThroughBusinessCombinationExplanatory",
        "terseLabel": "Increase through business combination"
       }
      }
     },
     "localname": "IncreaseThroughBusinessCombinationExplanatory",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofliabilityinrespectofgovernmentgrantsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_IndefinitelivedIntangibleAssetAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IndefinitelivedIntangibleAssetAxis",
        "terseLabel": "Indefinite-lived Intangible Asset [Axis]"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetAxis",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_IndefinitelivedIntangibleAssetDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IndefinitelivedIntangibleAsset [Domain]"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetDomain",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_IntangibleAssetsAmortizationandimpairmentlosses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IntangibleAssetsAmortizationandimpairmentlosses",
        "periodEndLabel": "Amortization and impairment losses, Ending balance",
        "periodStartLabel": "Amortization and impairment losses, Beginning balance"
       }
      }
     },
     "localname": "IntangibleAssetsAmortizationandimpairmentlosses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_IntangibleAssetsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets (Details) [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_IntangibleAssetsDetailsScheduleofmovementincarryingamountLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets (Details) - Schedule of movement in carrying amount [Line Items]"
       }
      }
     },
     "localname": "IntangibleAssetsDetailsScheduleofmovementincarryingamountLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_IntangibleAssetsDetailsScheduleofmovementincarryingamountTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets (Details) - Schedule of movement in carrying amount [Table]"
       }
      }
     },
     "localname": "IntangibleAssetsDetailsScheduleofmovementincarryingamountTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_IntangibleAssetsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets (Details) [Table]"
       }
      }
     },
     "localname": "IntangibleAssetsDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_IntangibleAssetsEndingBalance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IntangibleAssetsEndingBalance",
        "periodEndLabel": "Intangible Assets, ending",
        "periodStartLabel": "Intangible Assets, beginning"
       }
      }
     },
     "localname": "IntangibleAssetsEndingBalance",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_InterestRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "InterestRateMember",
        "terseLabel": "Increase at a rate of 5% [Member]"
       }
      }
     },
     "localname": "InterestRateMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_InterestRateOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "InterestRateOneMember",
        "terseLabel": "Increase at a rate of 10% [Member]"
       }
      }
     },
     "localname": "InterestRateOneMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_InterestRateThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "InterestRateThreeMember",
        "terseLabel": "Decrease at a rate of 10% [Member]"
       }
      }
     },
     "localname": "InterestRateThreeMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_InterestRateTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "InterestRateTwoMember",
        "terseLabel": "Decrease at a rate of 5% [Member]"
       }
      }
     },
     "localname": "InterestRateTwoMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofsensitivityanalysisofchangesinexchangerateofdollarTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_InterestReceived": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest received.",
        "label": "InterestReceived",
        "terseLabel": "Interest received"
       }
      }
     },
     "localname": "InterestReceived",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_InvestmentInRestrictedBankDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in restricted bank deposits.",
        "label": "InvestmentInRestrictedBankDeposits",
        "terseLabel": "Investment in bank deposits net"
       }
      }
     },
     "localname": "InvestmentInRestrictedBankDeposits",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_InvestorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "InvestorsMember",
        "terseLabel": "Investor [Member]"
       }
      }
     },
     "localname": "InvestorsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_IssuedAndPaidUpShareCapital": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued and paid-up share capital.",
        "label": "IssuedAndPaidUpShareCapital",
        "terseLabel": "Issued and paid-up share capital as at December 31"
       }
      }
     },
     "localname": "IssuedAndPaidUpShareCapital",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofsharecapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_IssuedAndPaidinShareCapital": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issued and paid-in share capital.",
        "label": "IssuedAndPaidinShareCapital",
        "terseLabel": "Issued and paid-in share capital as at December 31"
       }
      }
     },
     "localname": "IssuedAndPaidinShareCapital",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofissuedsharecapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_IssuedForPurchaseOfCompanies": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issued for purchase of companies.",
        "label": "IssuedForPurchaseOfCompanies",
        "terseLabel": "Issued for purchase of companies during the period"
       }
      }
     },
     "localname": "IssuedForPurchaseOfCompanies",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofissuedsharecapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_JAMESGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAMESGmbHMember",
        "terseLabel": "J.A.M.E.S GmbH [Member]"
       }
      }
     },
     "localname": "JAMESGmbHMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_LeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.",
        "label": "LeaseLiability",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_LeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LeaseMember",
        "terseLabel": "Lease [Member]"
       }
      }
     },
     "localname": "LeaseMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_LeasesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) [Line Items]"
       }
      }
     },
     "localname": "LeasesDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_LeasesDetailsScheduleofleaseliabilityandrightofuseassetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) - Schedule of lease liability and right of use asset [Line Items]"
       }
      }
     },
     "localname": "LeasesDetailsScheduleofleaseliabilityandrightofuseassetLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_LeasesDetailsScheduleofleaseliabilityandrightofuseassetTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) - Schedule of lease liability and right of use asset [Table]"
       }
      }
     },
     "localname": "LeasesDetailsScheduleofleaseliabilityandrightofuseassetTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofleaseliabilityandrightofuseassetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_LeasesDetailsScheduleofmaturityanalysisofthegroupsleaseliabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) - Schedule of maturity analysis of the group's lease liabilities [Line Items]"
       }
      }
     },
     "localname": "LeasesDetailsScheduleofmaturityanalysisofthegroupsleaseliabilitiesLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmaturityanalysisofthegroupsleaseliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_LeasesDetailsScheduleofmaturityanalysisofthegroupsleaseliabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) - Schedule of maturity analysis of the group's lease liabilities [Table]"
       }
      }
     },
     "localname": "LeasesDetailsScheduleofmaturityanalysisofthegroupsleaseliabilitiesTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmaturityanalysisofthegroupsleaseliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_LeasesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases (Details) [Table]"
       }
      }
     },
     "localname": "LeasesDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_LiabilityInRespectOfConvertibleNotesAndWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability in respect of convertible notes and warrants.",
        "label": "LiabilityInRespectOfConvertibleNotesAndWarrants",
        "terseLabel": "Liability in respect of warrants"
       }
      }
     },
     "localname": "LiabilityInRespectOfConvertibleNotesAndWarrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_LiabilityInRespectOfGovernmentGrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability in respect of government grants.",
        "label": "LiabilityInRespectOfGovernmentGrants",
        "terseLabel": "Liability in respect of government grants"
       }
      }
     },
     "localname": "LiabilityInRespectOfGovernmentGrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_LiabilityInRespectOfWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability in respect of warrants.",
        "label": "LiabilityInRespectOfWarrants",
        "terseLabel": "Liability in respect of warrants"
       }
      }
     },
     "localname": "LiabilityInRespectOfWarrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoffinancialinstrumentspositionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_LiabilityinRespectofGovernmentGrantsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability in Respect of Government Grants (Details) [Line Items]"
       }
      }
     },
     "localname": "LiabilityinRespectofGovernmentGrantsDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_LiabilityinRespectofGovernmentGrantsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability in Respect of Government Grants (Details) [Table]"
       }
      }
     },
     "localname": "LiabilityinRespectofGovernmentGrantsDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_LongTermLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LongTermLiabilities",
        "terseLabel": "Long term liabilities"
       }
      }
     },
     "localname": "LongTermLiabilities",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_LossAttributableToOrdinaryShareholders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss attributable to ordinary shareholders.",
        "label": "LossAttributableToOrdinaryShareholders",
        "terseLabel": "Loss attributable to ordinary shareholders"
       }
      }
     },
     "localname": "LossAttributableToOrdinaryShareholders",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoflossattributabletoownersofthecompanydilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_LossAttributableToOwnersOfTheCompanydilutedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss attributable to owners of the company (diluted).",
        "label": "LossAttributableToOwnersOfTheCompanydilutedTableTextBlock",
        "terseLabel": "Schedule of loss attributable to owners of the company (diluted)"
       }
      }
     },
     "localname": "LossAttributableToOwnersOfTheCompanydilutedTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_LossAttributableToTheOwnersOfTheCompany": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Attributable to the owners of the company.",
        "label": "LossAttributableToTheOwnersOfTheCompany",
        "terseLabel": "Loss attributable to the owners of the company"
       }
      }
     },
     "localname": "LossAttributableToTheOwnersOfTheCompany",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofbasiclosspershareTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_LossOnConversionPrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss on conversion price.",
        "label": "LossOnConversionPrice",
        "terseLabel": "Loss on conversion price"
       }
      }
     },
     "localname": "LossOnConversionPrice",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_LossUsedToCalculateBasicLossPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss used to calculate basic loss per share.",
        "label": "LossUsedToCalculateBasicLossPerShare",
        "terseLabel": "Loss used to calculate basic loss per share"
       }
      }
     },
     "localname": "LossUsedToCalculateBasicLossPerShare",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoflossattributabletoownersofthecompanydilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_MachineryAndEquipmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Machinery and equipments member.",
        "label": "MachineryAndEquipmentsMember",
        "terseLabel": "Machinery and equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_MachineryEquipmentAndVehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MachineryEquipmentAndVehiclesMember",
        "terseLabel": "Machinery, equipment and vehicles [Member]"
       }
      }
     },
     "localname": "MachineryEquipmentAndVehiclesMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_MarketingAndAdvertisingSalesAndMarketingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketing and advertising.",
        "label": "MarketingAndAdvertisingSalesAndMarketingExpenses",
        "terseLabel": "Marketing, advertising and commissions"
       }
      }
     },
     "localname": "MarketingAndAdvertisingSalesAndMarketingExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_Materials": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services.",
        "label": "Materials",
        "terseLabel": "Materials"
       }
      }
     },
     "localname": "Materials",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_MaturityTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturity term.",
        "label": "MaturityTerm",
        "terseLabel": "Maturity term"
       }
      }
     },
     "localname": "MaturityTerm",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nndm_MechanismPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mechanism period.",
        "label": "MechanismPeriod",
        "terseLabel": "Mechanism period"
       }
      }
     },
     "localname": "MechanismPeriod",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nndm_MrYaronEitanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MrYaronEitanMember",
        "terseLabel": "Mr. Yaron Eitan [Member]"
       }
      }
     },
     "localname": "MrYaronEitanMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NISMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NISMember",
        "terseLabel": "NIS [Member]"
       }
      }
     },
     "localname": "NISMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NanoDimensionGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NanoDimensionGmbHMember",
        "terseLabel": "Nano Dimension GmbH [Member]"
       }
      }
     },
     "localname": "NanoDimensionGmbHMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NanoDimensionHKLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NanoDimensionHKLimitedMember",
        "terseLabel": "Nano Dimension (HK) Limited [Member]"
       }
      }
     },
     "localname": "NanoDimensionHKLimitedMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NanoDimensionIPLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NanoDimensionIPLtdMember",
        "terseLabel": "Nano Dimension IP Ltd. [Member]"
       }
      }
     },
     "localname": "NanoDimensionIPLtdMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NanoDimensionSwissMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NanoDimensionSwissMember",
        "terseLabel": "Nano Dimension Swiss [Member]"
       }
      }
     },
     "localname": "NanoDimensionSwissMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NanoDimensionTechnologiesLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NanoDimensionTechnologiesLtdMember",
        "terseLabel": "Nano Dimension Technologies Ltd. [Member]"
       }
      }
     },
     "localname": "NanoDimensionTechnologiesLtdMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NanoDimensionUSAIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NanoDimensionUSAIncMember",
        "terseLabel": "Nano Dimension USA Inc. [Member]"
       }
      }
     },
     "localname": "NanoDimensionUSAIncMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NanoFabricaLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NanoFabricaLtdMember",
        "terseLabel": "NanoFabrica Ltd [Member]"
       }
      }
     },
     "localname": "NanoFabricaLtdMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable_Parentheticals",
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NanoFabricaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NanoFabricaMember",
        "terseLabel": "NanoFabrica [Member]"
       }
      }
     },
     "localname": "NanoFabricaMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails",
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NanoFabricasRevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NanoFabricasRevenuesMember",
        "terseLabel": "NanoFabrica\u2019s revenues [Member]"
       }
      }
     },
     "localname": "NanoFabricasRevenuesMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NegativeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NegativeMember",
        "terseLabel": "Negative [Member]"
       }
      }
     },
     "localname": "NegativeMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NetChangesOfTranslationReserve": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net changes of translation reserve.",
        "label": "NetChangesOfTranslationReserve",
        "terseLabel": "Net changes of translation reserve"
       }
      }
     },
     "localname": "NetChangesOfTranslationReserve",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_NetDefinedBenefitLiabilityassetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NetDefinedBenefitLiabilityassetMember",
        "terseLabel": "Net defined benefit liability (asset) [Member]"
       }
      }
     },
     "localname": "NetDefinedBenefitLiabilityassetMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NetTrustForEarnout": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net trust for earn-out.",
        "label": "NetTrustForEarnout",
        "terseLabel": "Net trust for earn-out"
       }
      }
     },
     "localname": "NetTrustForEarnout",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TradeReceivablesandOtherReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_NeutralMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NeutralMember",
        "terseLabel": "Neutral [Member]"
       }
      }
     },
     "localname": "NeutralMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_NonCashTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NonCashTransactionsAbstract",
        "terseLabel": "Non-cash transactions:"
       }
      }
     },
     "localname": "NonCashTransactionsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_NonTradableWarrantsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Tradable Warrants Exercise price.",
        "label": "NonTradableWarrantsExercisePrice",
        "terseLabel": "Non-tradable warrants exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "NonTradableWarrantsExercisePrice",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_NonTradableWarrantsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Tradable Warrants Term.",
        "label": "NonTradableWarrantsTerm",
        "terseLabel": "Non-tradable warrants term"
       }
      }
     },
     "localname": "NonTradableWarrantsTerm",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nndm_NonTradableWarrantsToPurchaseDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Non Tradable Warrants To Purchase Description",
        "label": "NonTradableWarrantsToPurchaseDescription",
        "terseLabel": "Non tradable warrants to purchase description"
       }
      }
     },
     "localname": "NonTradableWarrantsToPurchaseDescription",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_NontradableRightsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-tradable rights Term.",
        "label": "NontradableRightsTerm",
        "terseLabel": "Non-tradable rights term"
       }
      }
     },
     "localname": "NontradableRightsTerm",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nndm_NontradableRightsToPurchaseShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-tradable rights to purchase shares.",
        "label": "NontradableRightsToPurchaseShares",
        "terseLabel": "Non-tradable rights to purchase shares (in Shares)"
       }
      }
     },
     "localname": "NontradableRightsToPurchaseShares",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfAdditionalAmericanDepositorySharesPurchaseByIssuancesOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional american depository shares purchase by issuances of warrants.",
        "label": "NumberOfAdditionalAmericanDepositorySharesPurchaseByIssuancesOfWarrants",
        "terseLabel": "Number of additional american depository shares purchase by issuances of warrants"
       }
      }
     },
     "localname": "NumberOfAdditionalAmericanDepositorySharesPurchaseByIssuancesOfWarrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfAmericanDepositaryShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of american depositary share.",
        "label": "NumberOfAmericanDepositaryShare",
        "terseLabel": "Number of american depositary share (in Shares)"
       }
      }
     },
     "localname": "NumberOfAmericanDepositaryShare",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfAmericanDepositarySharePurchaseByIssuancesOfOption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of american depositary share purchase by issuances of option.",
        "label": "NumberOfAmericanDepositarySharePurchaseByIssuancesOfOption",
        "terseLabel": "Number of ADS purchase by issuances of option."
       }
      }
     },
     "localname": "NumberOfAmericanDepositarySharePurchaseByIssuancesOfOption",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfAmericanDepositorySharesPurchaseByIssuancesOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ADS purchase by issuances of warrants.",
        "label": "NumberOfAmericanDepositorySharesPurchaseByIssuancesOfWarrants",
        "terseLabel": "Number of ADS purchase by issuances of warrants"
       }
      }
     },
     "localname": "NumberOfAmericanDepositorySharesPurchaseByIssuancesOfWarrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfDirectorsinShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of directors transactions.",
        "label": "NumberOfDirectorsinShares",
        "terseLabel": "Number of directors"
       }
      }
     },
     "localname": "NumberOfDirectorsinShares",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofshareholderandotherrelatedpartiesbenefitsTable"
     ],
     "xbrltype": "integerItemType"
    },
    "nndm_NumberOfGrantedNonTradableShareOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of share options granted non-tradable in a share-based payment arrangement.",
        "label": "NumberOfGrantedNonTradableShareOptions",
        "terseLabel": "Number of granted non - tradable share options",
        "verboseLabel": "Grant of stock options (in Shares)"
       }
      }
     },
     "localname": "NumberOfGrantedNonTradableShareOptions",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfNonTradableWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Non tradable warrants.",
        "label": "NumberOfNonTradableWarrants",
        "terseLabel": "Number of non-tradable warrants (in Shares)"
       }
      }
     },
     "localname": "NumberOfNonTradableWarrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfOrdinarySharesExercisableByWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares exercisable by warrants.",
        "label": "NumberOfOrdinarySharesExercisableByWarrants",
        "terseLabel": "Number of ordinary shares exercisable by warrants"
       }
      }
     },
     "localname": "NumberOfOrdinarySharesExercisableByWarrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfPortionOfAmortization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equal annual portion of amortization.",
        "label": "NumberOfPortionOfAmortization",
        "terseLabel": "Number of equal annual portion of amortization"
       }
      }
     },
     "localname": "NumberOfPortionOfAmortization",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "nndm_NumberOfRelatedParties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of related parties held by the entity at a date.",
        "label": "NumberOfRelatedParties",
        "terseLabel": "Number of related parties"
       }
      }
     },
     "localname": "NumberOfRelatedParties",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofshareholderandotherrelatedpartiesbenefitsTable"
     ],
     "xbrltype": "integerItemType"
    },
    "nndm_NumberOfShareOptionsExercisableIntoOrdinaryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NumberOfShareOptionsExercisableIntoOrdinaryShares",
        "terseLabel": "Share options exercisable into ordinary shares"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisableIntoOrdinaryShares",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfShareOptionsGrantedExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options granted, Exercisable.",
        "label": "NumberOfShareOptionsGrantedExercisable",
        "terseLabel": "Exercisable as of December 31"
       }
      }
     },
     "localname": "NumberOfShareOptionsGrantedExercisable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable00"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfShareOptionsGrantedOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NumberOfShareOptionsGrantedOutstanding",
        "periodEndLabel": "Outstanding at December 31",
        "periodStartLabel": "Outstanding at January 1"
       }
      }
     },
     "localname": "NumberOfShareOptionsGrantedOutstanding",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable00"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfSharesOptionExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Shares Option Exercised.",
        "label": "NumberOfSharesOptionExercised",
        "terseLabel": "Exercised during the year"
       }
      }
     },
     "localname": "NumberOfSharesOptionExercised",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable00"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfSharesOptionForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Shares Option Forfeited.",
        "label": "NumberOfSharesOptionForfeited",
        "terseLabel": "Forfeited or expired during the year"
       }
      }
     },
     "localname": "NumberOfSharesOptionForfeited",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable00"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfSharesOptionGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Shares Option Granted.",
        "label": "NumberOfSharesOptionGranted",
        "terseLabel": "Granted during the year"
       }
      }
     },
     "localname": "NumberOfSharesOptionGranted",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable00"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberOfWarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants issued.",
        "label": "NumberOfWarrantsIssued",
        "terseLabel": "Warrants granted"
       }
      }
     },
     "localname": "NumberOfWarrantsIssued",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberofOrdinarySharesConvertedintoCoversionNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares converted in to conversion notes.",
        "label": "NumberofOrdinarySharesConvertedintoCoversionNotes",
        "terseLabel": "Conversion into shares of convertible notes during the period"
       }
      }
     },
     "localname": "NumberofOrdinarySharesConvertedintoCoversionNotes",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofissuedsharecapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberofOrdinarySharesExerciseOfShareOptionsDuringThePeriodinShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares exercise of share option during the period.",
        "label": "NumberofOrdinarySharesExerciseOfShareOptionsDuringThePeriodinShares",
        "terseLabel": "Exercise of share options during the period"
       }
      }
     },
     "localname": "NumberofOrdinarySharesExerciseOfShareOptionsDuringThePeriodinShares",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofissuedsharecapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberofOrdinarySharesExerciseOfWarrantsDuringThePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares exercise of warrants during the period.",
        "label": "NumberofOrdinarySharesExerciseOfWarrantsDuringThePeriod",
        "terseLabel": "Exercise of warrants during the period"
       }
      }
     },
     "localname": "NumberofOrdinarySharesExerciseOfWarrantsDuringThePeriod",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofissuedsharecapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_NumberofOrdinarySharesIssuedForCash": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares issued for cash.",
        "label": "NumberofOrdinarySharesIssuedForCash",
        "terseLabel": "Issued for cash during the period"
       }
      }
     },
     "localname": "NumberofOrdinarySharesIssuedForCash",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofissuedsharecapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_OfficeExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of office general and administrative expenses.",
        "label": "OfficeExpenses",
        "terseLabel": "Office expenses"
       }
      }
     },
     "localname": "OfficeExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_OfficeFurnitureAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office furniture and equipment.",
        "label": "OfficeFurnitureAndEquipmentMember",
        "terseLabel": "Office furniture and equipment [Member]"
       }
      }
     },
     "localname": "OfficeFurnitureAndEquipmentMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_OfficersAndDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Officers and directors [Member]",
        "label": "OfficersAndDirectorsMember",
        "terseLabel": "Officer and Director [Member]"
       }
      }
     },
     "localname": "OfficersAndDirectorsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_OperatingLossCarryforwardsTaxAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net operating loss carryforward tax as of the reporting date.",
        "label": "OperatingLossCarryforwardsTaxAmount",
        "terseLabel": "Net operating loss for tax"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTaxAmount",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_OptionVestedTermDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of option vested term.",
        "label": "OptionVestedTermDescription",
        "terseLabel": "Option vested term, description"
       }
      }
     },
     "localname": "OptionVestedTermDescription",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_OptionsAndWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options and warrants.",
        "label": "OptionsAndWarrants",
        "terseLabel": "Options and warrants"
       }
      }
     },
     "localname": "OptionsAndWarrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_OrdinarySharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of ordinary shares issued.",
        "label": "OrdinarySharesIssued",
        "terseLabel": "Issued as at January 1"
       }
      }
     },
     "localname": "OrdinarySharesIssued",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofissuedsharecapitalTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_OrdinarySharesIssuedToFounder": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OrdinarySharesIssuedToFounder",
        "terseLabel": "Ordinary shares issued to founder"
       }
      }
     },
     "localname": "OrdinarySharesIssuedToFounder",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_Other": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Othe payable amount.",
        "label": "Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "Other",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_OtherGeneralAndAdministrativeExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense arising from travel.",
        "label": "OtherGeneralAndAdministrativeExpenses",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherGeneralAndAdministrativeExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_OtherLongtermLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other long-term liability.",
        "label": "OtherLongtermLiability",
        "terseLabel": "Other long-term liability"
       }
      }
     },
     "localname": "OtherLongtermLiability",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrepaymentdatesoffinancialliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OtherMember",
        "terseLabel": "Other [Member]"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_OtherMovementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OtherMovementsAbstract",
        "terseLabel": "Other movements"
       }
      }
     },
     "localname": "OtherMovementsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementinnetdefinedbenefitliabilitiesassetsandintheircomponentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_OtherReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note.",
        "label": "OtherReceivable",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_OtherResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of other research and development expense related to research and development expenses.",
        "label": "OtherResearchAndDevelopmentExpenses",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherResearchAndDevelopmentExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_OtherSalesAndMarketingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other sales and marketing expense.",
        "label": "OtherSalesAndMarketingExpenses",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSalesAndMarketingExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_OtherShareholderPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other shareholder percentage.",
        "label": "OtherShareholderPercentage",
        "terseLabel": "Other shareholder percentage"
       }
      }
     },
     "localname": "OtherShareholderPercentage",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_OtherlongtermliabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other long-term liabilities [Abstract]"
       }
      }
     },
     "localname": "OtherlongtermliabilitiesLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Otherlongtermliabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_OtherlongtermliabilitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other long-term liabilities [Table]"
       }
      }
     },
     "localname": "OtherlongtermliabilitiesTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/Otherlongtermliabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_Others": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of other current receivables.",
        "label": "Others",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "Others",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofotherreceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_OthersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OthersMember",
        "terseLabel": "Other [Member]"
       }
      }
     },
     "localname": "OthersMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_OthersReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.",
        "label": "OthersReceivables",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OthersReceivables",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofotherreceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_OutstandingShareOptionsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding Share Options Granted.",
        "label": "OutstandingShareOptionsGranted",
        "terseLabel": "Outstanding as of December 31, 2021"
       }
      }
     },
     "localname": "OutstandingShareOptionsGranted",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_OutstandingShareOptionsGrantedExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding Share Options Granted Exercisable.",
        "label": "OutstandingShareOptionsGrantedExercisable",
        "terseLabel": "Exercisable as of December 31, 2021 (from grants granted in 2019-2021)"
       }
      }
     },
     "localname": "OutstandingShareOptionsGrantedExercisable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_OwnsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Owns percentage.",
        "label": "OwnsPercentage",
        "terseLabel": "Owns percentage"
       }
      }
     },
     "localname": "OwnsPercentage",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_PatentRightsCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of patent rights costs related to research and development expenses.",
        "label": "PatentRightsCosts",
        "terseLabel": "Patent registration"
       }
      }
     },
     "localname": "PatentRightsCosts",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_PaymentInEquityInstruments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment in equity instruments.",
        "label": "PaymentInEquityInstruments",
        "terseLabel": "Payment in equity instruments (in Shares)"
       }
      }
     },
     "localname": "PaymentInEquityInstruments",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_PayrollExpenseRelatedToResearchAndDevelopmentExpensesNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payroll expense related to research and development expenses.",
        "label": "PayrollExpenseRelatedToResearchAndDevelopmentExpensesNet",
        "terseLabel": "Payroll"
       }
      }
     },
     "localname": "PayrollExpenseRelatedToResearchAndDevelopmentExpensesNet",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_PayrollGeneralAndAdministrativeExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payroll general and administrative expenses.",
        "label": "PayrollGeneralAndAdministrativeExpenses",
        "terseLabel": "Payroll"
       }
      }
     },
     "localname": "PayrollGeneralAndAdministrativeExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_PayrollSalesAndMarketingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payroll expenses related to sales and marketing expenses.",
        "label": "PayrollSalesAndMarketingExpenses",
        "terseLabel": "Payroll"
       }
      }
     },
     "localname": "PayrollSalesAndMarketingExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_PensionersBenefitLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PensionersBenefitLiabilityMember",
        "terseLabel": "Pensioners Benefit Liability [Member]"
       }
      }
     },
     "localname": "PensionersBenefitLiabilityMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_PercentageOfDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of discount rate.",
        "label": "PercentageOfDiscountRate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "PercentageOfDiscountRate",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_PercentageOfFinancingFromGovernment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of of financing from the government.",
        "label": "PercentageOfFinancingFromGovernment",
        "terseLabel": "Percentage of financing from the government"
       }
      }
     },
     "localname": "PercentageOfFinancingFromGovernment",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_PercentageOfOptionVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of option vested at the grant date.",
        "label": "PercentageOfOptionVested",
        "terseLabel": "Percentage of option vested at the grant date"
       }
      }
     },
     "localname": "PercentageOfOptionVested",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_PercentageOfRoyalties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of royalties.",
        "label": "PercentageOfRoyalties",
        "terseLabel": "Royalties"
       }
      }
     },
     "localname": "PercentageOfRoyalties",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_PercentageOfWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of warrants exercised.",
        "label": "PercentageOfWarrantsExercised",
        "terseLabel": "Percentage of warrants exercised"
       }
      }
     },
     "localname": "PercentageOfWarrantsExercised",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_PercentagePointDecreaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PercentagePointDecreaseMember",
        "terseLabel": "0.5 Percentage Point Decrease [Member]"
       }
      }
     },
     "localname": "PercentagePointDecreaseMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_PercentagePointIncreaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PercentagePointIncreaseMember",
        "terseLabel": "0.5 Percentage Point Increase [Member]"
       }
      }
     },
     "localname": "PercentagePointIncreaseMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftherelevantactuarialassumptionsholdingotherassumptionsconstantTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_PositiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PositiveMember",
        "terseLabel": "Positive [Member]"
       }
      }
     },
     "localname": "PositiveMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_PostAcquisitionCompensationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of post acquisition compensation cost.",
        "label": "PostAcquisitionCompensationCost",
        "terseLabel": "Post acquisition compensation cost"
       }
      }
     },
     "localname": "PostAcquisitionCompensationCost",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_PostacquisitionCompensationCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Post-acquisition compensation cost.",
        "label": "PostacquisitionCompensationCost",
        "terseLabel": "Post-acquisition compensation cost (in Shares)"
       }
      }
     },
     "localname": "PostacquisitionCompensationCost",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_PresentedUnderCurrentLiabilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Presented under current liabilities.",
        "label": "PresentedUnderCurrentLiabilities",
        "terseLabel": "Presented under current liabilities"
       }
      }
     },
     "localname": "PresentedUnderCurrentLiabilities",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoffinancialinstrumentspositionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_PresentedUnderCurrentLiabilitiesOtherPayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PresentedUnderCurrentLiabilitiesOtherPayablesAbstract",
        "terseLabel": "Presented under current liabilities \u2013 other payables:"
       }
      }
     },
     "localname": "PresentedUnderCurrentLiabilitiesOtherPayablesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofemployeebenefitsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_PresentedUnderNonCurrentLiabilitiesEmployeeBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PresentedUnderNonCurrentLiabilitiesEmployeeBenefitsAbstract",
        "terseLabel": "Presented under non-current liabilities \u2013 employee benefits:"
       }
      }
     },
     "localname": "PresentedUnderNonCurrentLiabilitiesEmployeeBenefitsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcompositionofemployeebenefitsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_PrintersLeasedToClientsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Printers leased to clients member",
        "label": "PrintersLeasedToClientsMember",
        "terseLabel": "Printers leased to customers [Member]"
       }
      }
     },
     "localname": "PrintersLeasedToClientsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_PrivatePlacementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private placements",
        "label": "PrivatePlacementsMember",
        "terseLabel": "Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_ProFormaLoss": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro forma loss.",
        "label": "ProFormaLoss",
        "terseLabel": "Pro forma loss"
       }
      }
     },
     "localname": "ProFormaLoss",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ProFormaProfit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro forma profit.",
        "label": "ProFormaProfit",
        "terseLabel": "Pro forma profit"
       }
      }
     },
     "localname": "ProFormaProfit",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ProFormaRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro forma revenue.",
        "label": "ProFormaRevenue",
        "terseLabel": "Pro forma revenue"
       }
      }
     },
     "localname": "ProFormaRevenue",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ProceedFromIssuanceOfDebt": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "ProceedFromIssuanceOfDebt",
        "terseLabel": "Gross proceeds"
       }
      }
     },
     "localname": "ProceedFromIssuanceOfDebt",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ProceedsFromSaleOfFixedAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of fixed assets.",
        "label": "ProceedsFromSaleOfFixedAssets",
        "terseLabel": "Proceeds from sale of property plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfFixedAssets",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_PropertyAndEquipmentNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "PropertyAndEquipmentNet",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyAndEquipmentNet",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_PropertyPlantAndEquipmentAcquiredInCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property plant and equipment acquired in credit",
        "label": "PropertyPlantAndEquipmentAcquiredInCredit",
        "terseLabel": "Property plant and equipment acquired on credit"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAcquiredInCredit",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_PropertyplantandequipmentnetDetailsScheduleofpropertyplantandequipmentnetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment, net (Details) - Schedule of property plant and equipment, net [Line Items]"
       }
      }
     },
     "localname": "PropertyplantandequipmentnetDetailsScheduleofpropertyplantandequipmentnetLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_PropertyplantandequipmentnetDetailsScheduleofpropertyplantandequipmentnetTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property plant and equipment, net (Details) - Schedule of property plant and equipment, net [Table]"
       }
      }
     },
     "localname": "PropertyplantandequipmentnetDetailsScheduleofpropertyplantandequipmentnetTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_PublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public offering",
        "label": "PublicOfferingMember",
        "terseLabel": "Public Offering [Member]"
       }
      }
     },
     "localname": "PublicOfferingMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_QualifyingInsurancePoliciesAmountContributedFairValueOfPlanAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "QualifyingInsurancePoliciesAmountContributedFairValueOfPlanAssets",
        "terseLabel": "Qualifying insurance policies (in Dollars)"
       }
      }
     },
     "localname": "QualifyingInsurancePoliciesAmountContributedFairValueOfPlanAssets",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RawMaterialsForPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RawMaterialsForPropertyMember",
        "terseLabel": "Raw materials for property [Member]"
       }
      }
     },
     "localname": "RawMaterialsForPropertyMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentnetTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_RecoverableAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "RecoverableAmount",
        "terseLabel": "Recoverable amount (in Dollars)"
       }
      }
     },
     "localname": "RecoverableAmount",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RedemptionOfRestrictedBankDepositsClassifiedAsInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption of restricted bank deposits classified as investing activities",
        "label": "RedemptionOfRestrictedBankDepositsClassifiedAsInvestingActivities",
        "terseLabel": "Change in restricted bank deposits"
       }
      }
     },
     "localname": "RedemptionOfRestrictedBankDepositsClassifiedAsInvestingActivities",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RelationshipEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Relationship Entity",
        "label": "RelationshipEntityAxis",
        "terseLabel": "Relationship Entity [Axis]"
       }
      }
     },
     "localname": "RelationshipEntityAxis",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable00",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentTables",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_RelationshipEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RelationshipEntity [Domain]"
       }
      }
     },
     "localname": "RelationshipEntityDomain",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentTables",
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_RemainingFinancialLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining financial liabilities.",
        "label": "RemainingFinancialLiabilities",
        "terseLabel": "Remaining financial liabilities"
       }
      }
     },
     "localname": "RemainingFinancialLiabilities",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RentAndMaintenanceOfBuildings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "RentAndMaintenanceOfBuildings",
        "terseLabel": "Rental fees and maintenance"
       }
      }
     },
     "localname": "RentAndMaintenanceOfBuildings",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RentalFeesAndMaintenance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental fees and maintenance.",
        "label": "RentalFeesAndMaintenance",
        "terseLabel": "Rental fees and maintenance"
       }
      }
     },
     "localname": "RentalFeesAndMaintenance",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RentalFeesAndMaintenanceResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental fees and maintenance.",
        "label": "RentalFeesAndMaintenanceResearchAndDevelopmentExpenses",
        "terseLabel": "Rental fees and maintenance"
       }
      }
     },
     "localname": "RentalFeesAndMaintenanceResearchAndDevelopmentExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ReplacementAwardsExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ReplacementAwardsExercisable",
        "terseLabel": "Replacement awards, Exercisable as of December 31"
       }
      }
     },
     "localname": "ReplacementAwardsExercisable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ReplacementAwardsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ReplacementAwardsExercised",
        "terseLabel": "Replacement awards, Exercised during the year"
       }
      }
     },
     "localname": "ReplacementAwardsExercised",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ReplacementAwardsForfeitedOrExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ReplacementAwardsForfeitedOrExpired",
        "terseLabel": "Replacement awards, Forfeited or expired during the year"
       }
      }
     },
     "localname": "ReplacementAwardsForfeitedOrExpired",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ReplacementAwardsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ReplacementAwardsGranted",
        "terseLabel": "Replacement awards, Granted during the year"
       }
      }
     },
     "localname": "ReplacementAwardsGranted",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ReplacementAwardsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ReplacementAwardsOutstanding",
        "periodEndLabel": "Replacement awards, Outstanding at December 31",
        "periodStartLabel": "Replacement awards, Outstanding at January 1"
       }
      }
     },
     "localname": "ReplacementAwardsOutstanding",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ResearchAndDevelopmentDeductibleTermPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development deductible term period.",
        "label": "ResearchAndDevelopmentDeductibleTermPeriod",
        "terseLabel": "Research and development deductible term period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentDeductibleTermPeriod",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nndm_ResearchAndDevelopmentExpenseGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of research and development expense gross related to research and development expenses.",
        "label": "ResearchAndDevelopmentExpenseGross",
        "terseLabel": "Research and development expenses, gross"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseGross",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RestrictedDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash, in contrast to cash freely available for a company to spend or invest, refers to money that is held for a specific purpose and therefore not available to the company for immediate or general business use.",
        "label": "RestrictedDeposits",
        "terseLabel": "Restricted deposits",
        "verboseLabel": "Restricted deposit"
       }
      }
     },
     "localname": "RestrictedDeposits",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails",
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RevaluationOfFinancialLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revaluation of Financial liabilities.",
        "label": "RevaluationOfFinancialLiabilities",
        "negatedLabel": "Revaluation of financial liabilities accounted at fair value"
       }
      }
     },
     "localname": "RevaluationOfFinancialLiabilities",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RevaluationOfFinancialLiabilitiesAtFairValueThroughProfitOrLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revaluation of financial liabilities at fair value through profit or loss.",
        "label": "RevaluationOfFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
        "terseLabel": "Revaluation of financial liabilities at fair value through profit or loss"
       }
      }
     },
     "localname": "RevaluationOfFinancialLiabilitiesAtFairValueThroughProfitOrLoss",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RevaluationOfLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount indicates revaluation of lease liabilities.",
        "label": "RevaluationOfLeaseLiabilities",
        "terseLabel": "Finance expense in respect of lease liability"
       }
      }
     },
     "localname": "RevaluationOfLeaseLiabilities",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RevaluationOfLiabilitiesInRespectOfWarrantsAndRightsOfPurchase": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income relates to revaluation of liabilities in respect of warrants and rights of purchase.",
        "label": "RevaluationOfLiabilitiesInRespectOfWarrantsAndRightsOfPurchase",
        "terseLabel": "Revaluation of financial liabilities at fair value through profit or loss"
       }
      }
     },
     "localname": "RevaluationOfLiabilitiesInRespectOfWarrantsAndRightsOfPurchase",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RevaluationOfLiabilityInRespectOfGovernmentGrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expenses related to revaluation of liability in respect of government grants.",
        "label": "RevaluationOfLiabilityInRespectOfGovernmentGrants",
        "terseLabel": "Revaluation of liability in respect of government grants"
       }
      }
     },
     "localname": "RevaluationOfLiabilityInRespectOfGovernmentGrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RevaluationOfLiabilityInRespectsOfGovernmentGrant": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of incomes related to revaluation of liability in respect of government grants.",
        "label": "RevaluationOfLiabilityInRespectsOfGovernmentGrant",
        "terseLabel": "Revaluation of liability in respect of government grants"
       }
      }
     },
     "localname": "RevaluationOfLiabilityInRespectsOfGovernmentGrant",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_RevenuesAndRevenuesTerminalGrowthRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues and revenues terminal growth rate.",
        "label": "RevenuesAndRevenuesTerminalGrowthRate",
        "terseLabel": "Revenues and revenues terminal growth rate, description"
       }
      }
     },
     "localname": "RevenuesAndRevenuesTerminalGrowthRate",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_RevenuesDetailsScheduleofrevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues (Details) - Schedule of revenue [Line Items]"
       }
      }
     },
     "localname": "RevenuesDetailsScheduleofrevenueLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_RevenuesDetailsScheduleofrevenueTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues (Details) - Schedule of revenue [Table]"
       }
      }
     },
     "localname": "RevenuesDetailsScheduleofrevenueTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_RevenuesDetailsScheduleofrevenuespergeographicallocationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues (Details) - Schedule of revenues per geographical locations [Line Items]"
       }
      }
     },
     "localname": "RevenuesDetailsScheduleofrevenuespergeographicallocationsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenuespergeographicallocationsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_RevenuesDetailsScheduleofrevenuespergeographicallocationsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues (Details) - Schedule of revenues per geographical locations [Table]"
       }
      }
     },
     "localname": "RevenuesDetailsScheduleofrevenuespergeographicallocationsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenuespergeographicallocationsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_RevenuesDetailsScheduleoftimingofrevenuerecognitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues (Details) - Schedule of timing of revenue recognition [Line Items]"
       }
      }
     },
     "localname": "RevenuesDetailsScheduleoftimingofrevenuerecognitionLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftimingofrevenuerecognitionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_RevenuesDetailsScheduleoftimingofrevenuerecognitionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues (Details) - Schedule of timing of revenue recognition [Table]"
       }
      }
     },
     "localname": "RevenuesDetailsScheduleoftimingofrevenuerecognitionTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftimingofrevenuerecognitionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_RiskNeutralProbability": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk Neutral probability.",
        "label": "RiskNeutralProbability",
        "terseLabel": "Risk Neutral probability percentage"
       }
      }
     },
     "localname": "RiskNeutralProbability",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_RiskNeutralProbabilityOfGrossProfit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk neutral probability of gross profit.",
        "label": "RiskNeutralProbabilityOfGrossProfit",
        "terseLabel": "Risk neutral probability of gross profit percentage"
       }
      }
     },
     "localname": "RiskNeutralProbabilityOfGrossProfit",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_SalariesAndRelatedExpensesRelatedPartiesEmployedByTheGroup": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of salaries and related expenses.",
        "label": "SalariesAndRelatedExpensesRelatedPartiesEmployedByTheGroup",
        "terseLabel": "Salaries and related expenses- related parties employed by the Group"
       }
      }
     },
     "localname": "SalariesAndRelatedExpensesRelatedPartiesEmployedByTheGroup",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofshareholderandotherrelatedpartiesbenefitsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_SaleOfStockNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of stock name axis",
        "label": "SaleOfStockNameAxis",
        "terseLabel": "Sale Of Stock Name [Axis]"
       }
      }
     },
     "localname": "SaleOfStockNameAxis",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SaleOfStockNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SaleOfStockName [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameDomain",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_SalesOfPrintersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales of printers.",
        "label": "SalesOfPrintersMember",
        "terseLabel": "Sales of systems [Member]"
       }
      }
     },
     "localname": "SalesOfPrintersMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_ScheduleOfAcquisitionDateFairValueOfEachMajorClassOfConsiderationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of acquisition date fair value of each major class of consideration [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionDateFairValueOfEachMajorClassOfConsiderationAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfAcquisitionDateFairValueOfEachMajorClassOfConsiderationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfAcquisitionDateFairValueOfEachMajorClassOfConsiderationTableTextBlock",
        "terseLabel": "Schedule of assets acquired and liabilities assumed at the date of acquisition"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionDateFairValueOfEachMajorClassOfConsiderationTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAtTheDateOfAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of assets acquired and liabilities assumed at the date of acquisition [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAtTheDateOfAcquisitionAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAtTheDateOfAcquisitionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAtTheDateOfAcquisitionTableTextBlock",
        "terseLabel": "Schedule of assets acquired and liabilities assumed at the date of acquisition"
       }
      }
     },
     "localname": "ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAtTheDateOfAcquisitionTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_ScheduleOfBalancesWithRelatedPartiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of balances with related parties [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfBalancesWithRelatedPartiesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfBasicLossPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of basic loss per share [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfBasicLossPerShareAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfCashFlowsDerivedForTheGroupAsAResultOfTheAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of cash flows derived for the Group as a result of the acquisition [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowsDerivedForTheGroupAsAResultOfTheAcquisitionAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfClassificationAndLinkageTermsOfFinancialInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of classification and linkage terms of financial instruments [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfClassificationAndLinkageTermsOfFinancialInstrumentsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfComponentsOfCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of components of cash [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfCashAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfCompositionOfEmployeeBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of composition of employee benefits [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfCompositionOfEmployeeBenefitsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfCompositionOfEmployeeBenefitsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of composition of employee benefits.",
        "label": "ScheduleOfCompositionOfEmployeeBenefitsTableTextBlock",
        "terseLabel": "Schedule of composition of employee benefits"
       }
      }
     },
     "localname": "ScheduleOfCompositionOfEmployeeBenefitsTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_ScheduleOfCompositionOfIncomeTaxExpenseIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of composition of income tax expense (income) [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfCompositionOfIncomeTaxExpenseIncomeAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfContractAssetsAndContractLiabilitiesDerivingFromContractsWithCustomersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of contract assets and contract liabilities deriving from contracts with customers [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfContractAssetsAndContractLiabilitiesDerivingFromContractsWithCustomersAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfCostOfRevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of cost of revenues [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfCostOfRevenuesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfDetailsRegardingTheExchangeRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of details regarding the exchange rate [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfDetailsRegardingTheExchangeRateAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfEstimatedUsefulLivesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated useful lives [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLivesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfEstimatedUsefulLivesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfEstimatedUsefulLivesTableTextBlock",
        "terseLabel": "Schedule of estimated useful lives"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLivesTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_ScheduleOfFairValueOfFinancialInstrumentsPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value of financial instruments position [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfFinancialInstrumentsPositionAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfFairValueOfTheShareOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value of the share options [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfTheShareOptionsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfFurtherDetailOfProfitOrLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of further detail of profit or loss [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfFurtherDetailOfProfitOrLossAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfGroupsMaterialSubsidiariesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of group's material subsidiaries [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfGroupsMaterialSubsidiariesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfInventoryAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of inventory [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfInventoryAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfIssuedShareCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of issued share capital [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfIssuedShareCapitalAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfLeaseLiabilityAndRightOfUseAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of lease liability and right of use asset [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfLeaseLiabilityAndRightOfUseAssetAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfLevel3FinancialInstrumentsCarriedAtFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Level 3 financial instruments carried at fair value [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfLevel3FinancialInstrumentsCarriedAtFairValueAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfLiabilityInRespectOfGovernmentGrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of liability in respect of government grants [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfLiabilityInRespectOfGovernmentGrantsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfLossAttributableToOwnersOfTheCompanyDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of loss attributable to owners of the company (diluted) [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfLossAttributableToOwnersOfTheCompanyDilutedAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfMaturityAnalysisOfTheGroupsLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of maturity analysis of the group's lease liabilities [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfMaturityAnalysisOfTheGroupsLeaseLiabilitiesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfMovementInCarryingAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of movement in carrying amount [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfMovementInCarryingAmountAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfMovementInDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of movement in deferred tax assets and liabilities [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfMovementInDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfMovementInNetDefinedBenefitLiabilitiesAssetsAndInTheirComponentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of movement in net defined benefit liabilities (assets) and in their components [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfMovementInNetDefinedBenefitLiabilitiesAssetsAndInTheirComponentsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfMovementInNetDefinedBenefitLiabilitiesassetsAndInTheirComponentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Movement in net defined benefit liabilities (assets) and in their components.",
        "label": "ScheduleOfMovementInNetDefinedBenefitLiabilitiesassetsAndInTheirComponentsTableTextBlock",
        "terseLabel": "Schedule of movement in net defined benefit liabilities (assets) and in their components"
       }
      }
     },
     "localname": "ScheduleOfMovementInNetDefinedBenefitLiabilitiesassetsAndInTheirComponentsTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_ScheduleOfOtherPayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other payables [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfOtherPayablesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfOtherReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other receivables [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfOtherReceivablesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfPrincipalActuarialAssumptionsAtTheReportingDateExpressedAsWeightedAveragesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of principal actuarial assumptions at the reporting date (expressed as weighted averages) [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfPrincipalActuarialAssumptionsAtTheReportingDateExpressedAsWeightedAveragesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfPrincipalActuarialAssumptionsAtTheReportingDateexpressedAsWeightedAveragesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of principal actuarial assumptions at the reporting date (expressed as weighted averages).",
        "label": "ScheduleOfPrincipalActuarialAssumptionsAtTheReportingDateexpressedAsWeightedAveragesTableTextBlock",
        "terseLabel": "Schedule of principal actuarial assumptions at the reporting date (expressed as weighted averages)"
       }
      }
     },
     "localname": "ScheduleOfPrincipalActuarialAssumptionsAtTheReportingDateexpressedAsWeightedAveragesTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_ScheduleOfPropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of property plant and equipment, net [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfPropertyPlantAndEquipmentUsefulLifeSpanOfTheAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of property plant and equipment, useful life span of the assets [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentUsefulLifeSpanOfTheAssetsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfRepaymentDatesOfFinancialLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of repayment dates of financial liabilities [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfRepaymentDatesOfFinancialLiabilitiesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of revenue [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfRevenueAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfRevenuesPerGeographicalLocationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of revenues per geographical locations [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesPerGeographicalLocationsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfSensitivityAnalysisOfChangesInExchangeRateOfDollarAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of sensitivity analysis of changes in exchange rate of dollar [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfSensitivityAnalysisOfChangesInExchangeRateOfDollarAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfShareCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of share capital [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfShareCapitalAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfShareholderAndOtherRelatedPartiesBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of shareholder and other related parties benefits [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfShareholderAndOtherRelatedPartiesBenefitsAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfTheRelevantActuarialAssumptionsHoldingOtherAssumptionsConstantAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of the relevant actuarial assumptions, holding other assumptions constant [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfTheRelevantActuarialAssumptionsHoldingOtherAssumptionsConstantAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfTheRelevantActuarialAssumptionsHoldingOtherAssumptionsConstantWouldHaveAffectedTheDefinedBenefitObligationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of the relevant actuarial assumptions, holding other assumptions constant, would have affected the defined benefit obligation.",
        "label": "ScheduleOfTheRelevantActuarialAssumptionsHoldingOtherAssumptionsConstantWouldHaveAffectedTheDefinedBenefitObligationTableTextBlock",
        "terseLabel": "Schedule of the relevant actuarial assumptions, holding other assumptions constant"
       }
      }
     },
     "localname": "ScheduleOfTheRelevantActuarialAssumptionsHoldingOtherAssumptionsConstantWouldHaveAffectedTheDefinedBenefitObligationTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_ScheduleOfTimingOfRevenueRecognitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of timing of revenue recognition [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfTimingOfRevenueRecognitionAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfTradeReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of trade receivables [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfTradeReceivablesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfWeightedAverageNumberOfOrdinarySharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of weighted average number of ordinary shares [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfOrdinarySharesAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_ScheduleOfWeightedAverageNumberOfOrdinarySharesDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of weighted average number of ordinary shares (diluted) [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfOrdinarySharesDilutedAbstract",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nndm_SeriesAWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SeriesAWarrantsMember",
        "terseLabel": "Series A Warrants [Member]"
       }
      }
     },
     "localname": "SeriesAWarrantsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_SeriesBWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SeriesBWarrantsMember",
        "terseLabel": "Series B Warrants [Member]"
       }
      }
     },
     "localname": "SeriesBWarrantsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award fair value assumptions share price",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice",
        "terseLabel": "Range of share price (USD)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ShareBasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation shares authorized under stock options plans exercise price range lower range limit",
        "label": "ShareBasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeLowerRangeLimit",
        "terseLabel": "Range of exercise price (USD)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionsPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_ShareBasedPaymentDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment (Details) [Line Items]"
       }
      }
     },
     "localname": "ShareBasedPaymentDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ShareBasedPaymentDetailsScheduleoffairvalueoftheshareoptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment (Details) - Schedule of fair value of the share options [Line Items]"
       }
      }
     },
     "localname": "ShareBasedPaymentDetailsScheduleoffairvalueoftheshareoptionsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable00"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ShareBasedPaymentDetailsScheduleoffairvalueoftheshareoptionsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment (Details) - Schedule of fair value of the share options [Table]"
       }
      }
     },
     "localname": "ShareBasedPaymentDetailsScheduleoffairvalueoftheshareoptionsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0",
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable00"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ShareBasedPaymentDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment (Details) [Table]"
       }
      }
     },
     "localname": "ShareBasedPaymentDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ShareBasedPaymentExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ShareBasedPaymentExpense",
        "label": "ShareBasedPaymentExpense",
        "terseLabel": "Share-based payment expenses"
       }
      }
     },
     "localname": "ShareBasedPaymentExpense",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ShareBasedPaymentExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of share based payment expenses.",
        "label": "ShareBasedPaymentExpenses",
        "terseLabel": "Share based payment expenses (in Dollars)"
       }
      }
     },
     "localname": "ShareBasedPaymentExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ShareBasedPaymentExpensesSalesAndMarketingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based payment expenses sales and marketing expenses.",
        "label": "ShareBasedPaymentExpensesSalesAndMarketingExpenses",
        "terseLabel": "Share based payment expenses"
       }
      }
     },
     "localname": "ShareBasedPaymentExpensesSalesAndMarketingExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ShareBasedPaymentTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment (Tables) [Line Items]"
       }
      }
     },
     "localname": "ShareBasedPaymentTablesLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentTables"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ShareBasedPaymentTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment (Tables) [Table]"
       }
      }
     },
     "localname": "ShareBasedPaymentTablesTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentTables"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ShareBasedPaymentsExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "It represents of share based payments expenses.",
        "label": "ShareBasedPaymentsExpenses",
        "terseLabel": "Share based payment expenses"
       }
      }
     },
     "localname": "ShareBasedPaymentsExpenses",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ShareCapitalDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share capital description.",
        "label": "ShareCapitalDescription",
        "terseLabel": "Share capital description"
       }
      }
     },
     "localname": "ShareCapitalDescription",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ShareOptionProgramsExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ShareOptionProgramsExercisable",
        "terseLabel": "Share option programs, Exercisable as of December 31"
       }
      }
     },
     "localname": "ShareOptionProgramsExercisable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ShareOptionProgramsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Shares Option Exercised.",
        "label": "ShareOptionProgramsExercised",
        "terseLabel": "Share option programs, Exercised during the year"
       }
      }
     },
     "localname": "ShareOptionProgramsExercised",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ShareOptionProgramsForfeitedOrExpiredDuringTheYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share option programs, Forfeited or expired during the year.",
        "label": "ShareOptionProgramsForfeitedOrExpiredDuringTheYear",
        "negatedLabel": "Share option programs, Forfeited or expired during the year"
       }
      }
     },
     "localname": "ShareOptionProgramsForfeitedOrExpiredDuringTheYear",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ShareOptionProgramsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Shares Option Granted.",
        "label": "ShareOptionProgramsGranted",
        "terseLabel": "Share option programs, Granted during the year"
       }
      }
     },
     "localname": "ShareOptionProgramsGranted",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ShareOptionProgramsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ShareOptionProgramsOutstanding",
        "periodEndLabel": "Share option programs, Outstanding at December 31",
        "periodStartLabel": "Share option programs, Outstanding at January 1"
       }
      }
     },
     "localname": "ShareOptionProgramsOutstanding",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable0"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_ShareOptionsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options granted.",
        "label": "ShareOptionsGranted",
        "terseLabel": "Share options granted (in Shares)"
       }
      }
     },
     "localname": "ShareOptionsGranted",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_SharePremiumAndCapitalReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "SharePremiumAndCapitalReserves",
        "terseLabel": "Share premium and capital reserves"
       }
      }
     },
     "localname": "SharePremiumAndCapitalReserves",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_SharePriceDecreased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share price decreased.",
        "label": "SharePriceDecreased",
        "terseLabel": "Share price decreased percentage"
       }
      }
     },
     "localname": "SharePriceDecreased",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_SharePriceHadIncreased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share price had increased.",
        "label": "SharePriceHadIncreased",
        "terseLabel": "Share price had increased percentage"
       }
      }
     },
     "localname": "SharePriceHadIncreased",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_SharePriceProtectionForPreviewsShareholderOfSubsidiaryAcquired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share price protection for previews shareholders of subsidiary acquired.",
        "label": "SharePriceProtectionForPreviewsShareholderOfSubsidiaryAcquired",
        "terseLabel": "Share price protection for previews shareholders of subsidiary acquired"
       }
      }
     },
     "localname": "SharePriceProtectionForPreviewsShareholderOfSubsidiaryAcquired",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoffinancialinstrumentspositionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_SharePriceProtectionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share price protection period.",
        "label": "SharePriceProtectionPeriod",
        "terseLabel": "Share price protection period"
       }
      }
     },
     "localname": "SharePriceProtectionPeriod",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nndm_SharePriceProtectioninDollarsPerShare": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share price protection.",
        "label": "SharePriceProtectioninDollarsPerShare",
        "terseLabel": "Share price protection"
       }
      }
     },
     "localname": "SharePriceProtectioninDollarsPerShare",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term",
        "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm",
        "terseLabel": "Range of estimated life (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffairvalueoftheshareoptionsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "nndm_SharebasedPaymentArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SharebasedPaymentArrangementMember",
        "terseLabel": "Stock Compensation Plan [Member]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_SharebasedPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payments.",
        "label": "SharebasedPayments",
        "terseLabel": "Share-based payments"
       }
      }
     },
     "localname": "SharebasedPayments",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_ShareholdersLoanDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder\u2019s loan description.",
        "label": "ShareholdersLoanDescription",
        "terseLabel": "Shareholder\u2019s loan, description"
       }
      }
     },
     "localname": "ShareholdersLoanDescription",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_ShorttermGovernmentAuthorities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current liabilities in respect of government authorities.",
        "label": "ShorttermGovernmentAuthorities",
        "terseLabel": "Government authorities"
       }
      }
     },
     "localname": "ShorttermGovernmentAuthorities",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_SignificantAccountingPoliciesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SignificantAccountingPoliciesDetailsScheduleofestimatedusefullivesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of estimated useful lives [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofestimatedusefullivesLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SignificantAccountingPoliciesDetailsScheduleofestimatedusefullivesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of estimated useful lives [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofestimatedusefullivesTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SignificantAccountingPoliciesDetailsScheduleofpropertyplantandequipmentusefullifespanoftheassetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of property plant and equipment, useful life span of the assets [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofpropertyplantandequipmentusefullifespanoftheassetsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SignificantAccountingPoliciesDetailsScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) - Schedule of property plant and equipment, useful life span of the assets [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SignificantAccountingPoliciesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubContractorsCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "SubContractorsCosts",
        "terseLabel": "Subcontractors"
       }
      }
     },
     "localname": "SubContractorsCosts",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_SubsidiariesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) [Line Items]"
       }
      }
     },
     "localname": "SubsidiariesDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) - Schedule of acquisition date fair value of each major class of consideration [Line Items]"
       }
      }
     },
     "localname": "SubsidiariesDetailsScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationParentheticalsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) - Schedule of acquisition date fair value of each major class of consideration (Parentheticals) [Line Items]"
       }
      }
     },
     "localname": "SubsidiariesDetailsScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationParentheticalsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationParentheticalsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) - Schedule of acquisition date fair value of each major class of consideration (Parentheticals) [Table]"
       }
      }
     },
     "localname": "SubsidiariesDetailsScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationParentheticalsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable_Parentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) - Schedule of acquisition date fair value of each major class of consideration [Table]"
       }
      }
     },
     "localname": "SubsidiariesDetailsScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) - Schedule of assets acquired and liabilities assumed at the date of acquisition [Line Items]"
       }
      }
     },
     "localname": "SubsidiariesDetailsScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) - Schedule of assets acquired and liabilities assumed at the date of acquisition [Table]"
       }
      }
     },
     "localname": "SubsidiariesDetailsScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) - Schedule of cash flows derived for the Group as a result of the acquisition [Line Items]"
       }
      }
     },
     "localname": "SubsidiariesDetailsScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) - Schedule of cash flows derived for the Group as a result of the acquisition [Table]"
       }
      }
     },
     "localname": "SubsidiariesDetailsScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsScheduleofgroupsmaterialsubsidiariesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) - Schedule of group's material subsidiaries [Line Items]"
       }
      }
     },
     "localname": "SubsidiariesDetailsScheduleofgroupsmaterialsubsidiariesLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsScheduleofgroupsmaterialsubsidiariesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) - Schedule of group's material subsidiaries [Table]"
       }
      }
     },
     "localname": "SubsidiariesDetailsScheduleofgroupsmaterialsubsidiariesTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SubsidiariesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries (Details) [Table]"
       }
      }
     },
     "localname": "SubsidiariesDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/SubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_SupportServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SupportServicesMember",
        "terseLabel": "Support services [Member]"
       }
      }
     },
     "localname": "SupportServicesMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofrevenueTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_TaxDeductibleTemporaryDifferenceValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "TaxDeductibleTemporaryDifferenceValue",
        "terseLabel": "Tax deductible temporary difference value"
       }
      }
     },
     "localname": "TaxDeductibleTemporaryDifferenceValue",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_Technology": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology.",
        "label": "Technology",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "Technology",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_TechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TechnologyMember",
        "terseLabel": "Technology [Member]"
       }
      }
     },
     "localname": "TechnologyMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofmovementincarryingamountTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_TotalApprovedBudgetForDevelopmentProject": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total approved budget for development project.",
        "label": "TotalApprovedBudgetForDevelopmentProject",
        "terseLabel": "Total approved budget for development project (in Dollars)"
       }
      }
     },
     "localname": "TotalApprovedBudgetForDevelopmentProject",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_TotalOwnerLossAfterTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "TotalOwnerLossAfterTax",
        "totalLabel": "Loss attributable to owners"
       }
      }
     },
     "localname": "TotalOwnerLossAfterTax",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_TotalTradeReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total trade receivables.",
        "label": "TotalTradeReceivables",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "TotalTradeReceivables",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoftradereceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_TradeReceivablesnet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold.",
        "label": "TradeReceivablesnet",
        "terseLabel": "Trade receivables (net)"
       }
      }
     },
     "localname": "TradeReceivablesnet",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_TrademarkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TrademarkMember",
        "terseLabel": "Trademark [Member]"
       }
      }
     },
     "localname": "TrademarkMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofestimatedusefullivesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_TransactionsandbalanceswithrelatedpartiesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions and balances with related parties (Details) [Line Items]"
       }
      }
     },
     "localname": "TransactionsandbalanceswithrelatedpartiesDetailsLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_TransactionsandbalanceswithrelatedpartiesDetailsScheduleofbalanceswithrelatedpartiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions and balances with related parties (Details) - Schedule of balances with related parties [Line Items]"
       }
      }
     },
     "localname": "TransactionsandbalanceswithrelatedpartiesDetailsScheduleofbalanceswithrelatedpartiesLineItems",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofbalanceswithrelatedpartiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_TransactionsandbalanceswithrelatedpartiesDetailsScheduleofbalanceswithrelatedpartiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions and balances with related parties (Details) - Schedule of balances with related parties [Table]"
       }
      }
     },
     "localname": "TransactionsandbalanceswithrelatedpartiesDetailsScheduleofbalanceswithrelatedpartiesTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofbalanceswithrelatedpartiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_TransactionsandbalanceswithrelatedpartiesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions and balances with related parties (Details) [Table]"
       }
      }
     },
     "localname": "TransactionsandbalanceswithrelatedpartiesDetailsTable",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_TravelAbroad": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses for travel.",
        "label": "TravelAbroad",
        "terseLabel": "Travel abroad"
       }
      }
     },
     "localname": "TravelAbroad",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleoffurtherdetailofprofitorlossTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_TwoThousandThirtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TwoThousandThirtyMember",
        "terseLabel": "2030 [Member]"
       }
      }
     },
     "localname": "TwoThousandThirtyMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_TwoThousandTwentyTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TwoThousandTwentyTwoMember",
        "terseLabel": "2022 [Member]"
       }
      }
     },
     "localname": "TwoThousandTwentyTwoMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_TypeOfCurrenciesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TypeOfCurrenciesAxis",
        "terseLabel": "Type of Currencies [Axis]"
       }
      }
     },
     "localname": "TypeOfCurrenciesAxis",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_TypeOfCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TypeOfCurrencies [Domain]"
       }
      }
     },
     "localname": "TypeOfCurrenciesDomain",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_UnderwritersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UnderwritersMember",
        "terseLabel": "Underwriters [Member]"
       }
      }
     },
     "localname": "UnderwritersMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_UnitedStateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UnitedStateMember",
        "terseLabel": "U.S. dollar [Member]"
       }
      }
     },
     "localname": "UnitedStateMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofclassificationandlinkagetermsoffinancialinstrumentsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_UnrestrictedBankDeposits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "UnrestrictedBankDeposits",
        "terseLabel": "Unrestricted bank deposits"
       }
      }
     },
     "localname": "UnrestrictedBankDeposits",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/CashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_VotingInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voting interests percentage.",
        "label": "VotingInterests",
        "terseLabel": "Voting interests percentage"
       }
      }
     },
     "localname": "VotingInterests",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EventsafterthereportingdateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_WarrantInvestTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant invest term.",
        "label": "WarrantInvestTerm",
        "terseLabel": "Warrants investing condition, description"
       }
      }
     },
     "localname": "WarrantInvestTerm",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_Warrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants.",
        "label": "Warrants",
        "terseLabel": "Consideration for warrants (in Dollars)"
       }
      }
     },
     "localname": "Warrants",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nndm_WarrantsExercisableTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants exercisable term.",
        "label": "WarrantsExercisableTerm",
        "terseLabel": "Warrants exercisable term"
       }
      }
     },
     "localname": "WarrantsExercisableTerm",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nndm_WarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants",
        "label": "WarrantsMember",
        "terseLabel": "Warrants [Member]"
       }
      }
     },
     "localname": "WarrantsMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_WarrantsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage warrants.",
        "label": "WarrantsPercentage",
        "terseLabel": "Warrants percentage"
       }
      }
     },
     "localname": "WarrantsPercentage",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nndm_WarrantsToPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WarrantsToPurchase",
        "terseLabel": "Warrants to purchase"
       }
      }
     },
     "localname": "WarrantsToPurchase",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_WeightedAverageExercisePriceOfShareOptionsGrantedInPeriodSharebasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price Of Share Options Granted In Period Sharebased Payment Arrangement",
        "label": "WeightedAverageExercisePriceOfShareOptionsGrantedInPeriodSharebasedPaymentArrangement",
        "terseLabel": "Exercise price per share (in Dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInPeriodSharebasedPaymentArrangement",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "nndm_WeightedAverageNumberOfOrdinaryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WeightedAverageNumberOfOrdinaryShares",
        "terseLabel": "Balance as at January 1"
       }
      }
     },
     "localname": "WeightedAverageNumberOfOrdinaryShares",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_WeightedAverageNumberOfOrdinarySharesUsedToCalculateBasicEarningsLossPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WeightedAverageNumberOfOrdinarySharesUsedToCalculateBasicEarningsLossPerShare",
        "terseLabel": "Weighted average number of Ordinary Shares used to calculate basic loss per share as at December 31"
       }
      }
     },
     "localname": "WeightedAverageNumberOfOrdinarySharesUsedToCalculateBasicEarningsLossPerShare",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_WeightedAverageNumberOfOrdinarySharesUsedToCalculateDilutedLossPerShareAsAtDec": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average number of Ordinary Shares used to calculate diluted loss per share.",
        "label": "WeightedAverageNumberOfOrdinarySharesUsedToCalculateDilutedLossPerShareAsAtDec",
        "terseLabel": "Weighted average number of Ordinary Shares used to calculate diluted loss per share as at December 31"
       }
      }
     },
     "localname": "WeightedAverageNumberOfOrdinarySharesUsedToCalculateDilutedLossPerShareAsAtDec",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesdilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_WeightedAverageNumberOfOrdinarySharesUsedToCalculateLossPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average number of Ordinary Shares used to calculate loss per share.",
        "label": "WeightedAverageNumberOfOrdinarySharesUsedToCalculateLossPerShare",
        "terseLabel": "Weighted average number of Ordinary Shares used to calculate loss per share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfOrdinarySharesUsedToCalculateLossPerShare",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofweightedaveragenumberofordinarysharesdilutedTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "nndm_WeightedAverageNumberOfOrdinarySharesdilutedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average number of ordinary shares (diluted).",
        "label": "WeightedAverageNumberOfOrdinarySharesdilutedTableTextBlock",
        "terseLabel": "Schedule of weighted average number of ordinary shares (diluted)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfOrdinarySharesdilutedTableTextBlock",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nndm_YoavSternMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "YoavSternMember",
        "terseLabel": "Yoav Stern [Member]"
       }
      }
     },
     "localname": "YoavSternMember",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nndm_nontradableRightsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-tradable rights exercise price",
        "label": "nontradableRightsExercisePrice",
        "terseLabel": "Non-tradable rights exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "nontradableRightsExercisePrice",
     "nsuri": "http://www.Nanodimensionltd.com/20211231",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/EquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable_Parentheticals",
      "http://www.Nanodimensionltd.com/role/ScheduleofassetsacquiredandliabilitiesassumedatthedateofacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable",
      "http://www.Nanodimensionltd.com/role/ScheduleofgroupsmaterialsubsidiariesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofacquisitiondatefairvalueofeachmajorclassofconsiderationTable_Parentheticals",
      "http://www.Nanodimensionltd.com/role/ScheduleofcashflowsderivedfortheGroupasaresultoftheacquisitionTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofcomponentsofcashTable"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officer [Member]",
        "terseLabel": "Officer [Member]"
       }
      }
     },
     "localname": "OfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/TransactionsandbalanceswithrelatedpartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/LiabilityinRespectofGovernmentGrantsDetails",
      "http://www.Nanodimensionltd.com/role/ScheduleofpropertyplantandequipmentusefullifespanoftheassetsTable",
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ShareBasedPaymentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Loss per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability in Respect of Government Grants [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails",
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.Nanodimensionltd.com/role/FinancialInstrumentsDetails",
      "http://www.Nanodimensionltd.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r1": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r10": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r100": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r101": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r102": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Section": "Disclosures",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2021-03-24"
  },
  "r103": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r104": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r105": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r106": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r107": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r108": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r109": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r11": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r110": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r111": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r112": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r113": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "67",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r114": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r115": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r116": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2021-03-24"
  },
  "r117": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r118": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r119": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r12": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r120": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r121": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r122": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r123": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "86",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_86_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r124": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "87",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_87&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r125": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "89",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_89&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r126": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Section": "Example 1 Warranties",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex1__IAS37_IE_C_ex1_TI",
   "URIDate": "2021-03-24"
  },
  "r127": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r128": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r129": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r13": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r130": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r131": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r132": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r133": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r134": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r135": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2021-03-24"
  },
  "r136": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r137": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r138": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r139": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r14": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r140": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r141": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r142": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r143": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r144": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r145": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r146": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r147": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r148": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r149": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r15": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r150": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r151": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "40",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_40_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r152": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r153": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r154": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI",
   "URIDate": "2021-03-24"
  },
  "r155": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "8",
   "Section": "Accounting policies",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=8&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS08_g7-31_TI",
   "URIDate": "2021-03-24"
  },
  "r156": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r157": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r158": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r159": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r16": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r160": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "IG63",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG63&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r161": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "10",
   "Paragraph": "22",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r162": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r163": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r164": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r165": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r166": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r167": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r168": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r169": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r17": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r170": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r171": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r172": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r173": {
   "Clause": "ix",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r174": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r175": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r176": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r177": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r178": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r179": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r18": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r180": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r181": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r182": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r183": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r184": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r185": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r186": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r187": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "105",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r188": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r189": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "114",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r19": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r190": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "115",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r191": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "116",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_116_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r192": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r193": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r194": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r195": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r196": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r197": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r198": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r199": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r2": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r20": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "m",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_m&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r200": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "57",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_57&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r201": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "94",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r202": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "97",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r203": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2021-03-24"
  },
  "r204": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Section": "Presentation",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2021-03-24"
  },
  "r205": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "44",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r206": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r207": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r208": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r209": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r21": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r210": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r211": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r212": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r213": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r214": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r215": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "j",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_j_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r216": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "m",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r217": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r218": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r219": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r22": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_q&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r220": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r221": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "IE72",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r222": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r223": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r224": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r225": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r226": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r227": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r228": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35K",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r229": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r23": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_r&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r230": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r231": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35N",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r232": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "36",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r233": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r234": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r235": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r236": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r237": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r238": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG31A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r239": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Hedge accounting",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS07_g21A-24G_TI",
   "URIDate": "2021-03-24"
  },
  "r24": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r240": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r241": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r242": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r243": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r244": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r245": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r246": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r247": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r248": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r249": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r25": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "56",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r250": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r251": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r252": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r253": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r254": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r255": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r256": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r257": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r258": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r259": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r26": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r260": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r261": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_e&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r262": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_a&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r263": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "8",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_c&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r264": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG28",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_d&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r265": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r266": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r267": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r268": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r269": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r27": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r270": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r271": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r272": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r273": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r274": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r28": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r29": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r3": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "104",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r30": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "68",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r31": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r32": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "70",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r33": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r34": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r35": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r36": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r37": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r38": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r39": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r4": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r40": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r41": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r42": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r43": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r44": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r45": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r46": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r47": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r48": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r49": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r5": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r50": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r51": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r52": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "98",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_98_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r53": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r54": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "21",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_21_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r55": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "21",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r56": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Paragraph": "22",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r57": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2021-03-24"
  },
  "r58": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r59": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r6": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r60": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r61": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r62": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r63": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r64": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r65": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r66": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2021-03-24"
  },
  "r67": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r68": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r69": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r7": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r70": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r71": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r72": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r73": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r74": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "77",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_77_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r75": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "79",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_79_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r76": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2021-03-24"
  },
  "r77": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r78": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r79": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_142_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r8": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r80": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_142_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r81": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r82": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "144",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r83": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r84": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "148",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_148_d_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r85": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "5",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_5&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r86": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r87": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "9",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r88": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Section": "Scope",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI",
   "URIDate": "2021-03-24"
  },
  "r89": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r9": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r90": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r91": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r92": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI",
   "URIDate": "2021-03-24"
  },
  "r93": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "20",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=20&code=ifrs-tx-2021-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r94": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "20",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=20&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS20_g39-39_TI",
   "URIDate": "2021-03-24"
  },
  "r95": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r96": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r97": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r98": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r99": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_a&doctype=Standard",
   "URIDate": "2021-03-24"
  }
 },
 "version": "2.1"
}
